1) Louis DN et al : WHO classification of Tumors of the Central Nervous System, ed Rivised 4th edition. Lyon : International Agency For Research On Center, 2016
脳神経外科学レビュー 2023-’24
特記事項：
商品紹介
脳神経外科学分野のエキスパートによって厳選された、直近に国内外で発表された最新の文献レビューです。
広く脳神経外科学関連の最近のトピックスを把握でき、専門医だけでなく、専門医を目指す方にも必携の1冊です。
目次
- I章 脳腫瘍
1．WHO中枢神経系腫瘍病理分類第5版とcIMPACT-NOW update
2．Diffuse midline glioma
3．小児悪性脳腫瘍の分類と展望
4．グリオーマ遺伝子解析update
5．脊椎・脊髄腫瘍update
6．良性脳腫瘍の遺伝子解析と治療
7．下垂体腫瘍のWHO2022新分類
II章 脳血管障害
8．脳血管障害と遺伝子
9．未破裂脳動脈瘤の自然歴と治療
10．脳血管奇形の治療
11．もやもや病の治療
12．硬膜動静脈瘻
13．脳梗塞急性期と慢性期の抗血小板療法
14．脳卒中の再発予防のための抗凝固療法
15．脳卒中の医療提供体制と地域，施設間連携
16．血管内再開通療法
17．脳動脈瘤塞栓術（Coil，WEB 他）
18．脳動脈瘤に対するフローダイバーター治療
19．頚動脈狭窄に対するCEAとCAS
20．脳卒中の予防（高血圧、高脂血症 他）
III章 脳外傷
21．重症頭部外傷（最近の治療）
22．スポーツによる脳振盪（sports related concussion：SRC）
23．児童虐待
24．外傷に伴う高次脳機能障害
IV章 定位・機能
25．てんかんの診断と治療
26．ニューロモデュレーション
27．パーキンソン病・不随意運動の治療
28．FUS治療の現状と将来
29．痙縮の治療
30．定位的放射線治療の現状と展望
V章 小 児
31．脊髄髄膜瘤（胎児手術を含めた最近の進歩）
32．脊髄脂肪腫
33．頭蓋内嚢胞性病変
VI章 脊髄・脊椎・末梢神経
34．椎間板治療の現状（椎間板内酵素注入療法と椎間板再生）
35．脊椎脊髄外科におけるロボット手術
36．骨粗鬆症性椎体骨折の治療戦略と現在の課題
37．FESS（full-endoscopic spine surgery）
38．脊髄・脊椎領域におけるexoscope
39．脊髄・脊椎の画像診断
VII章 水頭症
40．正常圧水頭症 診断と治療
41．小児の水頭症
VIII章 感染症
42．脳炎・髄膜炎
43．脳膿瘍
IX章 神経科学
44．多能性幹細胞を用いた神経再生医療
45．脳卒中に対する細胞療法
46．グリオーマに対する新規分子標的薬
47．鏡視下手術の展望
48．脳機能解析
49．遺伝子治療
X章 手術・手技
50．神経内視鏡
51．定位放射線治療
52．手術用顕微鏡と3D外視鏡の進化
53．術中蛍光診断技術
54．ハイブリッド手術室と術中画像診断
55．術中ナビゲーション
56．術中モニタリング
XI章 画像診断
57．画像診断と人工知能
58．MRIの最新情報
59．血流と髄液動態のMRI
60．核医学検査の最新情報
61．術前シミュレーション画像
この書籍の参考文献
参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。
本参考文献は電子書籍掲載内容を元にしております。
I章 脳腫瘍
P.2 掲載の参考文献
P.3 掲載の参考文献
2) Sonoda Y, Yokoo H, Tanaka S et al : Practical procedures for the integrated diagnosis of astrocytic and oligodendroglial tumors. Brain Tumor Pathol 36 : 56-62, 2019
3) Louis DN, Wesseling P, Paulus W et al : cIMPACT-NOW update 1 : Not otherwise specified (NOS) and not elsewhere classified (NEC). Acta Neuropathol 135 : 481-484. 2018
4) Louis DN, Giannini C, Capper D et al : cIMPACT-NOW update 2 : diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant. Acta Neuropathol 135 : 639-642, 2018
P.4 掲載の参考文献
5) Brat DJ, Aldape K, Colman H et al : cIMPACT-NOW update 3 : recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV". Acta Neuropathol 136 : 805-810, 2018
6) Ellison DW, Hawkins C, Jones DTW et al : cIMPACT-NOW update 4 : diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAFV600E mutation. Acta Neuropathol 137 : 683-687, 2019
P.5 掲載の参考文献
7) Brat DJ, Aldape K, Colman H et al : cIMPACT-NOW update 5 : recommended grading criteria and terminologies for IDH-mutant astrocytomas. Acta Neuropathol 139 : 603-608, 2020
8) Louis DN, Wesseling P, Aldape K et al : cIMPACT-NOW update 6 : new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. Brain Pathol 30 : 844-856, 2020
9) Ellison DW, Aldape KD, Capper D et al : cIMPACT-NOW update 7 : advancing the molecular classification of ependymal tumors. Brain Pathol 30 : 863-866, 2020
10) WHO classification of tumors editorial board : WHO classification of Tumors of the Central Nervous System, 5th edition. Lyon : IARC Press, 2021
11) Louis DN, Perry A, Wesseling P et al : The 2021 WHO Classification of Tumors of the Central Nervous System : a summary. Neuro Oncol 23, 1231-1251, 2021
P.10 掲載の参考文献
1) Louis DN, Perry A, Wesseling P et al : The 2021 WHO Classification of Tumors of the Central Nervous System : a summary. Neuro Oncol 23 : 1231-1251, 2021
P.11 掲載の参考文献
2) Hubner JM, Muller T, Papageorgiou DN et al : EZHIP/CXorf67 mimics K27M mutated oncohistones and functions as an intrinsic inhibitor of PRC2 function in aggressive posterior fossa ependymoma. Neuro Oncol 21 : 878-889, 2019
3) Jain SU, Do TJ, Lund PJ et al : PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism. Nat Commun 10 : 2146, 2019
4) Castel D, Kergrohen T, Tauziede-Espariat A et al : Histone H3 wildtype DIPG/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation. Acta Neuropathol 139 : 1109-1113, 2020
P.12 掲載の参考文献
5) Mondal G, Lee JC, Ravindranathan A et al : Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition. Acta Neuropathol 139 : 1071-1088, 2020
6) Sievers P, Sill M, Schrimpf D et al : A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR. Neuro Oncol 23 : 34-43, 2021
P.13 掲載の参考文献
7) Schulte JD, Buerki RA, Lapointe S et al : Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults. Neurooncol Adv 2 : vdaa142, 2020
8) Grimaldi S, Harlay V, Appay R et al : Adult H3K27M mutated thalamic glioma patients display a better prognosis than unmutated patients. J Neurooncol 156 : 615-623, 2022
9) Chai RC, Zhang YW, Liu YQ et al : The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation. Acta Neuropathol Commun 8 : 40, 2020
10) Cheng L, Wang L, Yao Q et al : Clinicoradiological characteristics of primary spinal cord H3 K27M-mutant diffuse midline glioma. J Neurosurg Spine doi : 10.3171/2021.4.SPINE2140, 2021 [online ahead of print]
11) Wang YZ, Zhang YW, Liu WH et al : Spinal cord diffuse midline gliomas with H3 K27m-mutant : clinicopathological features and prognosis. Neurosurgery 89 : 300-307, 2021
12) Yi S, Choi S, Shin DA et al : Impact of H3.3 K27M mutation on prognosis and survival of grade IV spinal cord glioma on the basis of new 2016 World Health Organization Classification of the Central Nervous System. Neurosurgery 84 : 1072-1081, 2019
13) Akinduro OO, Garcia DP, Higgins DMO et al : A multicenter analysis of the prognostic value of histone H3 K27M mutation in adult high-grade spinal glioma. J Neurosurg Spine 35 : 834-843, 2021
14) Yao J, Wang L, Ge H et al : Diffuse midline glioma with H3 K27M mutation of the spinal cord : a series of 33 cases. Neuropathology 41 : 183-190, 2021
15) Ishi Y, Takamiya S, Seki T et al : Prognostic role of H3K27M mutation, histone H3K27 methylation status, and EZH2 expression in diffuse spinal cord gliomas. Brain Tumor Pathol 37 : 81-88, 2020
P.14 掲載の参考文献
16) Castel D, Philippe C, Kergrohen T et al : Transcriptomic and epigenetic profiling of 'diffuse midline gliomas, H3 K27M-mutant' discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location. Acta Neuropathol Commun 6 : 117, 2018
17) Williams JR, Young CC, Vitanza NA et al : Progress in diffuse intrinsic pontine glioma : advocating for stereotactic biopsy in the standard of care. Neurosurg Focus 48 : E4, 2020
18) Azad TD, Jin MC, Bernhardt LJ et al : Liquid biopsy for pediatric diffuse midline glioma : a review of circulating tumor DNA and cerebrospinal fluid tumor DNA. Neurosurg Focus 48 : E9, 2020
19) Pan C, Diplas BH, Chen X et al : Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA. Acta Neuropathol 137 : 297-306, 2019
20) On J, Natsumeda M, Watanabe J et al : Low detection rate of H3K27M mutations in cerebrospinal fluid obtained from lumbar puncture in newly diagnosed diffuse midline gliomas. Diagnostics (Basel) 11 : 681, 2021
21) Li D, Bonner ER, Wierzbicki K et al : Standardization of the liquid biopsy for pediatric diffuse midline glioma using ddPCR. Sci Rep 11 : 5098, 2021
22) Chen H, Hu W, He H et al : Noninvasive assessment of H3 K27M mutational status in diffuse midline gliomas by using apparent diffusion coefficient measurements. Eur J Radiol 114 : 152-159, 2019
23) Su X, Chen N, Sun H et al : Automated machine learning based on radiomics features predicts H3 K27M mutation in midline gliomas of the brain. Neuro Oncol 22 : 393-401, 2020
24) Leach JL, Roebker J, Schafer A et al : MR imaging features of diffuse intrinsic pontine glioma and relationship to overall survival : report from the International DIPG Registry. Neuro Oncol 22 : 1647-1657, 2020
25) Chi AS, Tarapore RS, Hall MD et al : Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201. J Neurooncol 145 : 97-105, 2019
P.15 掲載の参考文献
26) Persson ML, Douglas AM, Alvaro F et al : The intrinsic and microenvironmental features of diffuse midline glioma ; implications for the development of effective immunotherapeutic treatment strategies. Neuro Oncol doi : 10.1093/neuonc/noac117, 2022 [online ahead of print]
27) Majzner RG, Ramakrishna S, Yeom KW et al : GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas. Nature 603 : 934-941, 2022
28) de Billy E, Pellegrino M, Orlando D et al : Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant. Neuro Oncol 24 : 1150-1163, 2022
29) Mueller S, Taitt JM, Villanueva-Meyer JE et al : Mass cytometry detects H3.3K27-Mspecific vaccine responses in diffuse midline glioma. J Clin Invest 130 : 6325-6337, 2020
30) Gallego Perez-Larraya J, Garcia-Moure M, Labiano S et al : Oncolytic DNX-2401 virus for pediatric diffuse intrinsic pontine glioma. N Engl J Med 386 : 2471-2481, 2022
P.16 掲載の参考文献
1) WHO classification of tumours editorial board : WHO classification of Tumors of the Central Nervous System, 5th edition. Lyon : IARC Press, 2021
2) Louis DN, Perry A, Wesseling P et al : The 2021 WHO Classification of Tumors of the Central Nervous System : a summary. Neuro Oncol 23 : 1231-1251, 2021
P.17 掲載の参考文献
3) Bale TA, Rosenblum MK : The 2021 WHO Classification of Tumors of the Central Nervous System : an update on pediatric low-grade gliomas and glioneuronal tumors. Brain Pathol 32 : e13060, 2022
4) Chiang J, Harreld JH, Tinkle CL et al : A single-center study of the clinicopathologic correlates of gliomas with a MYB or MYBL1 alteration. Acta Neuropathol 138 : 1091-1092, 2019
P.18 掲載の参考文献
5) Huse JT, Snuderl M, Jones DT et al : Polymorphous low-grade neuroepithelial tumor of the young (PLNTY) : an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway. Acta Neuropathol 133 : 417-429, 2017
6) Gupta R, Lucas CG, Wu J et al : Low-grade glioneuronal tumors with FGFR2 fusion resolve into a single epigenetic group corresponding to 'Polymorphous low-grade neuroepithelial tumor of the young'. Acta Neuropathol 142 : 595-599, 2021
P.19 掲載の参考文献
7) Wen PY, Stein A, van den Bent M et al : Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR) : a multicentre, open-label, single-arm, phase 2, basket trial. Lancet Oncol 23 : 53-64, 2022
8) Fangusaro J, Onar-Thomas A, Young Poussaint T et al : Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma : a multicentre, phase 2 trial. Lancet Oncol 20 : 1011-1022, 2019
9) Fangusaro J, Onar-Thomas A, Poussaint TY et al : A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1 : a Pediatric Brain Tumor Consortium study. Neuro Oncol 23 : 1777-1788, 2021
P.20 掲載の参考文献
10) Guerreiro Stucklin AS, Ryall S, Fukuoka K et al : Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas. Nat Commun 10 : 4343, 2019
11) Desai AV, Robinson GW, Gauvain K et al : Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1 or ALK aberrations (STARTRK-NG). Neuro Oncol doi : 10.1093/neuonc/noac087, 2022 [online ahead of print]
12) Doz F, van Tilburg CM, Geoerger B et al : Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors. Neuro Oncol 24 : 997-1007, 2022
P.21 掲載の参考文献
13) Sharma T, Schwalbe EC, Williamson D et al : Second-generation molecular subgrouping of medulloblastoma : an international meta-analysis of Group 3 and Group 4 subtypes. Acta Neuropathol 138 : 309-326, 2019
14) Michalski JM, Janss AJ, Vezina LG et al : Children's oncology group phase III trial of reduced-dose and reduced-volume radiotherapy with chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 39 : 2685-2697, 2021
15) Leary SES, Packer RJ, Li Y et al : Efficacy of carboplatin and isotretinoin in children with high-risk medulloblastoma : a randomized clinical trial from the children's oncology group. JAMA Oncol 7 : 1313-1321, 2021
P.23 掲載の参考文献
16) Sonehara K, Kimura Y, Nakano Y et al : A common deletion at BAK1 reduces enhancer activity and confers risk of intracranial germ cell tumors. Nat Commun 13 : 4478, 2022
P.24 掲載の参考文献
1) Korber V, Yang J, Barah P et al : Evolutionary trajectories of IDHWT glioblastomas reveal a common path of early tumorigenesis instigated years ahead of initial diagnosis. Cancer Cell 35 : 692-704.e612, 2019
P.25 掲載の参考文献
2) Barthel FP, Johnson KC, Varn FS et al : Longitudinal molecular trajectories of diffuse glioma in adults. Nature 576 : 112-120, 2019
3) Umehara T, Arita H, Yoshioka E et al : Distribution differences in prognostic copy number alteration profiles in IDH-wildtype glioblastoma cause survival discrepancies across cohorts. Acta Neuropathol Commun 7 : 99, 2019
6) Fujimoto K, Arita H, Satomi K et al : TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma. Acta Neuropathol 142 : 323-338, 2021
7) Arita H, Matsushita Y, Machida R et al : TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations. Acta Neuropathol Commun 8 : 201, 2020
P.26 掲載の参考文献
8) Zhang Y, Lucas CG, Young JS et al : Prospective genomically-guided identification of 'early/evolving' and 'undersampled' IDH-wildtype glioblastoma leads to improved clinical outcomes. Neuro Oncol doi : 10.1093/neuonc/noac089, 2022 [online ahead of print]
9) Berzero G, Di Stefano AL, Ronchi S et al : IDH-wildtype lower-grade diffuse gliomas : the importance of histological grade and molecular assessment for prognostic stratification. Neuro Oncol 23 : 955-966, 2021
P.27 掲載の参考文献
10) Patel AP, Tirosh I, Trombetta JJ et al : Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344 : 1396-1401, 2014
11) Tirosh I, Venteicher AS, Hebert C et al : Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma. Nature 539 : 309-313, 2016
12) Venteicher AS, Tirosh I, Hebert C et al : Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq. Science 355 : eaai8478, 2017
13) Filbin MG, Tirosh I, Hovestadt V et al : Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq. Science 360 : 331-335, 2018
14) Neftel C, Laffy J, Filbin MG et al : An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell 178 : 835-849. e21, 2019
15) Chaligne R, Gaiti F, Silverbush D et al : Epigenetic encoding, heritability and plasticity of glioma transcriptional cell states. Nature Genet 53 : 1469-1479, 2021
16) Johnson KC, Anderson KJ, Courtois ET et al : Single-cell multimodal glioma analyses identify epigenetic regulators of cellular plasticity and environmental stress response. Nature Genet 53 : 1456-1468, 2021
P.28 掲載の参考文献
17) Gojo J, Englinger B, Jiang L et al : Single-cell RNA-seq reveals cellular hierarchies and impaired developmental trajectories in pediatric ependymoma. Cancer Cell 38 : 44-59.e49, 2020
18) Suzuki H, Kumar SA, Shuai S et al : Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma. Nature 574 : 707-711, 2019
P.30 掲載の参考文献
1) Louis DN, Perry A, Wesseling P et al : The 2021 WHO Classification of Tumors of the Central Nervous System : a summary. Neuro Oncol 23 : 1231-1251, 2021
2) Chai RC, Zhang YW, Liu YQ et al : The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation. Acta Neuropathol Commun 8 : 40, 2020
P.31 掲載の参考文献
3) Pang B, Chai RC, Zhang YW et al : A comprehensive model including preoperative peripheral blood inflammatory markers for prediction of the prognosis of diffuse spinal cord astrocytoma following surgery. Eur Spine J 30 : 2857-2866, 2021
4) Gu Q, Huang Y, Zhang H et al : Case report : five adult cases of H3K27-altered diffuse midline glioma in the spinal cord. Front Oncol 11 : 701113, 2021
5) Perwein T, Benesch M, Kandels D et al : High frequency of disease progression in pediatric spinal cord low-grade glioma (LGG) : management strategies and results from the German LGG study group. Neuro Oncol 23 : 1148-1162, 2021
P.32 掲載の参考文献
6) Nunna RS, Khalid S, Behbahani M et al : Pediatric primary high-grade spinal glioma : a National Cancer Database analysis of current patterns in treatment and outcomes. Childs Nerv Syst 37 : 185-193, 2021
P.33 掲載の参考文献
7) Ruda R, Bruno F, Pellerino A et al : Ependymoma : evaluation and management updates. Curr Oncol Rep doi : 10.1007/s11912-022-01260-w, 2022 [online ahead of print]
8) Ghasemi DR, Sill M, Okonechnikov K et al : MYCN amplification drives an aggressive form of spinal ependymoma. Acta Neuropathol 138 : 1075-1089, 2019
9) Goyal A, Rinaldo L, Alkhataybeh R et al : Clinical presentation, natural history and outcomes of intramedullary spinal cord cavernous malformations. J Neurol Neurosurg Psychiatry 90 : 695-703, 2019
P.34 掲載の参考文献
10) Nagoshi N, Tsuji O, Nakashima D et al : Clinical outcomes and prognostic factors for cavernous hemangiomas of the spinal cord : a retrospective cohort study. J Neurosurg Spine 31 : 271-278, 2019
11) Etli MU, Sarikaya C, Onen MR et al : Spinal hemangioblastomas and neuropathic pain. World Neurosurg 149 : e780-e784, 2021
12) Cvek J, Knybel L, Reguli S et al : Stereotactic radiotherapy for spinal hemangioblastoma-disease control and volume analysis in long-term follow up. Rep Pract Oncol Radiother 27 : 134-141, 2022
P.35 掲載の参考文献
13) Mori Y : Stereotactic radiotherapy for intramedullary spinal lesions. International Medicine 3 : 158-163, 2021
14) Maiuri F, Del Basso De Caro M, de Divitiis O et al : Recurrence of spinal meningiomas : analysis of the risk factors. Br J Neurosurg 34 : 569-574, 2020
15) Kwee LE, Harhangi BS, Ponne GA et al : Spinal meningiomas : treatment outcome and long-term follow-up. Clin Neurol Neurosurg 198 : 106238, 2020
P.38 掲載の参考文献
1) Louis DN, Perry A, Wesseling P et al : The 2021 WHO Classification of Tumors of the Central Nervous System : a summary. Neuro Oncol 23 : 1231-1251, 2021
2) Nassiri F, Mamatjan Y, Suppiah S et al : DNA methylation profiling to predict recurrence risk in meningioma : development and validation of a nomogram to optimize clinical management. Neuro Oncol 21 : 901-910, 2019
3) Driver J, Hoffman SE, Tavakol S et al : A molecularly integrated grade for meningioma. Neuro Oncol 24 : 796-808, 2022
P.39 掲載の参考文献
4) Rogers CL, Won M, Vogelbaum MA et al : High-risk meningioma : initial outcomes from NRG Oncology/RTOG 0539. Int J Radiat Oncol Biol Phys 106 : 790-799, 2020
5) Goldbrunner R, Stavrinou P, Jenkinson MD et al : EANO guideline on the diagnosis and management of meningiomas. Neuro Oncol 23 : 1821-1834, 2021
6) Oya S, Ikawa F, Ichihara N et al : Effect of adjuvant radiotherapy after subtotal resection for WHO grade I meningioma : a propensity score matching analysis of the Brain Tumor Registry of Japan. J Neurooncol 153 : 351-360, 2021
7) Takai S, Wanibuchi M, Kawabata S et al : Reactor-based boron neutron capture therapy for 44 cases of recurrent and refractory high-grade meningiomas with long-term follow-up. Neuro Oncol 24 : 90-98, 2022
P.40 掲載の参考文献
8) Graillon T, Sanson M, Campello C et al : Everolimus and octreotide for patients with recurrent meningioma : results from the phase II CEVOREM trial. Clin Cancer Res 26 : 552-557, 2020
9) Mirian C, Duun-Henriksen AK, Juratli T et al : Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification : an individual patient data meta-analysis. J Neurology Neurosurg Psychiatry 91 : 378-387, 2019
10) Spiegl-Kreinecker S, Lotsch D, Neumayer K et al : TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma. Neuro Oncol 20 : 1584-1593, 2018
11) Yeung J, Yaghoobi V, Aung TN et al : Spatially resolved and quantitative analysis of the immunological landscape in human meningiomas. J Neuropathol Exp Neurol 80 : 150-159, 2021
12) Giles AJ, Hao S, Padget M et al : Efficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK. JCI Insight 4 : e130688, 2019
13) Bi WL, Nayak L, Meredith DM et al : Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma : phase II trial results. Neuro Oncol 24 : 101-113, 2022
P.41 掲載の参考文献
14) Juratli TA, Jones PS, Wang N et al : Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations. Cancer 125 : 2910-2914, 2019
15) Yue Q, Yu Y, Shi Z et al : Prediction of BRAF mutation status of craniopharyngioma using magnetic resonance imaging features. J Neurosurg 129 : 27-34, 2018
16) Fujio S, Juratli TA, Arita K et al : A clinical rule for preoperative prediction of BRAF mutation status in craniopharyngiomas. Neurosurgery 85 : 204-210, 2019
17) Apps JR, Stache C, Gonzalez-Meljem JM et al : CTNNB1 mutations are clonal in adamantinomatous craniopharyngioma. Neuropath Appl Neuro 46 : 510-514, 2020
P.42 掲載の参考文献
18) Tamura R, Sato M, Morimoto Y et al : Quantitative assessment and clinical relevance of VEGFRs-positive tumor cells in refractory brain tumors. Exp Mol Pathol 114 : 104408, 2020
19) Fujii M, Ichikawa M, Iwatate K et al : Bevacizumab therapy of neurofibromatosis type 2 associated vestibular schwannoma in Japanese patients. Neurol Med Chir (Tokyo) 60 : 75-82, 2020
20) Plotkin SR, Duda DG, Muzikansky A et al : Multicenter, prospective, phase II and biomarker study of high-dose bevacizumab as induction therapy in patients with neurofibromatosis type 2 and progressive vestibular schwannoma. J Clin Oncol 37 : 3446-3454, 2019
21) Tamura R, Fujioka M, Morimoto Y et al : A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2. Nat Commun 10 : 5758, 2019
22) Karajannis MA, Hagiwara M, Schreyer M et al : Sustained imaging response and hearing preservation with low-dose bevacizumab in sporadic vestibular schwannoma. Neuro Oncol 21 : 822-824, 2019
P.43 掲載の参考文献
1) Asa SL, Mete O, Perry A et al : Overview of the 2022 WHO classification of pituitary tumors. Endocr Pathol 33 : 6-26, 2022
2) Villa C, Vasiljevic A, Jaffrain-Rea ML et al : A standardised diagnostic approach to pituitary neuroendocrine tumours (Pit-NETs) : a European Pituitary Pathology Group (EPPG) proposal. Virchows Arch 475 : 687-692, 2019
3) Mete O, Asa SL : Structure, function, and morphology in the classification of pituitary neuroendocrine tumors : the importance of routine analysis of pituitary transcription factors. Endocr Pathol 31 : 330-336, 2020
4) Drummond J, Roncaroli F, Grossman AB et al : Clinical and pathological aspects of silent pituitary adenomas. J Clin Endocrinol Metab 104 : 2473-2489, 2019
P.44 掲載の参考文献
5) Neou M, Villa C, Armignacco R et al : Pangenomic classification of pituitary neuroendocrine tumors. Cancer Cell 37 : 123-134.e5, 2020
6) Mete O, Ezzat S, Perry A et al : The pangenomic classification of pituitary neuroendocrine tumors : quality histopathology is required for accurate ranslational research. Endocr Pathol 32 : 415-417, 2021
7) Mete O, Kefeli M, Caliskan S et al : GATA3 immunoreactivity expands the transcription factor profile of pituitary neuroendocrine tumors. Mod Pathol 32 : 484-489, 2019
8) Asa SL, Ezzat S : An update on pituitary neuroendocrine tumors leading to acromegaly and gigantism. J Clin Med 10 : 2254, 2021
9) McDonald WC, McDonald KN, Helmer JA et al : The role of T-box transcription factor in a pituitary adenoma diagnostic algorithm. Arch Pathol Lab Med 145 : 592-598, 2021
P.45 掲載の参考文献
10) Andrews JP, Joshi RS, Pereira MP et al : Plurihormonal PIT-1-positive pituitary adenomas : a systematic review and singlecenter series. World Neurosurg 151 : e185-e191, 2021
11) Luo P, Zhang L, Yang L et al : Progress in the pathogenesis, diagnosis, and treatment of TSH-secreting pituitary neuroendocrine tumor. Front Endocrinol (Lausanne) 11 : 580264, 2020
12) Shimatsu A, Nakamura A, Takahashi Y et al : Preoperative and long-term efficacy and safety of lanreotide autogel in patients with thyrotropin-secreting pituitary adenoma : a multicenter, single-arm, phase 3 study in Japan. Endocr J 68 : 791-805, 2021
13) Asa SL, Casar-Borota O, Chanson P et al ; Attendees of 14th meeting of the International Pituitary Pathology Club, Annecy, France, November 2016 : Pituitary adenoma to pituitary neuroendocrine tumor (Pit-NET) : an International Pituitary Pathology Club proposal. Endocr Relat Cancer 24 : C5-C8, 2017
14) Asa SL, Asioli S, Bozkurt S et al : Pituitary neuroendocrine tumors (PitNETs) : nomenclature evolution, not clinical revolution. Pituitary 23 : 322-325, 2020
15) Asa SL, Mete O, Cusimano MD et al ; Attendees of the 15th meeting of the International Pituitary Pathology Club, Istanbul October 2019 : Pituitary neuroendocrine tumors : a model for neuroendocrine tumor classification. Mod Pathol 34 : 1634-1650, 2021
16) Ho KKY, Fleseriu M, Wass J et al : A tale of pituitary adenomas : to NET or not to NET : Pituitary Society position statement. Pituitary 22 : 569-573, 2019
17) Ho KKY, Fleseriu M, Wass J et al : The tale in evolution : clarity, consistency and consultation, not contradiction and confusion. Pituitary 23 : 476-477, 2020
18) Ho K, Fleseriu M, Kaiser U et al : Pituitary neoplasm nomenclature workshop : does adenoma stand the test of time? J Endocr Soc 5 : bvaa205, 2021
19) Ho KKY, Gadelha M, Kaiser UB et al : The NETting of pituitary adenoma : a gland illusion. Pituitary 25 : 349-351, 2022
20) Liu X, Wang R, Li M et al : Pituitary adenoma or pituitary neuroendocrine tumor : a narrative review of controversy and perspective. Transl Cancer Res 10 : 1916-1920, 2021
P.46 掲載の参考文献
21) Rindi G, Inzani F : Neuroendocrine neoplasm update : toward universal nomenclature. Endocr Relat Cancer 27 : R211-R218, 2020
22) Saeger W, Mawrin C, Meinhardt M et al : Two pituitary neuroendocrine tumors (PitNETs) with very high proliferation and TP53 mutation-high-grade PitNET or PitNEC? Endocr Pathol 33 : 257-262, 2022
23) Asa SL : Challenges in the diagnosis of pituitary neuroendocrine tumors. Endocr Pathol 32 : 222-227, 2021
24) Laws Jr ER, Penn DL, Repetti CS : Advances and controversies in the classification and grading of pituitary tumors. J Endocrinol Invest 42 : 129-135, 2019
25) Dai C, Kang J, Liu X et al : How to classify and define pituitary tumors : recent advances and current controversies. Front Endocrinol (Lausanne) 12 : 604644, 2021
26) Trouillas J, Jaffrain-Rea ML, Vasiljevic A et al : Are aggressive pituitary tumours and carcinomas two sides of the same coin? Pathologists reply to clinician's questions. Rev Endocr Metab Disord 21 : 243-251, 2020
27) Raverot G, Ilie MD, Lasolle H et al : Aggressive pituitary tumours and pituitary carcinomas. Nat Rev Endocrinol 17 : 671-684, 2021
28) Tatsi C, Stratakis CA : Aggressive pituitary tumors in the young and elderly. Rev Endocr Metab Disord 21 : 213-223, 2020
P.47 掲載の参考文献
29) Casar-Borota O, Boldt HB, Engstrom BE et al : Corticotroph aggressive pituitary tumors and carcinomas frequently harbor ATRX mutations. J Clin Endocrinol Metab 106 : 1183-1194, 2021
30) Schmid S, Solomon DA, Perez E et al : Genetic and epigenetic characterization of posterior pituitary tumors. Acta Neuropathol 142 : 1025-1043, 2021
31) Barresi V, Simbolo M, Gessi M et al : Clinical-pathological, immunohistochemical, and genetic characterization of a series of posterior pituitary tumors. J Neuropathol Exp Neurol 80 : 45-51, 2021
II章 脳血管障害
P.50 掲載の参考文献
1) Grami N, Chong M, Lali R et al : Global assessment of mendelian stroke genetic prevalence in 101 635 individuals from 7 ethnic groups. Stroke 51 : 1290-1293, 2020
P.51 掲載の参考文献
2) Hongo H, Miyawaki S, Imai H et al : Comprehensive investigation of RNF213 nonsynonymous variants associated with intracranial artery stenosis. Sci Rep 10 : 11942, 2020
3) Hara S, Mukawa M, Akagawa H et al : Absence of the RNF213 p.R4810K variant may indicate a severe form of pediatric moyamoya disease in Japanese patients. J Neurosurg Pediatr 29 : 48-56, 2022
4) Ishigami D, Miyawaki S, Imai H et al : RNF213 p.Arg4810Lys heterozygosity in Moyamoya disease indicates early onset and bilateral cerebrovascular events. Transl Stroke Res 13 : 410-419, 2022
5) Mineharu Y, Takagi Y, Koizumi A et al : Genetic and nongenetic factors for contralateral progression of unilateral moyamoya disease : the first report from the SUPRA Japan Study Group. J Neurosurg 136 : 1005-1014, 2021
6) Kim WH, Kim SD, Nam MH et al : Posterior circulation involvement and collateral flow pattern in moyamoya disease with the RNF213 polymorphism. Childs Nerv Syst 35 : 309-314, 2019
P.52 掲載の参考文献
7) Xue Y, Zeng C, Ge P et al : Association of RNF213 variants with periventricular anastomosis in moyamoya disease. Stroke 53 : 2906-2916, 2022
8) Tashiro R, Fujimura M, Katsuki M et al : Prolonged/delayed cerebral hyperperfusion in adult patients with moyamoya disease with RNF213 gene polymorphism c.14576G > A (rs112735431) after superficial temporal artery-middle cerebral artery anastomosis. J Neurosurg doi : 10.3171/2020.6.JNS201037, 2020 [online ahead of print]
9) Ito M, Kawabori M, Sugiyama T et al : Impact of RNF213 founder polymorphism (p.R4810K) on the postoperative development of indirect pial synangiosis after direct/indirect combined revascularization surgery for adult Moyamoya disease. Neurosurg Rev 45 : 2305-2313, 2022
10) Okazaki S, Morimoto T, Kamatani Y et al : Moyamoya disease susceptibility variant RNF213 p.R4810K increases the risk of ischemic stroke attributable to largeartery atherosclerosis. Circulation 139 : 295-298, 2019
11) Koyama S, Ito K, Terao C et al : Population-specific and trans-ancestry genomewide analyses identify distinct and shared genetic risk loci for coronary artery disease. Nat Genet 52 : 1169-1177, 2020
12) Ozaki D, Endo H, Tashiro R et al : Association between RNF213 c.14576G> A variant (rs112735431) and peripheral pulmonary artery stenosis in moyamoya disease. Cerebrovasc Dis 51 : 282-287, 2022
13) Hara S, Shimizu K, Nariai T et al : De novo renal artery stenosis developed in initially normal renal arteries during the long-term follow-up of patients with moyamoya disease. J Stroke Cerebrovasc Dis 29 : 104786, 2020
14) Tabara Y, Yamada H, Setoh K et al : The association between the Moyamoya disease susceptible gene RNF213 variant and incident cardiovascular disease in a general population : the Nagahama study. J Hypertens 39 : 2521-2526, 2021
15) Hiraide T, Kataoka M, Suzuki H et al : Poor outcomes in carriers of the RNF213 variant (p.Arg4810Lys) with pulmonary arterial hypertension. J Heart Lung Transplant 39 : 103-112, 2020
P.53 掲載の参考文献
16) Ahel J, Lehner A, Vogel A et al : Moyamoya disease factor RNF213 is a giant E3 ligase with a dynein-like core and a distinct ubiquitin-transfer mechanism. Elife 9 : e56185, 2020
17) Otten EG, Werner E, Crespillo-Casado A et al : Ubiquitylation of lipopolysaccharide by RNF213 during bacterial infection. Nature 594 : 111-116, 2021
18) Thery F, Martina L, Asselman C et al : Ring finger protein 213 assembles into a sensor for ISGylated proteins with antimicrobial activity. Nat Commun 12 : 5772, 2021
19) Tashiro R, Niizuma K, Kasamatsu J et al : Dysregulation of Rnf 213 gene contributes to T cell response via antigen uptake, processing, and presentation. J Cell Physiol 236 : 7554-7564, 2021
20) Duan L, Wei L, Tian Y et al : Novel susceptibility loci for moyamoya disease revealed by a genome-wide association study. Stroke 49 : 11-18, 2018
21) Kundishora AJ, Peters ST, Pinard A et al : DIAPH1 variants in non-East Asian patients with sporadic moyamoya disease. JAMA Neurol 78 : 993-1003, 2021
22) Nikolaev SI, Vetiska S, Bonilla X et al : Somatic activating KRAS mutations in arteriovenous malformations of the brain. N Engl J Med 378 : 250-261, 2018
P.54 掲載の参考文献
23) Hong T, Yan Y, Li J et al : High prevalence of KRAS/BRAF somatic mutations in brain and spinal cord arteriovenous malformations. Brain 142 : 23-34, 2019
24) Priemer DS, Vortmeyer AO, Zhang S et al : Activating KRAS mutations in arteriovenous malformations of the brain : frequency and clinicopathologic correlation. Hum Pathol 89 : 33-39, 2019
25) Goss JA, Huang AY, Smith E et al : Somatic mutations in intracranial arteriovenous malformations. PLoS One 14 : e0226852, 2019
26) Oka M, Kushamae M, Aoki T et al : KRAS G12D or G12V mutation in human brain arteriovenous malformations. World Neurosurg 126 : e1365-e1373, 2019
27) Bameri O, Salarzaei M, Parooie F : KRAS/BRAF mutations in brain arteriovenous malformations : a systematic review and meta-analysis. Interv Neuroradiol 27 : 539-546, 2021
28) Li H, Nam Y, Huo R et al : De novo germline and somatic variants convergently promote endothelial-to-mesenchymal transition in simplex brain arteriovenous malformation. Circ Res 129 : 825-839, 2021
29) Gao S, Nelson J, Weinsheimer S et al : Somatic mosaicism in the MAPK pathway in sporadic brain arteriovenous malformation and association with phenotype. J Neurosurg 136 : 148-155, 2022
P.55 掲載の参考文献
30) Fish JE, Flores Suarez CP, Boudreau E et al : Somatic gain of KRAS function in the endothelium is sufficient to cause vascular malformations that require MEK but not PI3K signaling. Circ Res 127 : 727-743, 2020
31) Hong T, Xiao X, Ren J et al : Somatic MAP3K3 and PIK3CA mutations in sporadic cerebral and spinal cord cavernous malformations. Brain 144 : 2648-2658, 2021
32) Peyre M, Miyagishima D, Bielle F et al : Somatic PIK3CA mutations in sporadic cerebral cavernous malformations. N Engl J Med 385 : 996-1004, 2021
33) Ren AA, Snellings DA, Su YS et al : PIK-3CA and CCM mutations fuel cavernomas through a cancer-like mechanism. Nature 594 : 271-276, 2021
34) Weng J, Yang Y, Song D et al : Somatic MAP3K3 mutation defines a subclass of cerebral cavernous malformation. Am J Hum Genet 108 : 942-950, 2021
P.56 掲載の参考文献
1) Greving JP, Wermer MJ, Brown RD Jr et al : Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms : a pooled analysis of six prospective cohort studies. Lancet Neurol 13 : 59-66, 2014
2) Tominari S, Morita A, Ishibashi T et al : Prediction model for 3-year rupture risk of unruptured cerebral aneurysms in Japanese patients. Ann Neurol 77 : 1050-1059, 2015
P.57 掲載の参考文献
3) Backes D, Rinkel GJE, Greving JP et al : ELAPSS score for prediction of risk of growth of unruptured intracranial aneurysms. Neurology 88 : 1600-1606, 2017
4) Cras TY, Bos D, Ikram MA et al : Determinants of the presence and size of intracranial aneurysms in the general population : the Rotterdam Study. Stroke 51 : 2103-2110, 2020
5) Vlak MH, Rinkel GJ, Greebe P et al : Independent risk factors for intracranial aneurysms and their joint effect : a casecontrol study. Stroke 44 : 984-987, 2013
6) Etminan N, Chang HS, Hackenberg K et al : Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population : a systematic review and meta-analysis. JAMA Neurol 76 : 588-597, 2019
7) Ikawa F, Morita A, Nakayama T et al : A register-based SAH study in Japan : high incidence rate and recent decline trend based on lifestyle. J Neurosurg 134 : 983-991, 2020
8) Ota N, Morita A, Tominari S et al : Differences between subarachnoid hemorrhage seen in daily practice and aneurysms that rupture during follow-up. Stroke 52 : e491-e493, 2021
P.58 掲載の参考文献
9) Ueda D, Yamamoto A, Nishimori M et al : Deep learning for MR angiography : automated detection of cerebral aneurysms. Radiology 290 : 187-194, 2019
10) Ikawa F, Morita A, Tominari S et al : Rupture risk of small unruptured cerebral aneurysms. J Neurosurg doi : 10.3171/2018.9.JNS181736, 2019 [online ahead of print]
11) Suzuki T, Takao H, Rapaka S et al : Rupture risk of small unruptured intracranial aneurysms in Japanese adults. Stroke 51 : 641-643, 2020
12) Sonobe M, Yamazaki T, Yonekura M et al : Small unruptured intracranial aneurysm verification study : SUAVe study, Japan. Stroke 41 : 1969-1977, 2010
P.59 掲載の参考文献
13) Inoue T, Shimizu H, Fujimura M et al : Annual rupture risk of growing unruptured cerebral aneurysms detected by magnetic resonance angiography. J Neurosurg 117 : 20-25, 2012
14) van der Kamp LT, Rinkel GJE et al : Risk of rupture after intracranial aneurysm growth. JAMA Neurol 78 : 1228-1235, 2021
15) Zuurbier CCM, Mensing LA, Wermer MJH et al : Difference in rupture risk between familial and sporadic intracranial aneurysms : an individual patient data meta-analysis. Neurology 97 : e2195-e2203, 2021
16) Zuurbier CCM, Molenberg R, Mensing LA et al : Sex difference and rupture rate of intracranial aneurysms : an individual patient data meta-analysis. Stroke 53 : 362-369, 2022
17) Hasan DM, Chalouhi N, Jabbour P et al : Evidence that acetylsalicylic acid attenuates inflammation in the walls of human cerebral aneurysms : preliminary results. J Am Heart Assoc 2 : e000019, 2013
18) Omodaka S, Endo H, Niizuma K et al : Circumferential wall enhancement in evolving intracranial aneurysms on magnetic resonance vessel wall imaging. J Neurosurg doi : 10.3171/2018.5.JNS18322, 2018 [online ahead of print]
P.60 掲載の参考文献
19) Shimonaga K, Matsushige T, Ishii D et al : Clinicopathological insights from vessel wall imaging of unruptured intracranial aneurysms. Stroke 49 : 2516-2519, 2018
20) Nakano K, Hokamura K, Taniguchi N et al : The collagen-binding protein of Streptococcus mutans is involved in haemorrhagic stroke. Nat Commun 2 : 485, 2011
21) Kawabata S, Takagaki M, Nakamura H et al : Dysbiosis of gut microbiome is associated with rupture of cerebral aneurysms. Stroke 53 : 895-903, 2022
22) Shikata F, Shimada K, Sato H et al : Potential influences of gut microbiota on the formation of intracranial aneurysm. Hypertension 73 : 491-496, 2019
23) Algra AM, Lindgren A, Vergouwen MDI et al : Procedural clinical complications, case-fatality risks, and risk factors in endovascular and neurosurgical treatment of unruptured intracranial aneurysms : a systematic review and meta-analysis. JAMA Neurol 76 : 282-293, 2019
P.61 掲載の参考文献
24) Nakatomi H, Kiyofuji S, Ono H et al : Giant fusiform and dolichoectatic aneurysms of the basilar trunk and vertebrobasilar junction-clinicopathological and surgical outcome. Neurosurgery 88 : 82-95, 2020
25) Dengler J, Rufenacht D, Meyer B et al : Giant intracranial aneurysms : natural history and 1-year case fatality after endovascular or surgical treatment. J Neurosurg 134 : 49-57, 2019
P.62 掲載の参考文献
1) Mohr JP, Parides MK, Stapf C et al ; international ARUBA investigators : Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA) : a multicentre, non-blinded, randomised trial. Lancet 383 : 614-621, 2014
P.63 掲載の参考文献
2) Al-Shahi Salman R, White PM, Counsell CE et al ; Scottish Audit of Intracranial Vascular Malformations Collaborators : Outcome after conservative management or intervention for unruptured brain arteriovenous malformations. JAMA 311 : 1661-1669, 2014
3) Mohr JP, Overbey JR, Hartmann A et al ; ARUBA co-investigators : Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA) : final follow-up of a multicentre, non-blinded, randomised controlled trial. Lancet Neurol 19 : 573-581, 2020
4) Derdeyn CP, Zipfel GJ, Albuquerque FC et al ; American Heart Association Stroke Council : Management of brain arteriovenous malformations : a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 48 : e200-e224, 2017
P.64 掲載の参考文献
5) Pezeshkpour P, Dmytriw AA, Phan K et al : Treatment strategies and related outcomes for brain arteriovenous malformations in children : a systematic review and meta-analysis. AJR Am J Roentgenol 215 : 472-487, 2020
6) Lu VM, Wahood W, Rinaldo L et al : Long-term functional outcome after intervention for pediatric intracranial arteriovenous malformations : a systematic review and meta-analysis. Clin Neurol Neurosurg 191 : 105707, 2020
7) Borcek AO, Celtikci E, Aksogan Y et al : Clinical outcomes of stereotactic radiosurgery for cerebral arteriovenous malformations in pediatric patients : systematic review and meta-analysis. Neurosurgery 85 : E629-E640, 2019
8) Wu EM, El Ahmadieh TY, McDougall CM et al : Embolization of brain arteriovenous malformations with intent to cure : a systematic review. J Neurosurg 132 : 388-399, 2019
9) Jiang Z, Zhang X, Wan X et al : Efficacy and safety of combined endovascular embolization and stereotactic radiosurgery for patients with intracranial arteriovenous malformations : a systematic review and meta-analysis. Biomed Res Int 2021 : 6686167, 2021
10) Jiang X, Zhao Z, Zhang Y et al : Preradiosurgery embolization in reducing the postoperative hemorrhage rate for patients with cerebral arteriovenous malformations : a systematic review and meta-analysis. Neurosurg Rev 44 : 3197-3207, 2021
P.65 掲載の参考文献
11) Chye CL, Wang KW, Chen HJ et al : Haemorrhage rates of ruptured and unruptured brain arteriovenous malformation after radiosurgery : a nationwide population-based cohort study. BMJ Open 10 : e036606, 2020
12) Davidoff CL, Lo Presti A, Rogers JM et al : Risk of first hemorrhage of brain arteriovenous malformations during pregnancy : a systematic review of the literature. Neurosurgery 85 : E806-E814, 2019
13) Nikolaev SI, Vetiska S, Bonilla X et al : Somatic activating KRAS mutations in arteriovenous malformations of the brain. N Engl J Med 378 : 250-261, 2018
14) Al-Olabi L, Polubothu S, Dowsett K et al : Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy. J Clin Invest 128 : 5185, 2018
15) Hong T, Yan Y, Li J et al : High prevalence of KRAS/BRAF somatic mutations in brain and spinal cord arteriovenous malformations. Brain 142 : 23-34, 2019
16) Goss JA, Huang AY, Smith E et al : Somatic mutations in intracranial arteriovenous malformations. PLoS One 14 : e0226852, 2019
17) Priemer DS, Vortmeyer AO, Zhang S et al : Activating KRAS mutations in arteriovenous malformations of the brain : frequency and clinicopathologic correlation. Hum Pathol 89 : 33-39, 2019
18) Oka M, Kushamae M, Aoki T et al : KRAS G12D or G12V mutation in human brain arteriovenous malformations. World Neurosurg 126 : e1365-e1373, 2019
19) Couto JA, Huang AY, Konczyk DJ et al : Somatic MAP2K1 mutations are associated with extracranial arteriovenous malformation. Am J Hum Genet 100 : 546-554, 2017
20) Goss JA, Konczyk DJ, Smits PJ et al : Intramuscular fast-flow vascular anomaly contains somatic MAP2K1 and KRAS mutations. Angiogenesis 22 : 547-552, 2019
21) Fish JE, Flores Suarez CP, Boudreau E et al : Somatic gain of KRAS function in the endothelium is sufficient to cause vascular malformations that require MEK but not PI3K signaling. Circ Res 127 : 727-743, 2020
22) Patel BG, Ahmed KA, Johnstone PA et al : Initial experience with combined BRAF and MEK inhibition with stereotactic radiosurgery for BRAF mutant melanoma brain metastases. Melanoma Res 26 : 382-386, 2016
P.66 掲載の参考文献
23) Lekwuttikarn R, Lim YH, Admani S et al : Genotype-guided medical treatment of an arteriovenous malformation in a child. JAMA Dermatol 155 : 256-257, 2019
24) Maynard K, LoPresti M, Iacobas I et al : Antiangiogenic agent as a novel treatment for pediatric intracranial arteriovenous malformations : case report. J Neurosurg Pediatr doi : 10.3171/2019.7.PEDS1976, 2019 [online ahead of print]
25) Akers A, Al-Shahi Salman R, A Awad I et al : Synopsis of guidelines for the clinical management of cerebral cavernous malformations : consensus recommendations based on systematic literature review by the angioma alliance scientific advisory board clinical experts panel. Neurosurgery 80 : 665-680, 2017
26) Gao X, Yue K, Sun J et al : Treatment of cerebral cavernous malformations presenting with seizures : a systematic review and meta-analysis. Front Neurol 11 : 590589, 2020
27) 日本脳卒中学会脳卒中ガイドライン委員会編 : 脳卒中治療ガイドライン 2021. 協和企画, 2021
P.67 掲載の参考文献
1) Oki K, Katsumata M, Izawa Y et al : Trends of antiplatelet therapy for the management of moyamoya disease in Japan : results of a nationwide survey. J Stroke Cerebrovasc Dis 27 : 3605-3612, 2018
2) Yamada S, Oki K, Itoh Y et al : Effects of surgery and antiplatelet therapy in ten-year follow-up from the registry study of Research Committee on Moyamoya Disease in Japan. J Stroke Cerebrovasc Dis 25 : 340-349, 2016
3) 冨永悌二, 鈴木則宏, 宮本享他 : もやもや病 (ウイリス動脈輪閉塞症) 診断・治療ガイドライン (改訂版). 脳卒中の外科 46 : 1-24, 2018
4) 日本脳卒中学会脳卒中ガイドライン委員会編 : もやもや病 (Willis 動脈輪閉塞症) : 内科治療. 脳卒中治療ガイドライン 2021. 協和企画, 215-216, 2021
P.68 掲載の参考文献
5) Seo WK, Kim JY, Choi EH et al : Association of antiplatelet therapy, including cilostazol, with improved survival in patients with moyamoya disease in a nationwide study. J Am Heart Assoc 10 : e017701, 2021
6) Chiba T, Setta K, Shimada Y et al : Comparison of effects between clopidogrel and cilostazol on cerebral perfusion in nonsurgical adult patients with symptomatically ischemic moyamoya disease : subanalysis of a prospective cohort. J Stroke Cerebrovasc Dis 27 : 3373-3379, 2018
7) Kitakami K, Kubo Y, Yabuki M et al : Five-year outcomes of medical management alone for adult patients with ischemic moyamoya disease without cerebral misery perfusion. Cerebrovasc Dis 51 : 158-164, 2022
P.69 掲載の参考文献
8) Kobayashi E, Saeki N, Oishi H et al : Long-term natural history of hemorrhagic moyamoya disease in 42 patients. J Neurosurg 93 : 976-980, 2000
9) Morioka M, Hamada J, Todaka T et al : High-risk age for rebleeding in patients with hemorrhagic moyamoya disease : long-term follow-up study. Neurosurgery 52 : 1049-1055, 2003
10) Kang S, Liu X, Zhang D et al : Natural course of moyamoya disease in patients with prior hemorrhagic stroke. Stroke 50 : 1060-1066, 2019
11) Takahashi JC, Funaki T, Houkin K et al ; JAM Trial Investigators : Significance of the hemorrhagic site for recurrent bleeding : prespecified analysis in the Japan Adult Moyamoya Trial. Stroke 47 : 37-43, 2016
12) Funaki T, Takahashi JC, Houkin K et al : Angiographic features of hemorrhagic moyamoya disease with high recurrence risk : a supplementary analysis of the Japan Adult Moyamoya Trial. J Neurosurg 128 : 777-784, 2018
P.70 掲載の参考文献
13) Funaki T, Takahashi JC, Houkin K et al : High rebleeding risk associated with choroidal collateral vessels in hemorrhagic moyamoya disease : analysis of a nonsurgical cohort in the Japan Adult Moyamoya Trial. J Neurosurg 130 : 525-530, 2019
14) Funaki T, Takahashi JC, Houkin K et al : Effect of choroidal collateral vessels on de novo hemorrhage in moyamoya disease : analysis of nonhemorrhagic hemispheres in the Japan Adult Moyamoya Trial. J Neurosurg 132 : 408-414, 2019
15) Takahashi JC, Funaki T, Houkin K et al : Impact of cortical hemodynamic failure on both subsequent hemorrhagic stroke and effect of bypass surgery in hemorrhagic moyamoya disease : a supplementary analysis of the Japan Adult Moyamoya Trial. J Neurosurg 134 : 940-945, 2020
16) Hayashi T, Kimiwada T, Karibe H et al : Preoperative risks of cerebral infarction in pediatric moyamoya disease. Stroke 52 : 2302-2310, 2021
P.71 掲載の参考文献
17) Funaki T, Takahashi JC, Takagi Y et al : Incidence of late cerebrovascular events after direct bypass among children with moyamoya disease : a descriptive longitudinal study at a single center. Acta Neurochir (Wien) 156 : 551-559, 2014
18) Ha EJ, Kim KH, Wang KC et al : Long-term outcomes of indirect bypass for 629 children with moyamoya disease : longitudinal and cross-sectional analysis. Stroke 50 : 3177-3183, 2019
19) Yanagihara W, Chida K, Kobayashi M et al : Impact of cerebral blood flow changes due to arterial bypass surgery on cognitive function in adult patients with symptomatic ischemic moyamoya disease. J Neurosurg 131 : 1716-1724, 2018
P.72 掲載の参考文献
20) Tokairin K, Kazumata K, Uchino H et al : Postoperative intracerebral hemorrhage after combined revascularization surgery in moyamoya disease : profiles and clinical associations. World Neurosurg 120 : e593-e600, 2018
21) Chen Y, Ma L, Lu J et al : Postoperative hemorrhage during the acute phase after direct or combined revascularization for moyamoya disease : risk factors, prognosis, and literature review. J Neurosurg 133 : 1450-1459, 2020
P.73 掲載の参考文献
1) Murai S, Hiramatsu M, Suzuki E et al : Trends in incidence of intracranial and spinal arteriovenous shunts : hospital-based surveillance in Okayama, Japan. Stroke 52 : 1455-1459, 2021
P.74 掲載の参考文献
2) Ferro JM, Coutinho JM, Jansen O et al : Dural arteriovenous fistulae after cerebral venous thrombosis. Stroke 51 : 3344-3347, 2020
3) Lindgren E, Rentzos A, Hiltunen S et al : Dural arteriovenous fistulas in cerebral venous thrombosis : data from the International Cerebral Venous Thrombosis Consortium : data from the International Cerebral Venous Thrombosis Consortium. Eur J Neurol 29 : 761-770, 2022
P.75 掲載の参考文献
4) Nishi H, Ikeda H, Ishii A et al : A multicenter prospective registry of Borden type I dural arteriovenous fistula : results of a 3-year follow-up study. Neuroradiology 64 : 795-805, 2022
5) Chen CJ, Buell TJ, Ding D et al : Observation versus intervention for low-grade intracranial dural arteriovenous fistulas. Neurosurgery 88 : 1111-1120, 2021
6) Shimizu K, Takeda M, Mitsuhara T et al : Asymptomatic spinal dural arteriovenous fistula : case series and systematic review. J Neurosurg Spine doi : 10.3171/2019.5.SPINE181513, 2019 [online ahead of print]
P.76 掲載の参考文献
7) Chen CJ, Buell TJ, Ding D et al : Intervention for unruptured high-grade intracranial dural arteriovenous fistulas : a multicenter study. J Neurosurg 136 : 962-970, 2021
8) Durnford AJ, Akarca D, Cullitord D et al : Risk of early versus later rebleeding from dural arteriovenous fistulas with cortical venous drainage. Stroke 53 : 2340-2345, 2022
P.77 掲載の参考文献
9) Ma Y, Hong T, Chen S et al : Steroid-associated acute clinical worsening and poor outcome in patients with spinal dural arteriovenous fistulas : a prospective cohort study. Spine (Phila Pa 1976) 45 : E656-E662, 2020
10) Brinjikji W, Cloft HJ, Lanzino G : Clinical, angiographic, and treatment characteristics of cranial dural arteriovenous fistulas with pial arterial supply. J Neurointerv Surg 13 : 331-335, 2021
11) Osada T, Krings T : Intracranial dural arteriovenous fistulas with pial arterial supply. Neurosurgery 84 : 104-115, 2019
P.78 掲載の参考文献
12) Toledano-Massiah S, Badat N, Ghorra C et al : Jugular venous reflux may mimic type I dural arterio-venous fistula on arterial spin labeling magnetic resonance images. Neuroradiology. 62 : 447-454, 2020
13) Iwamura M, Midorikawa H, Shibutani K et al : High-signal venous sinuses on MR angiography : discrimination between reversal of venous flow and arteriovenous shunting using arterial spin labeling. Neuroradiology. 63 : 889-896, 2020
14) Foo SY, Swaminathan SK, Krings T : Dilated MMA sign in cDAVF and other arterial feeders on 3D TOF MRA. Neuroradiol J 35 : 290-299, 2022
15) Lee J, Lee JY, Lee YJ et al : Differentiation of dural arteriovenous fistula from reflux venous flow on 3D TOF-MR angiography : identifying asymmetric enlargement of external carotid artery branches. Clin Radiol. 75 : 714.e15-714.e20, 2020
16) Patel B, Chatterjee A, Petr O et al : T2-weighted-fluid-attenuated inversion recovery hyperintensity on magnetic resonance imaging is associated with aggressive symptoms in patients with dural arteriovenous fistulas. Stroke 50 : 2565-2567, 2019
17) Ryu B, Sato S, Mochizuki T et al : Relative signal intensity on time-of-flight magnetic resonance angiography as a novel indicator of aggressive presentation of intracranial dural arteriovenous fistulas. J Cereb Blood Flow Metab 41 : 1428-1436, 2021
P.79 掲載の参考文献
18) Brinjikji W, Cloft HJ, Lanzino G : Clinical presentation and imaging findings of patients with dural arteriovenous fistulas with an angiographic pseudophlebitic pattern. AJNR Am J Neuroradiol 41 : 2285-2891, 2020
19) Melo Neto JF, Pelinca da Costa EE, Pinheiro Junior N et al : Cerebral venous drainage in patients with dural arteriovenous fistulas : correlation with clinical presentation. J Neurosurg doi : 10.3171/2020.6.JNS20922, 2020 [online ahead of print]
20) Guniganti R, Giordan E, Chen CJ et al : Consortium for Dural Arteriovenous Fistula Outcomes Research (CONDOR) : rationale, design, and initial characterization of patient cohort. J Neurosurg 136 : 951-961, 2021
P.80 掲載の参考文献
21) Li Y, Chen SH, Guniganti R et al : Onyx embolization for dural arteriovenous fistulas : a multi-institutional study. J Neurointerv Surg 14 : neurintsurg-2020-017109, 2022
22) Abecassis IJ, Meyer RM, Levitt MR et al : Recurrence after cure in cranial dural arteriovenous fistulas : a collaborative effort by the Consortium for Dural Arteriovenous Fistula Outcomes Research (CONDOR). J Neurosurg 136 : 981-989, 2021
23) Takai K, Endo T, Yasuhara T et al : Neurosurgical versus endovascular treatment of spinal dural arteriovenous fistulas : a multicenter study of 195 patients. J Neurosurg Spine doi : 10.3171/2020.6.SPINE20309, 2020 [online ahead of print]
24) Takai K, Endo T, Yasuhara T et al : Microsurgical versus endovascular treatment of spinal epidural arteriovenous fistulas with intradural venous drainage : a multicenter study of 81 patients. J Neurosurg Spine doi : 10.3171/2020.2.SPINE191432, 2020 [online ahead of print]
P.81 掲載の参考文献
25) Goyal A, Cesare J, Lu VM et al : Outcomes following surgical versus endovascular treatment of spinal dural arteriovenous fistula : a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 90 : 1139-1146, 2019
P.82 掲載の参考文献
1) Pan Y, Elm JJ, Li H et al : Outcomes associated with clopidogrel-aspirin use in minor stroke or transient ischemic attack : a pooled analysis of clopidogrel in high-risk patients with acute non-disabling cerebrovascular events (CHANCE) and plateletoriented inhibition in new TIA and minor ischemic stroke (POINT) trials. JAMA Neurol 76 : 1466-1473, 2019
P.83 掲載の参考文献
2) Johnston SC, Elm JJ, Easton JD et al : Time course for benefit and risk of clopidogrel and aspirin after acute transient ischemic attack and minor ischemic stroke. Circulation 140 : 658-664, 2019
3) Rostanski SK, Kvernland A, Liberman AL et al : Infarct on Brain Imaging, Subsequent Ischemic Stroke, and Clopidogrel-Aspirin Efficacy : a post hoc analysis of a randomized clinical trial. JAMA Neurol 79 : 244-250, 2022
4) Rahman H, Khan SU, Nasir F et al : Optimal duration of aspirin plus clopidogrel after ischemic stroke or transient ischemic attack. Stroke 50 : 947-953, 2019
5) 日本脳卒中学会脳卒中ガイドライン委員会編 : 脳卒中治療ガイドライン 2021. 協和企画, 2021
6) Kleindorfer DO, Towfighi A, Chaturvedi S et al : 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack : a guideline from the American Heart Association/American Stroke Association. Stroke 52 : e364-e467, 2021
7) Aoki J, Iguchi Y, Urabe T et al : Acute aspirin plus cilostazol dual therapy for noncardioembolic stroke patients within 48 hours of symptom onset. J Am Heart Assoc 8 : e012652, 2019
P.84 掲載の参考文献
8) Toyoda K, Uchiyama S, Yamaguchi T et al : Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan : a multicentre, open-label, randomised controlled trial. Lancet Neurol 18 : 539-548, 2019
9) Toyoda K, Omae K, Hoshino H et al : Association of timing for starting dual antiplatelet treatment with cilostazol and recurrent stroke. Neurology 98 : e983-e992, 2022
10) Hoshino H, Toyoda K, Omae K et al : Dual antiplatelet therapy using cilostazol with aspirin or clopidogrel : subanalysis of the CSPS.com trial. Stroke 52 : 3430-3439, 2021
11) Uchiyama S, Toyoda K, Omae K et al : Dual antiplatelet therapy using cilostazol in patients with stroke and intracranial arterial stenosis. J Am Heart Assoc 10 : e022575, 2021
P.85 掲載の参考文献
12) Kim BJ, Kwon SU, Park JH et al : Cilostazol versus aspirin in ischemic stroke patients with high-risk cerebral hemorrhage : subgroup analysis of the PICASSO trial. Stroke 51 : 931-937, 2020
13) Johnston SC, Amarenco P, Albers GW et al : Ticagrelor versus aspirin in acute stroke or transient ischemic attack. N Engl J Med 375 : 35-43, 2016
14) Johnston SC, Amarenco P, Denison H et al : Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA. N Engl J Med 383 : 207-217, 2020
15) Amarenco P, Denison H, Evans SR et al : Ticagrelor added to aspirin in acute ischemic stroke or transient ischemic attack in prevention of disabling stroke : a randomized clinical trial. JAMA Neurol 78 : 177-185, 2021
P.86 掲載の参考文献
16) Wang Y, Pan Y, Li H et al : Time course for benefit and risk of ticagrelor and aspirin in acute ischemic stroke or transient ischemic attack. Neurology 99 : e46-e54, 2022
17) Wang Y, Meng X, Wang A et al : Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA. N Engl J Med 385 : 2520-2530, 2021
18) Pan Y, Meng X, Jin A et al : Time course for benefit and risk with ticagrelor and aspirin in individuals with acute ischemic stroke or transient ischemic attack who carry CYP2C19 loss-of-function alleles : a secondary analysis of the CHANCE-2 randomized clinical trial. JAMA Neurol doi : 10.1001/jamaneurol.2022.1457, 2022 [online ahead of print]
19) Lun R, Dhaliwal S, Zitikyte G et al : Comparison of ticagrelor vs clopidogrel in addition to aspirin in patients with minor ischemic stroke and transient ischemic attack : a network meta-analysis. JAMA Neurol 79 : 141-148, 2022
20) Bhatia K, Jain V, Aggarwal D et al : Dual antiplatelet therapy versus aspirin in patients with stroke or transient ischemic attack : meta-analysis of randomized controlled trials. Stroke 52 : e217-e223, 2021
P.87 掲載の参考文献
21) Ogawa A, Toyoda K, Kitagawa K et al : Comparison of prasugrel and clopidogrel in patients with non-cardioembolic ischaemic stroke : a phase 3, randomised, noninferiority trial (PRASTRO-I). Lancet Neurol 18 : 238-247, 2019
22) Kitazono T, Kamouchi M, Matsumaru Y et al : Efficacy and safety of prasugrel vs clopidogrel in thrombotic stroke patients with risk factors for ischemic stroke recurrence : a double-blind, phase III study (PRASTRO-III). J Atheroscler Thromb doi : 10.5551/jat.63473, 2022 [online ahead of print]
23) RESTART Collaboration : Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART) : a randomised, open-label trial. Lancet 393 : 2613-2623, 2019
P.88 掲載の参考文献
24) Al-Shahi Salman R, Minks DP, Mitra D et al : Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases : subgroup analyses of the RESTART randomised, open-label trial. Lancet Neurol 18 : 643-652, 2019
25) Al-Shahi Salman R, Dennis MS, Sandercock PAG et al : Effects of antiplatelet therapy after stroke caused by intracerebral hemorrhage : extended follow-up of the RESTART randomized clinical trial. JAMA Neurol 78 : 1179-1186, 2021
P.89 掲載の参考文献
1) Jame S, Barnes G : Stroke and thromboembolism prevention in atrial fibrillation. Heart 106 : 10-17, 2020
2) Stretz C, Wu TY, Wilson D et al : Ischaemic stroke in anticoagulated patients with atrial fibrillation. J Neurol Neurosurg Psychiatry 92 : 1164-1172, 2021
3) Botto GL, Ameri P, De Caterina R : Many good reasons to switch from vitamin K antagonists to non-vitamin K antagonists in patients with non-valvular atrial fibrillation. J Clin Med 10 : 2866, 2021
P.90 掲載の参考文献
4) Bir S, Kelley RE : Antithrombotic therapy in the prevention of stroke. Biomedicines 9 : 1906, 2021
5) Yaghi S, Henninger N, Giles JA et al : Ischaemic stroke on anticoagulation therapy and early recurrence in acute cardioembolic stroke : the IAC study. J Neurol Neurosurg Psychiatry 92 : 1062-1067, 2021
6) Auer E, Frey S, Kaesmacher J et al : Stroke severity in patients with preceding direct oral anticoagulant therapy as compared to vitamin K antagonists. J Neurol 266 : 2263-2272, 2019
7) Seiffge DJ, De Marchis GM, Koga M et al ; RAF, RAF-DOAC, CROMIS-2, SAMURAI, NOACISP, Erlangen, and Verona registry collaborators : Ischemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation. Ann Neurol 87 : 677-687, 2020
8) Tokunaga K, Koga M, Itabashi R et al ; SAMURAI Study Investigators : Prior anticoagulation and short- or long-term clinical outcomes in ischemic stroke or transient ischemic attack patients with nonvalvular atrial fibrillation. J Am Heart Assoc 8 : e010593, 2019
9) Meinel TR, Frey S, Arnold M et al : Clinical presentation, diagnostic findings and management of cerebral ischemic events in patients on treatment with non-vitamin K antagonist oral anticoagulants-a systematic review. PLoS One 14 : e0213379, 2019
10) L'Allinec V, Sibon I, Mazighi M et al ; Endovascular Treatment in Ischemic Stroke Investigators : MT in anticoagulated patients : direct oral anticoagulants versus vitamin K antagonists. Neurology 94 : e842-e850, 2020
11) Meinel TR, Branca M, De Marchis GM et al ; Investigators of the Swiss Stroke Registry : Prior anticoagulation in patients with ischemic stroke and atrial fibrillation. Ann Neurol 89 : 42-53, 2021
12) Ohno J, Sotomi Y, Hirata A et al : Dose of direct oral anticoagulants and adverse outcomes in Asia. Am J Cardiol 139 : 50-56, 2021
P.91 掲載の参考文献
13) Seiffge DJ, Werring DJ, Paciaroni M et al : Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation. Lancet Neurol 18 : 117-126, 2019
14) Alrohimi A, Buck B, Jickling G et al : Early apixaban therapy after ischemic stroke in patients with atrial fibrillation. J Neurol 268 : 1837-1846, 2021
15) Boursier-Bossy V, Zuber M, Emmerich J : Ischemic stroke and non-valvular atrial fibrillation : when to introduce anticoagulant therapy? J Med Vasc 45 : 72-80, 2020
16) Kimura S, Toyoda K, Yoshimura S et al ; SAMURAI, RELAXED, RAF, RAF-NOAC, CROMIS-2, NOACISP LONGTERM, Erlangen Registry and Verona Registry Investigators : Practical "1-2-3-4-day" rule for starting direct oral anticoagulants after ischemic stroke with atrial fibrillation : combined hospital-based cohort study. Stroke 53 : 1540-1549, 2022
P.92 掲載の参考文献
17) Altavilla R, Caso V, Bandini F et al : Anticoagulation after stroke in patients with atrial fibrillation. Stroke 50 : 2093-2100, 2019
18) Douketis JD, Spyropoulos AC, Duncan J et al : Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant. JAMA Intern Med 179 : 1469-1478, 2019
19) MacDougall K, Douketis JD, Li N et al : Effect of direct oral anticoagulant, patient, and surgery characteristics on clinical outcomes in the perioperative anticoagulation use for surgery evaluation study. TH Open 4 : e255-e262, 2020
20) Tafur AJ, Clark NP, Spyropoulos AC et al : Predictors of bleeding in the perioperative anticoagulant use for surgery evaluation study. J Am Heart Assoc 9 : e017316, 2020
21) Botto G, Ameri P, Cappellari M et al : Unmet clinical needs in elderly patients receiving direct oral anticoagulants for stroke prevention in non-valvular atrial fibrillation. Adv Ther 38 : 2891-2907, 2021
P.93 掲載の参考文献
22) Yasuda S, Kaikita K, Akao M et al ; AFIRE Investigators : Antithrombotic therapy for atrial fibrillation with stable coronary disease. N Engl J Med 381 : 1103-1113, 2019
23) Noubiap JJ, Agbaedeng TA, Tochie JN et al : Meta-analysis comparing the frequency of carotid artery stenosis in patients with atrial fibrillation and vice versa. Am J Cardiol 138 : 72-79, 2021
24) Kupper C, Feil K, Wollenweber FA et al ; GSR investigators : Endovascular stroke treatment in orally anticoagulated patients : an analysis from the German Stroke Registry-Endovascular Treatment. J Neurol 268 : 1762-1769, 2021
25) Goldhoorn RB, van de Graaf RA, van Rees JM et al ; MR CLEAN Registry Investigators? Group Authors : Endovascular treatment for acute ischemic stroke in patients on oral anticoagulants : results from the MR CLEAN Registry. Stroke 51 : 1781-1789, 2020
26) Meinel TR, Kaesmacher J, Gralla J et al : MRI characteristics in acute ischemic stroke patients with preceding direct oral anticoagulant therapy as compared to vitamin K antagonists. BMC Neurol 20 : 86, 2020
P.94 掲載の参考文献
27) Connolly SJ, Crowther M, Eikelboom JW et al ; ANNEXA-4 Investigators : Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. N Engl J Med 380 : 1326-1335, 2019
P.95 掲載の参考文献
28) Osmancik P, Herman D, Neuzil P et al ; PRAGUE-17 Trial Investigators : Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation. J Am Coll Cardiol 75 : 3122-3135, 2020
29) Tavares SF, Ferreira I, Chaves V et al : Acute ischemic stroke outcome and preceding anticoagulation : direct oral anticoagulants versus vitamin K antagonists. J Stroke Cerebrovasc Dis 29 : 104691, 2020
P.96 掲載の参考文献
30) Okada M, Inoue K, Tanaka N et al ; J-ELD AF investigators : Clinical outcomes of very elderly patients with atrial fibrillation receiving on-label doses of apixaban : JELD AF Registry subanalysis. J Am Heart Assoc 10 : e021224, 2021
31) Yamashita T, Suzuki S, Inoue H et al : Two-year outcomes of more than 30 000 elderly patients with atrial fibrillation : results from the All Nippon AF In the Elderly (ANAFIE) Registry. Eur Heart J Qual Care Clin Outcomes 8 : 202-213, 2022
P.97 掲載の参考文献
1) Duncan PW, Bushnell C, Sissine M et al : Comprehensive stroke care and outcomes : time for a paradigm shift. Stroke 52 : 385-393, 2021
P.98 掲載の参考文献
2) Morris S, Ramsay AIG, Boaden RJ et al : Impact and sustainability of centralising acute stroke services in English metropolitan areas : retrospective analysis of hospital episode statistics and stroke national audit data. BMJ 364 : l1, 2019
3) Stein LK, Mocco J, Fifi J et al : Correlations between physician and hospital stroke thrombectomy volumes and outcomes : a nationwide analysis. Stroke 52 : 2858-2865, 2021
P.99 掲載の参考文献
4) Takagi T, Yoshimura S, Sakai N et al : Distribution and current problems of acute endovascular therapy for large artery occlusion from a two-year national survey in Japan. Int J Stroke 15 : 289-298, 2020
5) Kurogi A, Onozuka D, Hagihara A et al : Influence of hospital capabilities and prehospital time on outcomes of thrombectomy for stroke in Japan from 2013 to 2016. Sci Rep 12 : 3252, 2022
6) Schlemm L, Endres M, Nolte CH : Bypassing the closest stroke center for thrombectomy candidates : what additional delay to thrombolysis is acceptable? Stroke 51 : 867-875, 2020
P.100 掲載の参考文献
7) Okuno Y, Yamagami H, Kataoka H et al : Field assessment of critical stroke by emergency services for acute delivery to a comprehensive stroke center : FACE2AD. Transl Stroke Res 11 : 664-670, 2020
8) Elijovich L, Dornbos Iii D, Nickele C et al : Automated emergent large vessel occlusion detection by artificial intelligence improves stroke workflow in a hub and spoke stroke system of care. J Neurointerv Surg 14 : 704-708, 2022
P.101 掲載の参考文献
9) Nishimura K, Ogasawara K, Kitazono T et al : Impact of physician volume and specialty on in-hospital mortality of ischemic and hemorrhagic stroke. Circ J 85 : 1876-1884, 2021
10) Menon BK, Xu H, Cox M et al : Components and trends in door to treatment times for endovascular therapy in get with the guidelines-stroke hospitals. Circulation 139 : 169-179, 2019
P.102 掲載の参考文献
11) Ren N, Nishimura A, Kurogi A et al : Measuring quality of care for ischemic stroke treated with acute reperfusion therapy in Japan-the close the gap-stroke. Circ J 85 : 201-209, 2021
12) Grotta JC, Yamal JM, Parker SA et al : Prospective, multicenter, controlled trial of mobile stroke units. N Engl J Med 385 : 971-981, 2021
13) Maas WJ, Lahr MMH, Buskens E et al : Pathway design for acute stroke care in the era of endovascular thrombectomy : a critical overview of optimization efforts. Stroke 51 : 3452-3460, 2020
P.103 掲載の参考文献
14) Shah S, Xian Y, Sheng S et al : Use, temporal trends, and outcomes of endovascular therapy after interhospital transfer in the United States. Circulation 139 : 1568-1577, 2019
15) Dijkland SA, Jaja BNR, van der Jagt M et al : Between-center and between-country differences in outcome after aneurysmal subarachnoid hemorrhage in the Subarachnoid Hemorrhage International Trialists (SAHIT) repository. J Neurosurg doi : 10.3171/2019.5.JNS19483, 2019 [online ahead of print]
P.104 掲載の参考文献
16) Kurogi R, Kada A, Ogasawara K et al : Effects of case volume and comprehensive stroke center capabilities on patient outcomes of clipping and coiling for subarachnoid hemorrhage. J Neurosurg 134 : 929-939, 2020
17) Yang Q, Tong X, Coleman King S et al : Stroke hospitalizations before and during COVID-19 pandemic among medicare beneficiaries in the United States. Stroke 52 : 3586-3601, 2021
P.105 掲載の参考文献
18) Katsanos AH, Palaiodimou L, Zand R et al : Changes in stroke hospital care during the COVID-19 pandemic : a systematic review and meta-analysis. Stroke 52 : 3651-3660, 2021
19) Martins SO, Mont'Alverne F, Rebello LC et al : Thrombectomy for stroke in the public health care system of Brazil. N Engl J Med 382 : 2316-2326, 2020
20) Kunz WG, Hunink MG, Almekhlafi MA et al : Public health and cost consequences of time delays to thrombectomy for acute ischemic stroke. Neurology 95 : e2465-e2475, 2020
P.108 掲載の参考文献
1) Jovin TG, Nogueira RG, Lansberg MG et al : Thrombectomy for anterior circulation stroke beyond 6 h from time last known well (AURORA) : a systematic review and individual patient data meta-analysis. Lancet 399 : 249-258, 2022
2) Albers GW, Lansberg MG, Brown S et al : Assessment of optimal patient selection for endovascular thrombectomy beyond 6 hours after symptom onset : a pooled analysis of the AURORA database. JAMA Neurol 78 : 1064-1071, 2021
3) 日本脳卒中学会, 日本脳神経外科学会, 日本脳神経血管内治療学会 : 経皮経管的脳血栓回収用機器適正使用指針 第4版 2020年3月. 脳卒中 42 : 281-313, 2020
4) Lapergue B, Blanc R, Costalat V et al : Effect of thrombectomy with combined contact aspiration and stent retriever vs stent retriever alone on revascularization in patients with acute ischemic stroke and large vessel occlusion : the ASTER2 randomized clinical trial. JAMA 326 : 1158-1169, 2021
5) Liu X, Dai Q, Ye R et al : Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST) : an open-label, randomised controlled trial. Lancet Neurol 19 : 115-122, 2020
6) Langezaal LCM, van der Hoeven EJRJ, Mont'Alverne FJA et al : Endovascular therapy for stroke due to basilar-artery occlusion. N Engl J Med 384 : 1910-1920, 2021
P.109 掲載の参考文献
8) Yang P, Zhang Y, Zhang L et al : Endovascular thrombectomy with or without intravenous alteplase in acute stroke. N Engl J Med 382 : 1981-1993, 2020
9) Zi W, Qiu Z, Li F et al : Effect of endovascular treatment alone vs intravenous Alteplase plus endovascular treatment on functional independence in patients with acute ischemic stroke : The DEVT Randomized Clinical Trial. JAMA 325 : 234-243, 2021
10) Suzuki K, Matsumaru Y, Takeuchi M et al : Effect of mechanical thrombectomy without vs with intravenous thrombolysis on functional outcome among patients with acute ischemic stroke : the SKIP randomized clinical trial. JAMA 325 : 244-253, 2021
11) LeCouffe NE, Kappelhof M, Treurniet KM et al : A randomized trial of intravenous alteplase before endovascular treatment for stroke. N Engl J Med 385 : 1833-1844, 2021
12) 一般社団法人日本脳卒中学会脳卒中ガイドライン委員会編 : 脳卒中治療ガイドライン 2021. 協和企画, 2021
13) Hill MD, Goyal M, Menon BK et al : Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1) : a multicentre, double-blind, randomised controlled trial. Lancet 395 : 878-887, 2020
P.110 掲載の参考文献
14) Renu A, Millan M, Roman LS et al : Effect of intra-arterial alteplase vs placebo following successful thrombectomy on functional outcomes in patients with large vessel occlusion acute ischemic stroke. the CHOICE randomized clinical trial. JAMA 327 : 826-835, 2022
15) Schonenberger S, Henden PL, Simonsen CZ et al : Association of general anesthesia vs procedural sedation with functional outcome among patients with acute ischemic stroke undergoing thrombectomy : a systematic review and meta-analysis. JAMA 322 : 1283-1293, 2019
16) Mazighi M, Richard S, Lapergue B et al : Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET) : a multicentre, open-label, randomised controlled trial. Lancet Neurol 20 : 265-274, 2021
17) van der Steen W, van de Graaf RA, Chalos V et al : Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED) : an open-label, multicentre, randomised controlled trial. Lancet 399 : 1059-1069, 2022
P.111 掲載の参考文献
18) Requena M, Olive-Gadea M, Muchada M et al : Direct to angiography suite without stopping for computed tomography imaging for patients with acute stroke : a randomized clinical trial. JAMA Neurol 78 : 1099-1107, 2021
19) 早川幹人 : Clinical Topics感染症・炎症疾患新型コロナウイルスと脳卒中. Annual Review 神経 2021, 中外医学社, 158-165, 2021
20) AHA/ASA Stroke Council Leadership : Temporary emergency guidance to US Stroke Centers during the coronavirus disease 2019 (COVID-19) pandemic : on behalf of the American Heart Association/American Stroke Association Stroke Council Leadership. Stroke 51 : 1910-1912, 2020
21) Khosravani H, Rajendram P, Notario L et al : Protected code stroke : hyperacute stroke management during the coronavirus disease 2019 (COVID-19) pandemic. Stroke 51 : 1891-1895, 2020
22) 日本脳卒中学会, COVID-19対策プロジェクトチーム, JSS-PCS作成ワーキンググループ : COVID-19対応脳卒中プロトコル (日本脳卒中学会版Protected Code Stroke : JSS-PCS). 脳卒中 42 : 315-343, 2020
P.112 掲載の参考文献
23) Oxley TJ, Mocco J, Majidi S et al : Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 382 : e60, 2020
24) Yaghi S, Ishida K, Torres J et al : SARS-CoV-2 and stroke in a New York healthcare system. Stroke 51 : 2002-2011, 2020
25) Srivastava PK, Zhang S, Xian Y et al : Acute ischemic stroke in patients with COVID-19 : an analysis from Get With The Guidelines-Stroke. Stroke 52 : 1826-1829, 2021
26) Jabbour P, Dmytriw AA, Sweid A et al : Characteristics of a COVID-19 cohort with large vessel occlusion : a multicenter international study. Neurosurgery 90 : 725-733, 2022
27) Cagnazzo F, Piotin M, Escalard S et al : European multicenter study of ET-COVID-19. Stroke 52 : 31-39, 2021
28) Styczen H, Maus V, Goertz L et al : Mechanical thrombectomy for acute ischemic stroke in COVID-19 patients : multicenter experience in 111 cases. J Neurointerv Surg 14 : 858-862, 2022
29) Hernandez-Fernandez F, Valencia HS, Barbella-Aponte RA et al : Cerebrovascular disease in patients with COVID-19 : neuroimaging, histological and clinical description. Brain 143 : 3089-3103, 2020
30) Janardhan V, Janardhan V, Kalousek V : COVID-19 as a blood clotting disorder masquerading as a respiratory illness : a cerebrovascular perspective and therapeutic implications for stroke thrombectomy. J Neuroimaging 30 : 555-561, 2020
P.113 掲載の参考文献
1) Guglielmi G, Vinuela F, Sepetka I et al : Electrothrothrombosis of saccular aneurysms viaendovascular approach. Part 1 : electrochemical basis, technique, and experimental results. J Neurosurg 75 : 1-7, 1991
2) Guglielmi G, Vinuela F, Dion J et al : Electrothrombosis of saccular aneurysms via endovascular approach. Part2 : preliminary clinical experience. J Neurosurg 75 : 8-14, 1991
3) Salem MM, Ravindran K, Enriquez-Marulanda A et al : Pipeline embolization device versus stent-assisted coiling for intracranial aneurysm treatment : a retrospective propensity score-matched study. Neurosurgery 87 : 516-522, 2020
P.114 掲載の参考文献
4) Bendok BR, Abi-Aad KR, Ward JD et al : The hydrogel endovascular aneurysm treatment trial (HEAT) : a randomized controlled trial of the second-generation hydrogel coil. Neurosurgery 86 : 615-624, 2020
5) Zaidat OO, Hanel RA, Sauvageau EA et al : Pivotal trial of the neuroform atlas stent for treatment of anterior circulation aneurysms : one-year outcomes. Stroke 51 : 2087-2094, 2020
6) Jankowitz BT, Jadhav AP, Gross B et al : Pivotal trial of the Neuroform Atlas stent for treatment of posterior circulation aneurysms : one-year outcomes. J Neurointerv Surg. 14 : 143-148, 2022
7) Monteiro A, Cortez GM, Aghaebrahim A et al : Low-profile Visualized Intraluminal Support Jr Braided Stent versus Atlas Self-expandable Stent for treatment of intracranial aneurysms : a single center experience. Neurosurgery 88 : E170-E178, 2021
8) Vollherbst DF, Berlis A, Maurer C et al : Periprocedural safety and feasibility of the new LVIS EVO device for stent-assisted coiling of intracranial aneurysms : an observational multicenter study. AJNR Am J Neuroradiol 42 : 319-326, 2021
9) Foo M, Maingard J, Hall J et al : Endovascular treatment of intracranial aneurysms using the novel Low Profile Visualized Intraluminal Support EVO stent : multicenter early feasibility experience. Neurointervention 16 : 122-131, 2021
P.115 掲載の参考文献
10) Pierot L, Barbe C, Herbreteau D et al : Rebleeding and bleeding in the year following intracranial aneurysm coiling : analysis of a large prospective multicenter cohort of 1140 patients-Analysis of Recanalization after Endovascular Treatment of Intracranial Aneurysm (ARETA) Study. J Neurointerv Surg 12 : 1219-1225, 2020
11) Pierot L, Barbe C, Herbreteau D et al : Delayed thromboembolic events after coiling of unruptured intracranial aneurysms in a prospective cohort of 335 patients. J Neurointerv Surg 13 : 534-540, 2021
12) Spiotta AM, Chaudry MI, Turner RD 4th et al : An update on the Adjunctive Neurovascular Support of wide-neck aneurysm embolization and reconstruction trial : 1-year safety and angiographic results. AJNR Am J Neuroradiol 39 : 848-851, 2018
P.116 掲載の参考文献
13) Pierot L, Szikora I, Barreau X et al : Aneurysm treatment with WEB in the cumulative population of two prospective, multicenter series : 3-year follow-up. J Neurointerv Surg 13 : 363-368, 2021
14) Youssef PP, Dornbos Iii D, Peterson J et al : Woven EndoBridge (WEB) device in the treatment of ruptured aneurysms. J Neurointerv Surg 13 : 443-446, 2021
15) Peterson C, Cord BJ : recurrent and residual aneurysms after Woven EndoBridge (WEB) therapy : What's next? Cureus 13 : e14404, 2021
P.117 掲載の参考文献
1) Becske T, Kallmes DF, Saatci I et al : Pipeline for uncoilable or failed aneurysms : results from a multicenter clinical trial. Radiology 267 : 858-868, 2013
2) Hanel RA, Kallmes DF, Lopes DK et al : Prospective study on embolization of intracranial aneurysms with the pipeline device : the PREMIER study 1 year results. J Neurointerv Surg 12 : 62-66, 2020
P.118 掲載の参考文献
3) Rinaldo L, Brinjikji W, Cloft H et al : Effect of fetal posterior circulation on efficacy of flow diversion for treatment of posterior communicating artery aneurysms : a multi-institutional study. World Neurosurg 127 : e1232-e1236, 2019
4) Hanel RA, Cortez GM, Lopes DK et al : Prospective study on embolization of intracranial aneurysms with the pipeline device (PREMIER study) : 3-year results with the application of a flow diverter specific occlusion classification. J Neurointerv Surg doi : 10.1136/neurintsurg-2021-018501, 2022 [online ahead of print]
5) Becske T, Brinjikji W, Potts MB et al : Long-term clinical and angiographic outcomes following pipeline embolization device treatment of complex internal carotid artery aneurysms : five-year results of the pipeline for uncoilable or failed aneurysms trial. Neurosurgery 80 : 40-48, 2017
6) Lylyk I, Scrivano E, Lundquist J et al : Pipeline Embolization Devices for the treatment of intracranial aneurysms, single-center registry : long-term angiographic and clinical outcomes from 1000 aneurysms. Neurosurgery 89 : 443-449, 2021
7) Pierot L, Spelle L, Berge J et al : SAFE study (Safety and efficacy Analysis of FRED Embolic device in aneurysm treatment) : 1-year clinical and anatomical results. J Neurointerv Surg 11 : 184-189, 2019
P.119 掲載の参考文献
8) Meyers PM, Coon AL, Kan PT et al : SCENT trial. Stroke 50 : 1473-1479, 2019
9) Foreman PM, Ilyas A, Cress MC et al : Ruptured intracranial aneurysms treated with the Pipeline Embolization Device : a systematic review and pooled analysis of individual patient data. AJNR Am J Neuroradiol 42 : 720-725, 2021
10) Mokin M, Chinea A, Primiani CT et al : Treatment of blood blister aneurysms of the internal carotid artery with flow diversion. J Neurointerv Surg 10 : 1074-1078, 2018
P.120 掲載の参考文献
11) Mohlenbruch MA, Seker F, Ozluk E et al : Treatment of ruptured blister-like aneurysms with the FRED flow diverter : a multicenter experience. AJNR Am J Neuroradiol 41 : 2280-2284, 2020
12) Rice H, Martinez Galdamez M, Holtmannspotter M et al : Periprocedural to 1-year safety and efficacy outcomes with the Pipeline Embolization Device with Shield technology for intracranial aneurysms : a prospective, post-market, multicenter study. J NeuroInterv Surg 12 : 1107-1112, 2020
13) Pikis S, Mantziaris G, Mamalis V et al : Diffusion weighted image documented cerebral ischemia in the postprocedural period following pipeline embolization device with shield technology treatment of unruptured intracranial aneurysms : a prospective, single center study. J Neurointerv Surg 12 : 407-411, 2020
P.121 掲載の参考文献
14) Li YL, Roalfe A, Chu EY et al : Outcome of flow diverters with surface modifications in treatment of cerebral aneurysms : systematic review and meta-analysis. AJNR Am J Neuroradiol 42 : 327-333, 2021
15) de Castro-Afonso LH, Nakiri GS, Abud TG et al : Aspirin monotherapy in the treatment of distal intracranial aneurysms with a surface modified flow diverter : a pilot study. J Neurointerv Surg 13 : 336-341, 2021
16) Foreman PM, Salem MM, Griessenauer CJ et al : Flow diversion for treatment of partially thrombosed aneurysms : a multicenter cohort. World Neurosurg 135 : e164-e173, 2020
17) Hanel RA, Monteiro A, Nelson PK et al : Predictors of incomplete aneurysm occlusion after treatment with the Pipeline Embolization Device : PREMIER trial 1 year analysis. J Neurointerv Surg doi : 10.1136/neurintsurg-2021-018054, 2021 [online ahead of print]
18) Guedon A, Thepenier C, Shotar E et al : Predictive score for complete occlusion of intracranial aneurysms treated by flow-diverter stents using machine learning. J Neurointerv Surg 13 : 341-346, 2021
19) Shiraz Bhurwani MM, Waqas M, Podgorsak AR et al : Feasibility study for use of angiographic parametric imaging and deep neural networks for intracranial aneurysm occlusion prediction. J Neurointerv Surg 12 : 714-719, 2020
P.122 掲載の参考文献
20) Fukuda H, Sato D, Kato Y et al : Comparing retreatments and expenditures in flow diversion versus coiling for unruptured intracranial aneurysm treatment : a retrospective cohort study using a real-world national database. Neurosurgery 87 : 63-70, 2020
P.123 掲載の参考文献
1) Batchelder AJ, Saratzis A, Ross Naylor A : Editor's choice-overview of primary and secondary analyses from 20 randomised controlled trials comparing carotid artery stenting with carotid endarterectomy. Eur J Vasc Endovasc Surg 58 : 479-493, 2019
P.124 掲載の参考文献
2) Halliday A, Bulbulia R, Bonati LH et al : Second asymptomatic carotid surgery trial (ACST-2) : a randomized comparison of carotid artery stenting versus carotid endarterectomy. Lancet 398 : 1065-1073, 2021
3) Meschia JF, Barrett KM, Brown RD Jr et al : The CREST-2 experience with the evolving challenges of COVID-19 : a clinical trial in a pandemic. Neurology 95 : 29-36, 2020
4) Reiff T, Eckstein HH, Mansmann U et al : Angioplasty in asymptomatic carotid artery stenosis vs. endarterectomy compared to best medical management : oneyear interim results of SPACE-2. Int J Stroke 15 : 1747493019833017, 2019
5) Savardekar AR, Narayan V, Patra DP et al : Timing of carotid endarterectomy for symptomatic carotid stenosis : a snapshot of current trends and systemic review of literature on changing paradigm towards early surgery. Neurosurgery 85 : E214-E225, 2019
P.125 掲載の参考文献
6) Cui CL, Dakour-Aridi H, Lu JJ et al : Inhospital outcomes of urgent, early, or late revascularization for symptomatic carotid artery stenosis. Stroke 53 : 100-107, 2022
7) Howard VJ, Algra A, Howard G et al : Absence of consistent sex differences in outcomes from symptomatic carotid endarterectomy and stenting randomized trials. Stroke 52 : 416-423, 2021
8) Gasbarrino K, Di Iorio D, Daskalopoulou SS : Importance of sex and gender in ischemic stroke and carotid atherosclerotic disease. Eur Heart J 43 : 460-473, 2022
9) Tzoumas A, Xenos D, Giannopoulos S et al : Revascularization approaches in patients with radiation-induced carotid stenosis : an updated systematic review and meta-analysis. Kardiol Pol 79 : 645-653, 2021
P.126 掲載の参考文献
10) Kashyap VS, Schneider PA, Foteh M et al : Early outcomes in the ROADSTER 2 study of transcarotid artery revascularization in patients with significant carotid artery disease. Stroke 51 : 2620-2629, 2020
11) Galyfos GC, Tsoutsas I, Konstantopoulos T et al : Editor's choice-early and late outcomes after transcarotid revascularization for internal carotid artery stenosis : a systematic review and meta-analysis. Eur J Vasc Endovasc Surg 61 : 725-738, 2021
12) Cheng SF, Richards T, Gregson J et al : Long term restenosis rate after carotid endarterectomy : comparison of three surgical technique and intra-operative shunt use. Eur J Vasc Endovasc Surg 62 : 513-521, 2021
13) Khan JM, Mclnnis CL, Ross-White A et al : Overview and diagnostic accuracy of near infrared spectroscopy in carotid endarterectomy : a systemic review and meta-analysis. Eur J Vasc Endovasc Surg 62 : 695-704, 2021
14) Hasan D, Zanaty M, Starke RM et al : Feasibility, safety, and changes in systolic blood pressure associated with endovascular revascularization of symptomatic and chronically occluded cervical internal carotid artery using a newly suggested radiographic classification of chronically occluded cervical internal carotid artery : pilot study. J Neurosurg doi : 10.3171/2018.1.JNS172858, 2018 [online ahead of print]
15) Zanaty M, Roa JA, Jabbour PM et al : Recanalization of the chronically occluded internal carotid artery : review of the literature. World Neurosurg X 5 : 100067, 2019
P.127 掲載の参考文献
16) Karpenko A, Bugurov S, Ignatenko P et al : Randomized controlled trial of conventional versus MicroNet-covered stent in carotid artery revascularization. JACC Cardiovasc Interv 14 : 2377-2387, 2021
17) Carvalho P, Coelho A, Mansilha A : Effectiveness and safety of dual-layer stents in carotid artery disease : a systematic review. Int Angiol 40 : 97-104, 2021
18) Feil K, Herzberg M, Dorn F et al : Tandem lesions in anterior circulation stroke : analysis of the German Stroke Registry-Endovascular Treatment. Stroke 52 : 1265-1275, 2021
19) Anadani M, Marnat G, Consoli A et al : Endovascular therapy of anterior circulation tandem occlusions : pooled analysis from the TITAN and ETIS registries. Stroke 52 : 3097-3105, 2021
20) Zevallos CB, Farooqui M, Quispe-Orozco D et al : Acute carotid artery stenting versus balloon angioplasty for tandem occlusions : a systematic review and meta-analysis. J Am Heart Assoc 11 : e022335, 2022
21) de Vries EE, Vonken EJ, Kappelle LJ et al : Short-term double layer mesh stent patency for emergent or elective carotid artery stenting : a single center experience. Stroke 50 : 1898-1901, 2019
P.128 掲載の参考文献
22) Igarashi S, Ando T, Takahashi T et al : Development of cerebral microbleeds in patients with hyperperfusion following carotid endarterectomy and its relation to postoperative cognitive decline. J Neurosurg doi : 10.3171/2020.7.JNS202353, 2021 [online ahead of print]
23) Hayakawa M, Sugiu K, Yoshimura S et al : Effectiveness of staged angioplasty for avoidance of cerebral hyperperfusion syndrome after carotid revascularization. J Neurosurg doi : 10.3171/2018.8.JNS18887, 2019 [online ahead of print]
24) Zhao B, Jiang X, Wang P et al : Staged angioplasty : a sensible approach to prevent hyperperfusion syndrome after carotid artery stenting? A meta-analysis. Interv Neuroradiol 28 : 115-123, 2022
25) Kamtchum-Tatuene J, Noubiap JJ, Wilman AH et al : Prevalence of high-risk plaques and risk of stroke in patients with asymptomatic carotid stenosis : a meta-analysis. JAMA Neurol 77 : 1524-1535, 2020
26) Kelly PJ, Camps-Renom P, Giannotti N et al : A risk score including carotid plaque inflammation and stenosis severity improves identification of recurrent stroke. Stroke 51 : 838-845, 2020
27) Nardi V, Benson J, Bois MC et al : Carotid plaques from symptomatic patients with mild stenosis is associated with intraplaque hemorrhage. Hypertension 79 : 271-282, 2022
P.129 掲載の参考文献
1) Yusuf S, Joseph P, Rangarajan S et al : Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, amd low-income countries (PURE) : a prospective cohort study. Lancet 395 : 765-808, 2020
2) Flint AC, Conell C, Ren X et al : Effect of systolic and diastolic blood pressure on cardiovascular outcomes. N Engl J Med 381 : 243-251, 2019
3) Musini VM, Tejani AM, Bassett K et al : Pharmacotherapy for hypertension in adults 60 years or older. Cochrane Database Syst Rev 6 : CD000028, 2019
P.130 掲載の参考文献
4) Asayama K, Kinoshita Y, Watanabe S et al : Impact of diastolic blood pressure threshold for the young population : the Japan Arteriosclerosis Longitudinal Study (JALS). J Hypertens 37 : 652-653, 2019
5) Harada A, Ueshima H, Kinoshita Y et al : Absolute risk score for stroke, myocardial infarction, and all cardiovascular disease : Japan Arteriosclerosis Longitudinal Study. Hypertens Res 42 : 567-579, 2019
6) Kitagawa K, Yamamoto Y, Arima H et al : Effect of standard vs intensive blood pressure control on the risk of recurrent stroke. A randomized clinical trial and meta-analysis. JAMA Neurol 76 : 1309-1318, 2019
7) Boncoraglio GB, Del Giovane C, Tramacere I : Antihypertensive drugs for secondary prevention after ischemic stroke or transient ischemic attack. A systematic review and meta-analysis. Stroke 52 : 1974-1982, 2021
P.131 掲載の参考文献
8) Armed N, Audebert H, Turc G et al : Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11-13 November 2018. Eur Stroke J 4 : 307-317, 2019
9) Rasmussen M, Schonenberger S, Henden PL et al : Blood pressure thresholds and neurologic outcomes after endovascular therapy for acute ischemic stroke : an analysis of individual patient data from 3 randomized clinical trials. JAMA Neurol 77 : 622-631, 2020
10) Anderson CS, Huang Y, Lindley RI et al : Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED) : an international, randomised, open-label, blinded-endpoint, phase 3 trial. Lancet 393 : 877-888, 2019
11) Bang OY, Chung JW, Kim SK et al : Therapeutic-induced hypertension in patient with noncardioembolic acute stroke. Neurology 93 : e1955-e1963, 2019
P.132 掲載の参考文献
12) Toyoda K, Koga M, Yamamoto H et al : Clinical outcomes depending on acute blood pressure after cerebral hemorrhage. Ann Neurol 85 : 105-113, 2019
13) Cholesterol Treatment Trialists' Collaboration : Efficacy and safety of statin therapy in older people : a meta-analysis of individual participant data from 28 randomised controlled trials. Lancet 393 : 407-415, 2019
14) Toth PP, Fazio S, Wong ND et al : Risk of cardiovascular events in patients with hypertriglyceridaemia : a review of real-world evidence. Diabetes Obes Metab 22 : 279-289, 2020
15) Lawler PR, Kotrri G, Koh M et al : Real-world risk of cardiovascular outcomes associated with hypertriglyceridaemia among individuals with atherosclerotic cardiovascular disease and potential eligibility for emerging therapies. Eur Heart J 41 : 86-94, 2020
P.133 掲載の参考文献
16) Marston NA, Giugliano RP, Im K et al : Association between triglyceride lowering and reduction of cardiovascular risk across multiple lipid-lowering therapeutic classes. A systematic review and meta-regression analysis of randomized controlled trials. Circulation 140 : 1308-1317, 2019
17) Hoshino T, Ishizuka K, Toi S et al : Athrogenic dyslipidemia and residual vascular risk after stroke or transient ischemic attack. Stroke 52 : 79-86, 2022
18) Bhatt DL, Steg PG, Miller M et al : Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med 380 : 11-22, 2019
19) Tan C, Liu X, Mo L et al : Statin, cholesterol, and sICH after acute ischemic stroke : systematic review and meta-analysis. Neurol Sci 40 : 2267-2275, 2019
20) He L, Xu R, Wang J et al : Prestroke statins use reduces oxidized low density lipoprotein levels and improves clinical outcomes in patients with atrial fibrillation related acute ischemic stroke. BMC Neurol 19 : 240, 2019
21) Amarenco P, Kim JS, Labreuche J et al : A comparison of two LDL cholesterol targets after ischemic stroke. N Engl J Med 382 : 9, 2020
P.134 掲載の参考文献
22) Amarenco P, Hobeanu C, Labreuche J et al : Carotid atherosclerosis evolution when targeting a low-density lipoprotein cholesterol concentration < 70 mg/dL after an ischemic stroke of atherosclerotic origin. Circulation 142 : 748-757, 2020
23) Tramacere I, Boncoraglio GB, Banzi R et al : Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack : a systematic review and network meta-analysis. BMC Med 17 : 67, 2019
24) Skotsimara G, Antonopoulos AS, Oikonomou E et al : Cardiovascular effects of electronic cigarettes : a systematic review and meta-analysis. Eur J Prev Caridol 26 : 1219-1228, 2019
25) George J, Hussain M, Vadiveloo T et al : Cardiovascular effects of switching from tobacco cigarettes to electronic cigarettes. J Am Coll Cardiol 74 : 3112-3120, 2019
III章 脳外傷
P.136 掲載の参考文献
1) Nakae R, Murai Y, Morita A et al : Coagulopathy and traumatic brain injury : overview of new diagnostic and therapeutic strategies. Neurol Med Chir (Tokyo) 62 : 261-269, 2022
2) Nakae R, Yokobori S, Takayama Y et al : A retrospective study of the effect of fibrinogen levels during fresh frozen plasma transfusion in patients with traumatic brain injury. Acta Neurochir (Wien) 161 : 1943-1953, 2019
P.137 掲載の参考文献
3) Nakae R, Fujiki Y, Takayama Y et al : Age-related differences in the time course of coagulation and fibrinolytic parameters in patients with traumatic brain injury. Int J Mol Sci 21 : 5613, 2020
4) Nakae R, Fujiki Y, Takayama Y et al : Time course of coagulation and fibrinolytic parameters in pediatric traumatic brain injury. J Neurosurg Pediatr 28 : 526-532, 2021
5) Scotti P, Seguin C, Lo BWY et al : Antithrombotic agents and traumatic brain injury in the elderly population : hemorrhage patterns and outcomes. J Neurosurg doi : 10.3171/2019.4.JNS19252, 2019 [online ahead of print]
7) Wettervik TS, Lenell S, Enblad P et al : Pre-injury antithrombotic agents predict intracranial hemorrhagic progression, but not worse clinical outcome in severe traumatic brain injury. Acta Neurochir (Wien) 163 : 1403-1413, 2021
P.138 掲載の参考文献
8) Yorkgitis BK, Tatum DM, Taghavi S et al : Eastern association for the surgery of trauma multicenter trial : comparison of pre-injury antithrombotic use and reversal strategies among severe traumatic brain injury patients. J Trauma Acute Care Surg 92 : 88-92, 2022
9) Robba C, Graziano F, Rebora P et al : Intracranial pressure monitoring in patients with acute brain injury in the intensive care unit (SYNAPSE-ICU) : an international, prospective observational cohort study. Lancet Neurol 20 : 548-558, 2021
10) Hawryluk GWJ, Aguilera S, Buki A et al : A management algorithm for patients with intracranial pressure monitoring : the Seattle international severe traumatic brain injury consensus conference (SIBICC). Intensive Care Med 45 : 1783-1794, 2019
P.139 掲載の参考文献
11) Chesnut R, Aguilera S, Buki A et al : A management algorithm for adult patients with both brain oxygen and intracranial pressure monitoring : the Seattle international severe traumatic brain injury consensus conference (SIBICC). Intensive Care Med 46 : 919-929, 2020
12) Hays LMC, Udy A, Adamides AA et al : Effects of brain tissue oxygen (PbtO2) guided management on patient outcomes following severe traumatic brain injury : a systematic review and meta-analysis. J Clin Neurosci 99 : 349-358, 2022
13) Schepici G, Silvestro S, Bramanti P et al : Traumatic brain injury and stem cells : an overview of clinical trials, the current treatments and future therapeutic approaches. Medicina (Kaunas) 56 : 137, 2020
14) Yasuhara T, Kawauchi S, Kin K et al : Cell therapy for central nervous system disorders : current obstacles to progress. CNS Neurosci Ther 26 : 595-602, 2020
15) Cozene B, Sadanandan N, Farooq J et al : Mesenchymal stem cell-induced anti-neuroinflammation against traumatic brain injury. Cell Transplant 30 : 9636897211035715, 2021
16) Kawabori M, Weintraub AH, Imai H et al : Cell therapy for chronic TBI : interim analysis of the randomized controlled STEMTRA Trial. Neurology 96 : e1202-e1214, 2021
P.140 掲載の参考文献
17) Wilkins TE, Beers SR, Borrasso AJ et al : Favorable functional recovery in severe traumatic brain injury survivors beyond six months. J Neurotrauma 36 : 3158-3163, 2019
18) McCrea MA, Giacino JT, Barber J et al : Functional outcomes over the first year after moderate to severe traumatic brain injury in the prospective, longitudinal TRACK-TBI study. JAMA Neurol 78 : 982-992, 2021
19) Suehiro E, Kiyohira M, Haji K et al : Changes in outcomes after discharge from an acute hospital in severe traumatic brain injury. Neurol Med Chir (Tokyo) 62 : 111-117, 2022
20) Forslund MV, Perrin PB, Roe C et al : Global outcome trajectories up to 10 years after moderate to severe traumatic brain injury. Front Neurol 10 : 219, 2019
P.141 掲載の参考文献
1) Van Pelt KL, Puetz T, Swallow J et al : Data-driven risk classification of concussion rates : a systematic review and meta-analysis. Sports Med 51 : 1227-1244, 2021
2) Cheng J, Ammerman B, Santiago K et al : Sex-based differences in the incidence of sports-related concussion : systematic review and meta-analysis. Sports Health 11 : 486-491, 2019
3) Ling DI, Cheng J, Santiago K et al : Women are at higher risk for concussions due to ball or equipment contact in soccer and lacrosse. Clin Orthop Relat Res 478 : 14691479, 2020
P.142 掲載の参考文献
4) 荻野雅宏, 中山晴雄, 重森裕他 : スポーツにおける脳振盪に関する共同声明-第5回スポーツ脳振盪会議 (ベルリン, 2016) -解説と翻訳. 神経外傷 42 : 1-34, 2019
5) Zuckerman SL, Yengo-Kahn AM, Tang AR et al : Sport-related structural brain injury and return to play : systematic review and expert insight. Neurosurgery 88 : E495-E504, 2021
P.143 掲載の参考文献
6) 永廣信治, 谷諭, 荻野雅宏他 : スポーツ頭部外傷における脳神経外科医の対応-ガイドライン作成に向けた中間提言-. 神経外傷 36 : 119-128, 2013
7) Mannix R, Levy R, Zemek R et al : Fluid biomarkers of pediatric mild traumatic brain injury : a systematic review. J Neurotrauma 37 : 2029-2044, 2020
8) Meyer J, Bartolomei C, Sauer A et al : The relationship between fluid biomarkers and clinical outcomes in sports-related concussions : a systematic review. Brain Inj 34 : 1435-1445, 2020
9) Di Pietro V, O'Halloran P, Watson CN et al : Unique diagnostic signatures of concussion in the saliva of male athletes : the Study of Concussion in Rugby Union through MicroRNAs (SCRUM). Br J Sports Med 55 : 1395-1404, 2021
10) Chong CD, Wang L, Wang K et al : Homotopic region connectivity during concussion recovery : a longitudinal fMRI study. PLoS One 14 : e0221892, 2019
P.144 掲載の参考文献
11) Chung S, Chen J, Li T et al : Investigating brain white matter in football players with and without concussion using a biophysical model from multi shell diffusion MRI. AJNR Am J Neuroradiol 43 : 823-828, 2022
12) Lees B, Earls NE, Meares S et al : Diffusion tensor imaging in sport-related concussion : a systematic review using an a priori quality rating system. J Neurotrauma 38 : 3032-3046, 2021
13) Petraglia AL, Maroon JC, Bailes JE : From the field of play to the field of combat : a review of the pharmacological management of concussion. Neurosurgery 70 : 1520-1533, 2012
14) Feinberg C, Carr C, Zemek R et al : Association of pharmacological interventions with symptom burden reduction in patients with mild traumatic brain injury : a systematic review. JAMA Neurol 78 : 596-608, 2021
15) Standiford L, O'Daniel M, Hysell M et al : A randomized cohort study of the efficacy of PO magnesium in the treatment of acute concussions in adolescents. Am J Emerg Med 44 : 419-422, 2021
16) Baker B, Koch E, Vicari K et al : Mode and intensity of physical activity during the postacute phase of sport-related concussion : a systematic review. J Sport Rehabil 30 : 492-500, 2020
P.145 掲載の参考文献
17) Worts PR, Mason JR, Burkhart SO et al : The acute, systemic effects of aerobic exercise in recently concussed adolescent student-athletes : preliminary findings. Eur J Appl Physiol 122 : 1441-1457, 2022
18) Kontos AP, Eagle SR, Mucha A et al : A randomized controlled trial of precision vestibular rehabilitation in adolescents following concussion : preliminary findings. J Pediatr 239 : 193-199, 2021
19) Howell DR, Seehusen CN, Carry PM et al : An 8-week neuromuscular training program after concussion reduces 1-year subsequent injury risk : a randomized clinical trial. Am J Sports Med 50 : 1120-1129, 2022
20) Piedade SR, Hutchinson MR, Ferreira DM et al : The management of concussion in sport is not standardized. A systematic review. J Safety Res 76 : 262-268, 2021
21) JFA技術委員会医学委員会 : 育成年代でのヘディング習得のためのガイドライン (幼児期～U-15) 第一版. 日本サッカー協会, 2021 https://www.jfa.jp/coach/pdf/heading_guidelines.pdf
22) 国際サッカー連盟. FIFA11+日本語版. 日本サッカー協会, 2017 https://www.jfa.jp/medical/11plus.html
23) Peek K, Andersen J, McKay MJ et al : The effect of the FIFA 11+ with added neck exercises on maximal isometric neck strength and peak head impact magnitude during heading : a pilot study. Sports Med 52 : 655-668, 2022
24) McCrea MA, Shah A, Duma S et al : Opportunities for prevention of concussion and repetitive head impact exposure in college football players : a concussion assessment, research, and education (CARE) consortium study. JAMA Neurol 78 : 346-350, 2021
P.146 掲載の参考文献
25) Smith DW, Bailes JE, Fisher JA et al : Internal jugular vein compression mitigates traumatic axonal injury in a rat model by reducing the intracranial slosh effect. Neurosurgery 70 : 740-746, 2012
26) Mannix R, Morriss NJ, Conley GM et al : Internal jugular vein compression collar mitigates histopathological alterations after closed head rotational head impact in swine : a pilot study. Neuroscience 437 : 132-144, 2020
27) Diekfuss JA, Yuan W, Barber Foss KD et al : The effects of internal jugular vein compression for modulating and preserving white matter following a season of American tackle football : a prospective longitudinal evaluation of differential head impact exposure. J Neurosci Res 99 : 423-445, 2021
28) Yuan W, Diekfuss JA, Barber Foss KD et al : High school sports-related concussion and the effect of a jugular vein compression collar : a prospective longitudinal investigation of neuroimaging and neurofunctional outcomes. J Neurotrauma 38 : 2811-2821, 2021
29) Mez J, Daneshvar DH, Abdolmohammadi B et al : Duration of American football play and chronic traumatic encephalopathy. Ann Neurol 87 : 116-131, 2020
30) Mackay DF, Russell ER, Stewart K et al : Neurodegenerative disease mortality among former professional soccer players. N Engl J Med 381 : 1801-1808, 2019
P.148 掲載の参考文献
1) Duhaime AC, Christian CW : Abusive head trauma : evidence, obfuscation, and informed management. J Neurosurg Pediatr 24 : 481-488, 2019
2) Kemp AM, Dunstan F, Harrison S et al : Patterns of skeletal fractures in child abuse : systematic review. BMJ 337 : a1518, 2008
3) Hajiaghamemar M, Lan IS, Christian CW et al : Infant skull fracture risk for low height falls. Int J Legal Med 133 : 847-862, 2019
4) Tavor O, Boddu S, Glatstein M et al : The importance of skull impact site for minor mechanism head injury requiring neurosurgical intervention. Childs Nerv Syst 36 : 3021-3025, 2020
5) Boruah AP, Potter TO, Shammassian BH et al : Evaluation of nonaccidental trauma in infants presenting with skull fractures : a retrospective review. J Neurosurg Pediatr doi : 10.3171/2021.2.PEDS20872, 2021 [online ahead of print]
7) Sidpra J, Jeelani NUO, Ong J et al : Skull fracture in abusive head trauma : a single centre experience and review of the literature. Child Nerv Syst 37 : 919-929, 2021
8) Kriss S, Morris J, Martich V : Pediatric skull fractures contacting sutures : relevance in abusive head trauma. AJR 217 : 218-222, 2021
9) Ucan B, Tokur O, Aydin S : Pediatric skull fractures : could suture contact be a sign of abuse? Emerg Radiol 29 : 403-408, 2022
10) Campobasso CP, De Micco F, Bugelli V et al : Undetected traumatic diastasis of cranial sutures : a case of child abuse. Forensic Sci Int 298 : 307-311, 2019
P.149 掲載の参考文献
11) Purushothaman R, Desai S, Jayappa S et al : Utility of three-dimensional and reformatted head computed tomography images in the evaluation of pediatric abusive head trauma. Pediatr Radiol 51 : 927-938, 2021
12) Cosgrave L, Bowie S, Walker C et al : Abusive head trauma in children : radiographs of the skull do not provide additional information in the diagnosis of skull fracture when multiplanar computed tomography with three-dimensional reconstructions is available. Pediatr Radiol 52 : 924-931, 2022
13) Haq I, Jayappa S, Desai SK et al : Spinal ligamentous injury in abusive head trauma : a pictorial review. Pediatr Radiol 51 : 971-979, 2021
14) Choudhary AK, Ishak R, Zacharia TT et al : Imaging of spinal injury in abusive head trauma : a retrospective study. Pediatr Radiol 44 : 1130-1140, 2014
15) Kemp A, Cowley L, Maguire S et al : Spinal injuries in abusive head trauma : patterns and recommendations. Pediatr Radiol 44 Suppl 4 : S604-S612, 2014
16) Brennan LK, Rubin D, Christian CW et al : Neck injuries in young pediatric homicide victims. J Neurosurg Pediatr 3 : 232-239, 2009
17) Garcia-Pires F, Jayappa S, Desai S et al : Spinal subdural hemorrhage in abusive head trauma : a pictorial review. Pediatr Radiol 51 : 980-990, 2021
18) Colombari M, Troakes C, Turrina S et al : Spinal cord injury as an indicator of abuse in forensic assessment of abusive head trauma (AHT). Int J Legal Med 135 : 1481-1498, 2021
19) Rabbitt AL, Kelly TG, Yan K et al : Characteristics associated with spine injury on magnetic resonance imaging in children evaluated for abusive head trauma. Pediatr Radiol 50 : 83-97, 2020
20) Kadom N, Khademian Z, Vezina G et al : Usefulness of MRI detection of cervical spine and brain injuries in the evaluation of abusive head trauma. Pediatr Radiol 44 : 839-848, 2014
21) Oates AJ, Sidpra J, Mankad K : Parenchymal brain injuries in abusive head trauma. Pediatr Radiol 51 : 898-910, 2021
P.150 掲載の参考文献
22) Vilanilam GK, Jayappa S, Desai S et al : Venous injury in pediatric abusive head trauma : a pictorial review. Pediatr Radiol 51 : 918-926, 2021
23) Akutsu N, Nonaka M, Narisawa A et al : Infantile subdural hematoma in Japan : a multicenter, retrospective study by the JHITs (Japanese head injury of infants and toddlers study) group. PLoS One 17 : e0264396, 2022
24) Miller Ferguson N, Rebsamen S, Field AS et al : Magnetic resonance imaging findings in infants with severe traumatic brain injury and associations with abusive head trauma. Children (Basel) 9 : 1092, 2022
25) Orman G, Kralik SF, Desai NK et al : An in-depth analysis of brain and spine neuroimaging in children with abusive head trauma : beyond the classic imaging findings. AJNR Am J Neuroradiol 43 : 764-768, 2022
26) Gunda D, Cornwell BO, Dahmoush HM et al : Pediatric central nervous system imaging of nonaccidental trauma : beyond subdural hematomas. Radiographics 39 : 213-228, 2019
27) Sidpra J, Chhabda S, Oates AJ et al : Abusive head trauma : neuroimaging mimics and diagnostic complexities. Pediatr Radiol 51 : 947-965, 2021
28) Costine-Bartell B, Price G, Shen J et al : A perfect storm : the distribution of tissue damage depends on seizure duration, hemorrhage, and developmental stage in a gyrencephalic, multi-factorial, severe traumatic brain injury model. Neurobiol Dis 154 : 105334, 2021
P.151 掲載の参考文献
31) Kurz JE, Poloyac SM, Abend NS et al : Variation in anticonvulsant selection and electroencephalographic monitoring following severe traumatic brain injury in children-understanding resource availability in sites participating in a comparative effectiveness study. Pediatr Crit Care Med 17 : 649-657, 2016
32) Ruzas CM, DeWitt PE, Bennett KS et al : EEG monitoring and antiepileptic drugs in children with severe TBI. Neurocrit Care 26 : 256-266, 2017
33) Haque KD, Grinspan ZM, Mauer E et al : Early use of antiseizure medication in mechanically ventilated traumatic brain injury cases : a retrospective pediatric health information system database study. Pediatr Crit Care Med 22 : 90-100, 2021
34) Yang L, Afroz S, Valsamis HA et al : Early intervention with levetiracetam prevents the development of cortical hyperexcitability and spontaneous epileptiform activity in two models of neurotrauma in rats. Exp Neurol 337 : 113571, 2021
35) Fang T, Valdes E, Frontera JA : Levetiracetam for seizure prophylaxis in neurocritical care : a systematic review and meta-analysis. Neurocrit Care 36 : 248-258, 2022
36) Ang SC, Marret MJ, Jayanath S et al : Outcome of abusive head trauma in children less than 2 years : a single center study from a middle-income country. Child Abuse Negl 120 : 105187, 2021
P.152 掲載の参考文献
37) Chevignard MP, Lind K : Long-term outcome of abusive head trauma. Pediatr Radiol 44 Suppl 4 : S548-S558, 2014
38) Keenan HT, Runyan DK, Marshall SW et al : A population-based comparison of clinical and outcome characteristics of young children with serious inflicted and noninflicted traumatic brain injury. Pediatrics 114 : 633-639, 2004
39) Regeffe F, Chevignard M, Millet A et al : Factors associated with poor neurological outcome in children after abusive head trauma : a multicenter retrospective study. Child Abuse Negl 131 : 105779, 2022
40) Primalani NK, Chan YH, Ng ZM et al : Abusive head injury in the very young : outcomes from a Singapore children's hospital. Childs Nerv Syst doi : 10.1007/s00381-022-05572-x, 2022 [online ahead of print]
41) Miller Ferguson N, Sarnaik A, Miles D et al : Abusive head trauma and mortality-an analysis from an international comparative effectiveness study of children with severe traumatic brain injury. Crit Care Med 45 : 1398-1407, 2017
P.153 掲載の参考文献
1) van der Naalt J, Timmerman ME, de Koning ME et al : Early predictors of outcome after mild traumatic brain injury (UPFRONT) : an observational cohort study. Lancet Neurol 16 : 532-540, 2017
P.154 掲載の参考文献
2) Nelson LD, Temkin NR, Dikmen S et al : Recovery after mild traumatic brain injury in patients presenting to US Level I Trauma Centers : a Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) study. JAMA Neurol 76 : 1049-1059, 2019
3) Yuh EL, Jain S, Sun X et al : Pathological computed tomography features associated with adverse outcomes after mild traumatic brain injury : a TRACK-TBI study with external validation in CENTER-TBI. JAMA Neurol 78 : 1137-1148, 2021
4) Levin HS, Temkin NR, Barber J et al : Association of sex and age with mild traumatic brain injury-related symptoms : a TRACK-TBI study. JAMA Netw Open 4 : e213046, 2021
P.155 掲載の参考文献
5) Bussell CA, Gavett BE : Effects of media sensationalization on cognitive performance and post concussive symptoms. J Int Neuropsychol Soc 25 : 90-100, 2019
6) Moffatt CE, Hennessy MJ, Marshman LAG et al : Long-term health outcomes in survivors after chronic subdural haematoma. J Clin Neurosci 66 : 133-137, 2019
P.156 掲載の参考文献
7) Blaauw J, Boxum AG, Jacobs B et al : Prevalence of cognitive complaints and impairment in patients with chronic subdural hematoma and recovery after treatment : a systematic review. J Neurotrauma 38 : 159-168, 2021
8) Blaauw J, Meelis GA, Jacobs B et al : Pre senting symptoms and functional outcome of chronic subdural hematoma patients. Acta Neurol Scand 145 : 38-46, 2022
9) Katsuki M, Yasuda I, Narita N et al : Chronic subdural hematoma in patients over 65 years old : results of using a postoperative cognitive evaluation to determine whether to permit return to driving. Surg Neurol Int 12 : 212, 2021
10) Mackay DF, Russell ER, Stewart K et al : Neurodegenerative disease mortality among former professional soccer players. N Engl J Med 381 : 1801-1808, 2019
11) Snowden T, Reid H, Kennedy S et al : Heading in the right direction : A critical review of studies examining the effects of heading in soccer players. J Neurotrauma 38 : 169-188, 2021
P.157 掲載の参考文献
12) Maroon JC, Winkelman R, Bost J et al : Correction : chronic traumatic encephalopathy in contact sports : a systematic review of all reported pathological cases. PLoS One 10 : e0130507, 2015
13) Roberts AL, Zafonte RD, Speizer FE et al : Modifiable risk factors for poor cognitive function in former Americanstyle football players : findings from the Harvard Football Players Health Study. J Neurotrauma 38 : 189-195, 2021
14) Stern RA, Adler CH, Chen K et al : Tau positron-emission tomography in former National Football League players. N Engl J Med 380 : 1716-1725, 2019
P.158 掲載の参考文献
15) Felitti VJ, Anda RF, Nordenberg D et al : Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults : the adverse childhood experiences (ACE) study. Am J Prev Med 14 : 245-258, 1998
16) Felitti VJ, Anda RF, Nordenberg D et al : REPRINT OF : Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults : the adverse childhood experiences (ACE) study. Am J Prev Med 56 : 774-786, 2019
17) Roberts AL, Zafonte R, Chibnik LB et al : Association of adverse childhood experiences with poor neuropsychiatric health and dementia among former professional US football players. JAMA Netw Open 2022 5 : e223299, 2022
18) Arif H, Troyer EA, Paulsen JS et al : Long-term psychiatric outcomes in adults with history of pediatric traumatic brain injury. J Neurotrauma 38 : 1515-1525, 2021
19) Jacob L, Azouvi P, Kostev K : Age-related changes in the association between traumatic brain injury and dementia in older men and women. J Head Trauma Rehabil 36 : E139-E146, 2021
P.159 掲載の参考文献
20) McKerral M, Moreno A, Delhomme P et al : Driving behaviors 2-3 years after traumatic brain injury rehabilitation : a multicenter case-control study. Front Neurol 10 : 144, 2019
21) Finley JC, Matuszb EF, Parente F : Cognitive differences between adults with traumatic brain injury and specific learning disorder. Brain Inj 35 : 411-415, 2021
IV章 定位・機能
P.162 掲載の参考文献
1) Legnani M Bertinat A, Decima R et al : Applicability and contribution of the new ILAE 2017 classification of epileptic seizures and epilepsies. Epileptic Disord 21 : 549-554, 2019
P.163 掲載の参考文献
2) Sharma S, Anand A, Garg D et al : Use of the International League Against Epilepsy (ILAE) 1989, 2010, and 2017 Classification of Epilepsy in children in a low-resource setting : a hospital-based cross-sectional study. Epilepsia Open 5 : 397-405, 2020
3) Luders H, Vaca GF, Akamatsu N et al : Classification of paroxysmal events and the four-dimensional epilepsy classification system. Epileptic Disord 21 : 1-29, 2019
4) Rosenow F, Akamatsu N, Bast T et al : Could the 2017 ILAE and the four-dimensional epilepsy classifications be merged to a new "Integrated Epilepsy Classification"? Seizure 78 : 31-37, 2020
5) Garg D, Agarwal A, Malhotra V et al : Classification and comparative analysis of psychogenic nonepileptic seizures (PNES) semiology based on video-electroencephalography (VEEG). Epilepsy Behav 115 : 107697, 2021
6) Asadi-Pooya AA : Semiological classification of psychogenic nonepileptic seizures : a systematic review and a new proposal. Epilepsy Behav 100 : 106412, 2019
7) Zsom A, Tsekhan S, Hamid T et al : Ictal autonomic activity recorded via wearable-sensors plus machine learning can discriminate epileptic and psychogenic nonepileptic seizures. Annu Int Conf IEEE Eng Med Biol Soc 2019 : 3502-3506, 2019
8) GBD 2016 Epilepsy Collaborators : Global, regional, and national burden of epilepsy, 1990-2016 : a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18 : 357-375, 2019
9) Thijs RD, Surges R, O'Brien TJ et al : Epilepsy in adults. Lancet 393 : 689-701, 2019
10) Freitas ME, Ruiz-Lopez M, Dalmau J et al : Seizures and movement disorders : phenomenology, diagnostic challenges and therapeutic approaches. J Neurol Neurosurg Psychiatry 90 : 920-928, 2019
P.164 掲載の参考文献
11) Sen A, Jette N, Husain M et al : Epilepsy in older people. Lancet 395 : 735-748, 2020
12) Hardtstock F, Foskett N, Gille P et al : Poststroke epilepsy incidence, risk factors and treatment : German claims analysis. Acta Neurol Scand 143 : 614-623, 2021
13) Redfors P, Holmegaard L, Pedersen A et al : Long-term follow-up of post-stroke epilepsy after ischemic stroke : room for improved epilepsy treatment. Seizure 76 : 50-55, 2020
14) Dziadkowiak E, Guzinski M, Chojdak-Lukasiewicz J et al : Predictive factors in post-stroke epilepsy : retrospective analysis. Adv Clin Exp Med 30 : 29-34, 2021
15) van Vliet EA, Marchi N : Neurovascular unit dysfunction as a mechanism of seizures and epilepsy during aging. Epilepsia 63 : 1297-1313, 2022
16) Kwon SY, Obeidat AZ, Sekar P et al : Risk factors for seizures after intracerebral hemorrhage : Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) Study. Clin Neurol Neurosurg 192 : 105731, 2020
17) Pinto D, Prabhakaran S, Tipton E et al : Why physicians prescribe prophylactic seizure medications after intracerebral hemorrhage : an adaptive conjoint analysis. J Stroke Cerebrovasc Dis 29 : 104628, 2020
18) Kanner AM, Bicchi MM : Antiseizure medications for adults with epilepsy : a review. JAMA 327 : 1269-1281, 2022
19) Lattanzi S, Trinka E, Del Giovane C et al : Antiepileptic drug monotherapy for epilepsy in the elderly : a systematic review and network meta-analysis. Epilepsia 60 : 2245-2254, 2019
20) Lezaic N, Gore G, Josephson CB et al : The medical treatment of epilepsy in the elderly : a systematic review and meta-analysis. Epilepsia 60 : 1325-1340, 2019
P.165 掲載の参考文献
21) Martinez-Fernandez I, Sanchez-Larsen A, Gonzalez-Villar E et al : Observational retrospective analysis of vaccination against SARS-CoV-2 and seizures : VACCI-COVID registry. Epilepsy Behav 134 : 108808, 2022
22) Asadi-Pooya AA, Farazdaghi M : Newonset functional seizures during the COVID-19 pandemic. Clin Neurol Neurosurg 219 : 107310, 2022
23) Asadi-Pooya AA, Trinka E, Hingray C et al : An international study of the effects of the COVID-19 pandemic on characteristics of functional seizures. Epilepsy Behav 127 : 108530, 2022
24) Kuroda N, Gajera PK, Yu H et al : Seizure control in patients with epilepsy during the COVID-19 pandemic : a systematic review and meta-analysis. Intern Med doi : 10.2169/internalmedicine.9321-22, 2022 [online ahead of print]
25) Ahrens SM, Ostendorf AP, Lado FA et al : Impact of the COVID-19 pandemic on epilepsy center practice in the United States. Neurology 98 : e1893-e1901, 2022
26) Kuroda N, Kubota T, Horinouchi T et al : Impact of COVID-19 pandemic on epilepsy care in Japan : a national-level multicenter retrospective cohort study. Epilepsia Open doi : 10.1002/epi4.12616, 2022 [online ahead of print]
27) Miller C, Schatmeyer B, Landazuri P et al : sEEG for expansion of a surgical epilepsy program : safety and efficacy in 152 consecutive cases. Epilepsia Open 6 : 694-702, 2021
28) Gadot R, Korst G, Shofty B et al : Thalamic stereoelectroencephalography in epilepsy surgery : a scoping literature review. J Neurosurg doi : 10.3171/2022.1.JNS212613, 2022 [online ahead of print]
29) Passos GAR, Silvado CES, Borba LAB : Drug resistant epilepsy of the insular lobe : a review and update article. Surg Neurol Int 13 : 197, 2022
30) Dorfer C, Rydenhag B, Baltuch G et al : How technology is driving the landscape of epilepsy surgery. Epilepsia 61 : 841-855, 2020
P.166 掲載の参考文献
31) Najm I, Lal D, Alonso Vanegas M et al : The ILAE consensus classification of focal cortical dysplasia : an update proposed by an ad hoc task force of the ILAE diagnostic methods commission. Epilepsia doi : 10.1111/epi.17301, 2022 [online ahead of print]
32) Youngerman BE, Save AV, McKhann GM : Magnetic resonance imaging-guided laser interstitial thermal therapy for epilepsy : systematic review of technique, indications, and outcomes. Neurosurgery 86 : E366-E382, 2020
33) Wang R, Beg U, Padmanaban V et al : A systematic review of minimally invasive procedures for mesial temporal lobe epilepsy : too minimal, too fast? Neurosurgery 89 : 164-176, 2021
34) McGrath H, Mandel M, Sandhu MRS et al : Optimizing the surgical management of MRI-negative epilepsy in the neuromodulation era. Epilepsia Open 7 : 151-159, 2022
35) Ilyas A, Snyder KM, Thomas TM et al : Optimal targeting of the anterior nucleus of the thalamus for epilepsy : a meta-analysis. J Neurosurg doi : 10.3171/2022.2.JNS212550, 2022 [online ahead of print]
P.168 掲載の参考文献
1) Touma L, Dansereau B, Chan AY et al : Neurostimulation in people with drugresistant epilepsy : systematic review and meta-analysis from the ILAE Surgical Therapies Commission. Epilepsia 63 : 1314-1329, 2022
2) Lo WB, Chevill B, Philip S et al : Seizure improvement following vagus nerve stimulator (VNS) battery change with cardiac-based seizure detection automatic stimulation (AutoStim) : early experience in a regional paediatric unit. Childs Nerv Syst 37 : 1237-1241, 2021
4) Schaper FLWVJ, Plantinga B, Colon AJ et al : Deep brain stimulation in epilepsy : a role for modulation of the mammillothalamic tract in seizure control? Neurosurgery 87 : 602-610, 2020
5) Dawson J, Liu CY, Francisco GE et al : Vagus nerve stimulation paired with rehabilitation for upper limb motor function after ischaemic stroke (VNS-REHAB) : a randomised, blinded, pivotal, device trial. Lancet 397 : 1545-1553, 2021
6) Wu D, Ma J, Zhang L et al : Effect and safety of transcutaneous auricular vagus nerve stimulation on recovery of upper limb motor function in subacute ischemic stroke patients : a randomized pilot study. Neural Plast 2020 : 8841752, 2020
P.169 掲載の参考文献
7) Bocci T, Prenassi M, Arlotti M et al : Eight-hours conventional versus adaptive deep brain stimulation of the subthalamic nucleus in Parkinson's disease. NPJ Parkinsons Dis 7 : 88, 2021
8) Marceglia S, Conti C, Svanidze O et al : Double-blind cross-over pilot trial protocol to evaluate the safety and preliminary efficacy of long-term adaptive deep brain stimulation in patients with Parkinson's disease. BMJ Open 12 : e049955, 2022
9) Paschen S, Forstenpointner J, Becktepe J et al : Long-term efficacy of deep brain stimulation for essential tremor : an observer-blinded study. Neurology 92 : e1378-e1386, 2019
10) Graat I, Mocking R, Figee M et al : Long-term outcome of deep brain stimulation of the ventral part of the anterior limb of the internal capsule in a cohort of 50 patients with treatment-refractory obsessive-compulsive disorder. Biol Psychiatry 90 : 714-720, 2021
11) Ramasubbu R, Clark DL, Golding S et al : Long versus short pulse width subcallosal cingulate stimulation for treatment-resistant depression : a randomised, double-blind, crossover trial. Lancet Psychiatry 7 : 29-40, 2020
P.170 掲載の参考文献
12) Dalic LJ, Warren AEL, Bulluss KJ : DBS of thalamic centromedian nucleus for lennox-gastaut syndrome (ESTEL trial). Ann Neurol 91 : 253-267, 2022
13) 慢性疼痛診療ガイドライン作成ワーキンググループ編 : 慢性疼痛診療ガイドライン. 真興交易 (株) 医書出版部, 2021
14) Head J, Mazza J, Sabourin V et al : Waves of pain relief : a systematic review of clinical trials in spinal cord stimulation waveforms for the treatment of chronic neuropathic low back and leg pain. World Neurosurg 131 : 264-274.e3, 2019
P.171 掲載の参考文献
15) Samotus O, Parrent A, Jog M : Long-term update of the effect of spinal cord stimulation in advanced Parkinson's disease patients. Brain Stimul 13 : 1196-1197, 2020
16) Prasad S, Aguirre-Padilla DH, Poon YY et al : Spinal cord stimulation for very advanced Parkinson's disease : a 1-year prospective trial. Mov Disord 35 : 1082-1083, 2020
17) Cai Y, Reddy RD, Varshney V et al : Spinal cord stimulation in Parkinson' disease : a review of the preclinical and clinical data and future prospects. Bioelectron Med 6 : 5, 2020
18) Furusawa Y, Matsui A, Kobayashi-Noami K et al : Burst spinal cord stimulation for pain and motor function in Parkinson's disease : a case series. Clin Park Relat Disord 3 : 100043, 2020
19) Samotus O, Parrent A, Jog M : Spinal cord stimulation therapy for gait dysfunction in two corticobasal syndrome patients. Can J Neurol Sci 48 : 278-280, 2021
20) Zhang Y, Song T, Zhuang P et al : Spinal cord stimulation improves freezing of gait in a patient with multiple system atrophy with predominant parkinsonism. Brain Stimul 13 : 653-654, 2020
21) Greenberg A, Cohen A, Grewal M : Patent landscape of brain-machine interface technology. Nat Biotechnol 39 : 1194-1199, 2021
22) Chari A, Budhdeo S, Sparks R et al : Brainmachine interfaces : the role of the neurosurgeon. World Neurosurg 146 : 140-147, 2021
23) Miller KJ, Hermes D, Staff NP : The current state of electrocorticography-based brain-computer interfaces. Neurosurg Focus 49 : E2, 2020
24) Keogh C : Optimizing the neuron-electrode interface for chronic bioelectronic interfacing. Neurosurg Focus 49 : E7, 2020
P.172 掲載の参考文献
25) Soldozy S, Young S, Kumar JS et al : A systematic review of endovascular stentelectrode arrays, a minimally invasive approach to brain-machine interfaces. Neurosurg Focus 49 : E3, 2020
26) Gogia AS, Martin Del Campo-Vera R, Chen KH et al : Gamma-band modulation in the human amygdala during reaching movements. Neurosurg Focus 49 : E4, 2020
27) Wang Y, Zhang C, Zhang Y et al : Habenula deep brain stimulation for intractable schizophrenia : a pilot study. Neurosurg Focus 49 : E9, 2020
28) Knotkova H, Hamani C, Sivanesan E et al : Neuromodulation for chronic pain. Lancet 397 : 2111-2124, 2021
29) Lefaucheur JP, Aleman A, Baeken C et al : Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS) : an update (2014-2018). Clin Neurophysiol 131 : 474-528, 2020
30) Miyauchi E, Kawasaki M : Behavioural effects of task-relevant neuromodulation by rTMS on giving-up. Sci Rep 11 : 22250, 2021
P.174 掲載の参考文献
1) Lachenmayer ML, Murset M, Antih N et al : Subthalamic and pallidal deep brain stimulation for Parkinson's disease-meta-analysis of outcomes. NPJ Parkinsons Dis 7 : 77, 2021
2) Au KLK, Wong JK, Tsuboi T et al : Globus pallidus internus (GPi) deep brain stimulation for Parkinson's disease : expert review and commentary. Neurol Ther 10 : 7-30, 2021
3) Boutet A, Madhavan R, Elias GJ et al : Predicting optimal deep brain stimulation parameters for Parkinson's disease using functional MRI and machine learning. Nat Commun 12 : 3043, 2021
P.175 掲載の参考文献
4) Eisenberg HM, Krishna V, Elias WJ et al : MR-guided focused ultrasound pallidotomy for Parkinson's disease : safety and feasibility. J Neurosurg 135 : 792-798, 2020
5) Martinez-Fernandez R, Manez-Miro JU, Rodriguez-Rojas R et al : Randomized trial of focused ultrasound subthalamotomy for Parkinson's disease. N Engl J Med 383 : 2501-2513, 2020
6) Gasca-Salas C, Fernandez-Rodriguez B, Pineda-Pardo JA et al : Blood-brain barrier opening with focused ultrasound in Parkinson's disease dementia. Nat Commun 12 : 779, 2021
P.176 掲載の参考文献
7) Paschen S, Forstenpointner J, Becktepe J et al : Long-term efficacy of deep brain stimulation for essential tremor : an observer-blinded study. Neurology 92 : e1378-e1386, 2019
9) Park YS, Jung NY, Na YC et al : Four-year follow-up results of magnetic resonance-guided focused ultrasound thalamotomy for essential tremor. Mov Disord 34 : 727-734, 2019
10) Martinez-Fernandez R, Mahendran S, Pineda-Pardo JA et al : Bilateral staged magnetic resonance-guided focused ultrasound thalamotomy for the treatment of essential tremor : a case series study. J Neurol Neurosurg Psychiatry 92 : 927-931, 2021
11) Iorio-Morin C, Yamamoto K, Sarica C et al : Bilateral focused ultrasound thalamotomy for essential tremor (BEST-FUS phase 2 trial). Mov Disord 36 : 2653-2662, 2021
P.177 掲載の参考文献
12) Fukutome K, Hirabayashi H, Osakada Y et al : Bilateral magnetic resonance imagingguided focused ultrasound thalamotomy for essential tremor. Stereotact Funct Neurosurg 100 : 44-52, 2022
13) Lin S, Wu Y, Li H et al : Deep brain stimulation of the globus pallidus internus versus the subthalamic nucleus in isolated dystonia. J Neurosurg 132 : 721-732, 2019
14) Tsuboi T, Wong JK, Almeida L et al : A pooled meta-analysis of GPi and STN deep brain stimulation outcomes for cervical dystonia. J Neurol 267 : 1278-1290, 2020
15) Horisawa S, Fukui A, Kohara K et al : Unilateral pallidotomy in the treatment of cervical dystonia : a retrospective observational study. J Neurosurg doi : 10.3171/2019.9.JNS191202, 2019 [online ahead of print]
P.178 掲載の参考文献
16) Horisawa S, Kohara K, Nonaka T et al : Unilateral pallidothalamic tractotomy at Forel's field H1 for cervical dystonia. Ann Clin Transl Neurol 9 : 478-487, 2022
17) Horisawa S, Arai T, Suzuki N et al : The striking effects of deep cerebellar stimulation on generalized fixed dystonia : case report. J Neurosurg 132 : 712-716, 2019
18) Brown EG, Bledsoe IO, Luthra NS et al : Cerebellar deep brain stimulation for acquired hemidystonia. Mov Disord Clin Pract 7 : 188-193, 2020
19) Horisawa S, Kohara K, Nonaka T et al : Case report : deep cerebellar stimulation for tremor and dystonia. Front Neurol 12 : 642904, 2021
20) Horisawa S, Yamaguchi T, Abe K et al : Magnetic resonance-guided focused ultrasound thalamotomy for focal hand dystonia : a pilot study. Mov Disord 36 : 1955-1959, 2021
P.181 掲載の参考文献
1) 前澤聡, 中坪大輔, 津川隆彦他 : MRガイド下集束超音波治療による凝固術-神経疾患への応用と治療手技 (特集 : 定位・機脳神経外科の基礎と臨床). 脳神経外科 49 : 847-856, 2021
2) Maesawa S, Nakatsubo D, Tsugawa T et al : Techniques, indications, and outcomes in magnetic resonance-guided focused ultrasound thalamotomy for tremor. Neurol Med Chir (Tokyo) 61 : 629-639, 2021
3) Park YS, Jung NY, Na YC et al : Four-year follow-up results of magnetic resonance-guided focused ultrasound thalamotomy for essential tremor. Mov Disord 34 : 727-734, 2019
4) Boutet A, Gwun D, Gramer R et al : The relevance of skull density ratio in selecting candidates for transcranial MR guided focused ultrasound. J Neurosurg 132 : 1785-1791, 2019
5) D'Souza M, Chen KS, Rosenberg J et al : Impact of skull density ratio on efficacy and safety of magnetic resonance guided focused ultrasound treatment of essential tremor. J Neurosurg 132 : 1392-1397, 2019
6) Fukutome K, Kuga Y, Ohnishi H et al : What factors impact the clinical outcome of magnetic resonance imaging-guided focused ultrasound thalamotomy for essential tremor? J Neurosurg 134 : 1618-1623, 2020
7) Yamamoto K, Ito H, Fukutake S et al : Factors asso ciated with heating efficiency in transcranial focused ultrasound therapy. Neurol Med Chir (Tokyo) 60 : 594-599, 2020
8) Abe K, Horisawa S, Yamaguchi T et al : Focused ultra sound thalamotomy for refractory essential tremor : a Japanese multicenter single-arm study. Neurosurgery 88 : 751-757, 2021
9) Torii J, Maesawa S, Nakatsubo D et al : Cutoff values for the best management strategy for magnetic resonance-guided focused ultrasound ablation for essential tremor. J Neurosurg doi.org/10.3171/2022.3.JNS212460, 2022 [online ahead of print]
10) Krishna V, Sammartino F, Cosgrove R et al : Predictors of outcomes after focused ultrasound thalamotomy. Neurosurgery 87 : 229-237, 2020
11) Pineda-Pardo JA, Urso D, Martinez-Fernandez R et al : Transcranial magnetic resonance-guided focused ultrasound thalamotomy in essential tremor : a comprehensive lesion characterization. Neurosurgery 87 : 256-265, 2020
P.182 掲載の参考文献
12) Park YS, Jung NY, Na YC et al : Fouryear follow-up results of magnetic resonance-guided focused ultrasound thalamotomy for essential tremor. Mov Disord 34 : 727-734, 2019
13) Sinai A, Nassar M, Eran A et al : Magnetic resonance guided focused ultrasound thalamotomy for essential tremor : a 5-year single-center experience. J Neurosurg doi : 10.3171/2019.3.JNS19466, 2020 [online ahead of print]
14) Fukutome K, Hirabayashi H, Osakada Y et al : Bilateral magnetic resonance imaging-guided focused ultrasound thalamotomy for essential tremor. Stereotact Funct Neurosurg 100 : 44-52, 2022
15) Kato S, Maesawa S, Bagarinao E et al : Magnetic resonance-guided focused ultrasound thalamotomy restored distinctive resting-state networks in patients with essential tremor. J Neurosurg doi : 10.3171/2022.5.JNS22411, 2022 [online ahead of print]
16) Sinai A, Nassar M, Sprecher E et al : Focused ultrasound thalamotomy in tremor dominant Parkinson's disease : long-term results. J Parkinsons Dis 12 : 199-206, 2022
P.183 掲載の参考文献
17) Eisenberg HM, Krishna V, Elias WJ et al : MR-guided focused ultrasound pallidotomy for Parkinson's disease : safety and feasibility. J Neurosurg doi : 10.3171/2020.6.JNS192773, 2020 [online ahead of print]
18) Miller TR, Guo S, Melhem ER et al : Predicting final lesion characteristics during MR-guided focused ultrasound pallidotomy for treatment of Parkinson's disease. J Neurosurg 134 : 1083-1090, 2020
19) Martinez-Fernandez R, Rodriguez-Rojas R, Del Alamo M et al : Focused ultrasound subthalamotomy in patients with asymmetric Parkinson's disease : a pilot study. Lancet Neurol 17 : 54-63, 2018
20) Martinez-Fernandez R, Manez-Miro JU, Rodriguez-Rojas R et al : Randomized trial of focused ultrasound subthalamotomy for Parkinson's disease. N Engl J Med 383 : 2501-2513, 2020
P.184 掲載の参考文献
21) Lipsman N, Meng Y, Bethune AJ et al : Blood-brain barrier opening in Alzheimer's disease using MR-guided focused ultrasound. Nat Commun 9 : 2336, 2018
22) Rezai AR, Ranjan M, D'Haese PF et al : Noninvasive hippocampal blood-brain barrier opening in Alzheimer's disease with focused ultrasound. Proc Natl Acad Sci U S A 117 : 9180-9182, 2020
23) Germann J, Elias GJB, Neudorfer C et al : Potential optimization of focused ultrasound capsulotomy for obsessive compulsive disorder. Brain 144 : 3529-3540, 2021
24) Horisawa S, Yamaguchi T, Abe K et al : Magnetic resonance-guided focused ultrasound thalamotomy for focal hand dystonia : a pilot study. Mov Disord 36 : 1955-1959, 2021
P.185 掲載の参考文献
25) Lee CC, Chou CC, Hsiao FJ et al : Pilot study of focused ultrasound for drug-resistant epilepsy. Epilepsia 63 : 162-175, 2022
P.186 掲載の参考文献
1) Zeng H, Chen J, Guo Y et al : Prevalence and risk factors for spasticity after stroke : a systematic review and meta-analysis. Front Neurol 11 : 616097, 2021
2) Glaess-Leistner S, Ri SJ, Audebert HJ et al : Early clinical predictors of post stroke spasticity. Top Stroke Rehabil 28 : 508-518, 2021
P.187 掲載の参考文献
3) Biering-Soerensen B, Stevenson V, Bensmail D et al : European expert consensus on improving patient selection for the management of disabling spasticity with intrathecal baclofen and/or botulinum toxin type A. J Rehabil Med 54 : jrm00241, 2021
4) Jacobs NW, Maas EM, Brusse-Keizer M et al : Effectiveness and safety of cervical catheter tip placement in intrathecal baclofen treatment of spasticity : a systematic review. J Rehabil Med 53 : jrm00215, 2021
5) Lake W, Shah H : Intrathecal baclofen infusion for the treatment of movement disorders. Neurosurg Clin N Am 30 : 203-209, 2019
6) Andringa A, van de Port I, van Wegen E et al : Effectiveness of botulinum toxin treatment for upper limb spasticity poststroke over different ICF domains : a systematic review and meta-analysis. Arch Phys Med Rehabl 100 : 1703-1725, 2019
7) Varvarousis DN, Martzivanou C, Dimopoulos D et al : The effectiveness of botulinum toxin on spasticity and gait of hemiplegic patients after stroke : a systematic review and meta-analysis. Toxicon 203 : 74-84, 2021
8) Francisco GE, Balbert A, Bavikatte G et al : A practical guide to optimizing the benefits of post-stroke spasticity interventions with botulinum toxin A : an international group consensus. J Rehabil Med 53 : jrm00134, 2021
9) Masakado Y, Abo M, Kondo K et al : Efficacy and safety of incobotulinumtoxinA in post-stroke upper-limb spasticity in Japanese subjects : results from a randomized, double-blind, placebo-controlled study (JPURE). J Neurol 267 : 2029-2041, 2020
P.188 掲載の参考文献
10) Masakado Y, Kagaya H, Kondo K et al : Efficacy and safety of incobotulinumtoxinA in the treatment of lower limb spasticity in Japanese subjects. Front Neurol 13 : 832937, 2022
11) Scaglione F : Conversion ratio between Botox(R), Dysport(R), and Xeomin(R) in clinical practice. Toxins (Basel) 8 : 65, 2016
12) Ledda C, Artusi CA, Tribolo A et al : Time to onset and duration of botulinum toxin efficacy in movement disorders. J Neurol 269 : 3706-3712, 2022
13) Bavikatte G, Subramanian G, Ashford S et al : Early identification, intervention and management of post-stroke spasticity : expert consensus recommendations. J Cent Nerv Syst Dis 13 : 11795735211036576, 2021
14) Picelli A, Santamato A, Cosma M et al : Early botulinum toxin type A injection for post-stroke spasticity : a longitudinal cohort study. Toxins (Basel) 13 : 374, 2021
15) Lindsay C, Ispoglou S, Helliwell B et al : Can the early use of botulinum toxin in post stroke spasticity reduce contracture development? A randomised controlled trial. Clin Rehabil 35 : 399-409, 2021
16) Hara T, Momosaki R, Niimi M et al : Botulinum toxin therapy combined with rehabilitation for stroke : a systematic review of effect on motor function. Toxins (Basel) 11 : 707, 2019
17) Nasb M, Li Z, S A Youssef A et al : Comparison of the effects of modified constraint-induced movement therapy and intensive conventional therapy with a botulinum-a toxin injection on upper limb motor function recovery in patients with stroke. Libyan J Med 14 : 1609304, 2019
18) Munari D, Serina A, Disaro J et al : Combined effects of backward treadmill training and botulinum toxin type A therapy on gait and balance in patients with chronic stroke : a pilot, single-blind, randomized controlled trial. NeuroRehabilitation 46 : 519-528, 2020
19) Megna M, Marvulli R, Fari G et al : Pain and muscles properties modifications after botulinum toxin type A (BTX-A) and radial extracorporeal shock wave (rESWT) combined treatment. Endocr Metab Immune Disord Drug Targets 19 : 1127-1133, 2019
20) Kim J, Kim DY, Chun MH et al : Effects of robot- (Morning Walk(R)) assisted gait training for patients after stroke : a randomized controlled trial. Clin Rehabil 33 : 516-523, 2019
P.189 掲載の参考文献
21) Gandolfi M, Vale N, Dimitrova EK et al : Effectiveness of robot-assisted upper limb training on spasticity, function and muscle activity in chronic stroke patients treated with Botulinum toxin : a randomized single-blinded controlled trial. Front Neurol 10 : 41, 2019
P.190 掲載の参考文献
1) Lehrer EJ, Patterson J, Brown PD et al : Treatment of brain metastases with stereotactic radiosurgery and immune checkpoint inhibitors : an international meta-analysis of individual patient data. Radiother Oncol 130 : 104-112, 2019
P.191 掲載の参考文献
2) Kotecha R, Kim JM, Miller JA et al : The impact of sequencing PD-1/PD-L1 inhibitors and stereotactic radiosurgery for patients with brain metastasis. Neuro Oncol 21 : 1060-1068, 2019
3) Shepard MJ, Xu Z, Donahue J et al : Stereotactic radiosurgery with and without checkpoint inhibitor for patients with metastatic non-small cell lung cancer to the brain : a matched cohort study. J Neurosurg 26 : 685-692, 2019
4) Tawbi H, To TM, Bartley K et al : Treatment patterns and clinical outcomes for patients with melanoma and central nervous system metastases : a real world study. Cancer Med 11 : 139-150, 2022
5) Yang L, Liu L, Wu X et al : Hypofractionated radiation therapy with versus without immune checkpoint inhibitors in patients with brain metastases : a meta-analysis. Int Immunopharmacol 80 : 106148, 2020
P.192 掲載の参考文献
6) Berber T, Raturi V, Aksaray F et al : Clinical outcome after CyberKnife(R) radiosurgery re-irradiation for recurrent brain metastases. Cancer Radiother 25 : 457-462, 2021
7) Martinage G, Geffrelot J, Stefan D et al : Efficacy and tolerance of post-operative hypo-fractionated stereotactic radiotherapy in a large series of patients with brain metasatases. Front Oncol 9 : 184, 2019
8) Ehret F, Senger C, Kufeld M et al : Image-guided robotic radiosurgery for the management of intramedullary spinal cord metastases-a multicenter experience. Cancers (Basel) 13 : 297, 2021
9) De Maria L, Terzi di Bergamo L, Conti A et al : CyberKnife for recurrent malignant gliomas : a sustematic review and meta-analysis. Front Oncol 11 : 652646, 2021
10) Kulinich DP, Sheppard JP, Nguyen T et al : Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma : a systematic review. Acta Neurochir (Wien) 163 : 1921-1934, 2021
P.193 掲載の参考文献
11) Zhang J, Liu Q, Yuan Z et al : Clinical efficacy of CyberKnife radiosurgery for adult brainstem glioma : 10years experience at Tianjin CyberKnife center and review of the literature. Front Oncol 9 : 257, 2019
12) Ehret F, Kufeld M, Furweger C et al : Image-guided robotic radiosurgery for the management of spinal ependymomas. Front Oncol 11 : 654251, 2021
13) Przybylowski CJ, Baranoski JF, Paisan GM et al : CyberKnife radiosurgery for acoustic neuromas : tumor control and clinical outcomes. J Clin Neurosci 63 : 72-76, 2019
14) Putaweepong P, Dhanachai M, Swangsilpa T et al : Long-term clinical outcomes of stereotactic radiosurgery and hypofractionated stereotactic radiotherapy using the CyberKnife(R) robotic radiosurgery system for vestibular schwannoma. Asia Pac J Clin Oncol 1 : 1-8, 2021
P.194 掲載の参考文献
15) Oh HJ, Cho YH, Kim JH et al : Hypofractionated stereotactic radiosurgery for large-sized skull base meningiomas. J Neurooncol 149 : 87-93, 2020
16) Senger C, Kluge A, Kord M et al : Effectiveness and safety of robotic radiosurgery for optic nerve sheath meningiomas : a single institution series. Cancers (Basel) 13 : 2165, 2021
17) Tuleasca C, Regis J, Sahgal A et al : Stereotactic radiosurgery for trigeminal neuralgia : a systematic review. J Neurosurg 130 : 733-757, 2018
P.195 掲載の参考文献
18) 高橋弘 : 三叉神経痛に対するサイバーナイフを用いた定位放射線治療. 日ペインクリニック学誌 26 : 279-287, 2019
19) Romanelli P, Conti A, Redaelli I et al : CyberKnife radiosurgery for trigeminal neuralgia. Cureus 11 : e6014, 2019
20) Conti A, Acker G, Pontoriero A et al : Factors affecting outcome in frameless nonisocentric stereotactic radiosurgery for trigeminal neuralgia : a multicentric cohort study : Radiat Oncol 15 : 115, 2020
V章 小児
P.199 掲載の参考文献
1) 阪本博昭 : II部 各論脊髄髄膜瘤. 胎児期水頭症診断と治療ガイドライン. 金芳堂 104-119, 2010
2) クリアリングハウス国際モニタリングセンター日本支部 : 2018年度外表奇形等統計調査結果. 2018 https://icbdsr-j.jp/2018data.html
3) 近藤厚生, 多田克彦, 和田誠司他 : 葉酸による神経管閉鎖障害の予防 : 発生率, リスク因子, 葉酸サプリメントの摂取, 行政への要望. 日周産期・新生児会誌 57 : 8-18, 2021
P.200 掲載の参考文献
4) Adzick NS, Thom EA, Spong CY et al : A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 364 : 993-1004, 2011
5) Tamber MS, Flannery AM, McClung-Smith C et al : Congress of neurological surgeons systematic review and evidence-based guideline on the incidence of shunt-dependent hydrocephalus in infants with myelomeningocele after prenatal versus postnatal repair. Neurosurgery 85 : E405-E408, 2019
6) Bauer DF, Beier AD, Nikas DC et al : Congress of neurological surgeons systematic review and evidence-based guideline on the management of patients with myelomeningocele : whether prenatal or postnatal closure affects future ambulatory status. Neurosurgery 85 : E409-E411, 2019
P.201 掲載の参考文献
7) Beier AD, Nikas DC, Assassi N et al : Congress of neurological surgeons systematic review and evidence-based guideline on closure of myelomeningocele within 48 hours to decrease infection risk. Neurosurgery 85 : E412-E413, 2019
8) Blount JP, Durham SR, Klimo P Jr et al : Congress of neurological surgeons systematic review and evidence-based guideline on the management of patients with myelomeningocele : whether persistent ventriculomegaly adversely impacts neurocognitive development. Neurosurgery 85 : E414-E416, 2019
9) Mazzola CA, Tyagi R, Assassi N et al : Congress of neurological surgeons systematic review and evidence-based guideline on the incidence of tethered cord syndrome in infants with myelomeningocele with prenatal versus postnatal repair. Neurosurgery 85 : E417-E419, 2019
10) 五味玲, 埜中正博 : 日本小児神経外科学会の脊髄髄膜瘤治療ガイドライン作成に向けて. 脳外誌 31 : 212-217, 2022
11) Riley JS, Antiel RM, Flake AW et al : Pediatric neurosurgeons' views regarding prenatal surgery for myelomeningocele and the management of hydrocephalus : a national survey. Neurosurg Focus 47 : E8, 2019
P.202 掲載の参考文献
12) Cavalheiro S, da Costa MDS, Barbosa MM et al : Hydrocephalus in myelomeningocele. Childs Nerv Syst 37 : 3407-3415, 2021
13) Danzer E, Thomas NH, Thomas A et al : Long-term neurofunctional outcome, executive functioning, and behavioral adaptive skills following fetal myelomeningocele surgery. Am J Obstet Gynecol 214 : 269.e1-269.e8, 2016
14) Houtrow AJ, Thom EA, Fletcher JM et al : Prenatal repair of myelomeningocele and school-age functional outcomes. Pediatrics 145 : e20191544, 2020
15) Brock JW 3rd, Carr MC, Adzick NS et al : Bladder function after fetal surgery for myelomeningocele. Pediatrics 136 : e906-e913, 2015
P.203 掲載の参考文献
16) Brock JW 3rd, Thomas JC, Baskin LS et al : Effect of prenatal repair of myelomeningocele on urological outcomes at school age. J Urol 202 : 812-818, 2019
17) Clayton DB, Thomas JC, Brock JW 3rd : Fetal repair of myelomeningocele : current status and urologic implications. J Pediatr Urol 16 : 3-9, 2020
18) Tanaka ST, Paramsothy P, Thibadeau J et al : Baseline urinary tract imaging in infants enrolled in the UMPIRE protocol for children with spina bifida. J Urol 201 : 1193-1198, 2019
19) Inversetti A, Van der Veeken L, Thompson D et al : Neurodevelopmental outcome of children with spina bifida aperta repaired prenatally vs postnatally : systematic review and meta-analysis. Ultrasound Obstet Gynecol 53 : 293-301, 2019
20) Farmer DL, Thom EA, Brock JW 3rd et al ; Management of Myelomeningocele Study Investigators : The Management of Myelomeningocele Study : full cohort 30-month pediatric outcomes. Am J Obstet Gynecol 218 : 256.e1-256.e13, 2018
21) Zamlynski J, Olejek A, Koszutski T et al : Comparison of prenatal and postnatal treatments of spina bifida in Poland--a nonrandomized, single center study. J Matern Fetal Neonatal Med 27 : 1409-1417, 2014
P.204 掲載の参考文献
22) McLone DG, Knepper PA : The cause of Chiari II malformation : a unified theory. Pediatr Neurosci 15 : 1-12, 1989
23) Heffez DS, Aryanpur J, Hutchins GM et al : The paralysis associated with myelomeningocele : clinical and experimental data implicating a preventable spinal cord injury. Neurosurgery 26 : 987-992, 1990
24) Espinoza J, Shamshirsaz AA, Sanz Cortes M et al : Two-port, exteriorized uterus, fetoscopic meningomyelocele closure has fewer adverse neonatal outcomes than open hysterotomy closure. Am J Obstet Gynecol 225 : 327.e1-327.e9, 2021
25) Dewan MC, Wellons JC : Fetal surgery for spina bifida. J Neurosurg Pediatr 24 : 105-114, 2019
26) Takahashi YO, Wada S, Miya M et al : Nationwide survey of fetal myelomeningocele in Japan : Background for fetal surgery. Pediatr Int 61 : 715-719, 2019
27) Boyd PA, Devigan C, Khoshnood B et al : Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down's syndrome. BJOG 115 : 689-696, 2008
P.205 掲載の参考文献
28) Prevention of neural tube defects : results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 338 : 131-137, 1991
29) 金正めぐみ, 前田恵理, 村田勝敬 : 本邦女子医学生の妊娠・出産に関する意識及び知識調査. 秋田県公衆衛生学雑誌 14 : 29-34, 2018
30) 高橋敦史, 小原拓, 大原宏司他 : 葉酸による出生時の神経管閉鎖障害リスク低下効果に関する薬学生の認識. 医薬品情報学 17 : 185-191, 2016
P.206 掲載の参考文献
1) Sarkar S, Vora TK, Rajshekhar V : Risk factors for pre-operative functional deterioration in children with lipomyelomeningocele. Childs Nerv Syst 38 : 587-595, 2022
2) Hayashi T, Kimiwada T, Shirane R et al : Retethering risk in pediatric spinal lipoma of the conus medullaris. J Neurosurg Pediatr doi : 10.3171/2021.9.PEDS21413, 2021 [online ahead of print]
P.207 掲載の参考文献
3) Idriceanu T, Beuriat PA, Di Rocco F et al : Recurrent tethering in conus lipomas : a late complication not to be ignored. World Neurosurg doi : 10.1016/j.wneu.2022.07.048, 2022 [online ahead of print]
4) Manoranjan B, Pozdnyakov A, Ajani O : Neurosurgical management of conus lipoma in Canada : a multi-center survey. Childs Nerv Syst 36 : 3041-3045, 2020
P.208 掲載の参考文献
5) Bruzek AK, Starr J, Garton HJL et al : Syringomyelia in children with closed spinal dysraphism : long-term outcomes after surgical intervention. J Neurosurg Pediatr doi : 10.3171/2019.9.PEDS1944, 2019 [online ahead of print]
P.209 掲載の参考文献
6) Abraham AP, Vora TK, Selvi BT et al : Characterizing syringomyelia and its clinical significance in 140 patients with lipomyelomeningocele. J Neurosurg Pediatr doi : 10.3171/2022.6.PEDS2286, 2022 [online ahead of print]
7) Ishisaka E, Usami K, Ogiwara H : Surgical outcomes by sectioning a filum terminale in patients with terminal syringomyelia. Childs Nerv Syst 36 : 3035-3039, 2020
8) Hayashi C, Kumano Y, Hirokawa D et al : Long-term urological outcomes of spinal lipoma after prophylactic untethering in infancy : real-world outcomes by lipoma anatomy. Spinal Cord 58 : 490-495, 2020
P.210 掲載の参考文献
9) Valentini LG, Babini M, Cordella R et al : Early de-tethering : analysis of urological and clinical consequences in a series of 40 children. Childs Nerv Syst 37 : 941-949, 2021
10) Sapir Y, Buzaglo N, Korn A et al : Dynamic mapping using an electrified ultrasonic aspirator in lipomyelomeningocele and spinal cord detethering surgery-a feasibility study. Childs Nerv Syst 37 : 1633-1639, 2021
P.211 掲載の参考文献
11) Oh JE, Lim GY, Kim HW et al : Filum terminale lipoma revealed by screening spinal ultrasonography in infants with simple sacral dimple. Childs Nerv Syst 36 : 1037-1042, 2020
12) Nonaka M, Ueno K, Isozaki H et al : Familial tendency in patients with lipoma of the filum terminale. Childs Nerv Syst 37 : 1641-1647, 2021
13) Kumar N, Chatur C, Balani A et al : Patterns of spinal cord malformation in cloacal exstrophy. J Neurosurg Pediatr doi : 10.3171/2021.1.PEDS20648, 2021 [online ahead of print]
P.212 掲載の参考文献
14) Yoshifuji K, Morota N, Omori Y et al : Physiological rapid growth of spinal lipoma in the early postnatal period. J Neurosurg Pediatr doi : 10.3171/2022.1.PEDS21474, 2022 [online ahead of print]
P.213 掲載の参考文献
1) Hall S, Smedley A, Sparrow O et al : Natural history of intracranial arachnoid cysts. World Neurosurg 126 : e1315-e1320, 2019
2) Jafrani R, Raskin JS, Kaufman A : Intracranial arachnoid cysts : pediatric neurosurgery update. Surg Neurol Int 10 : 15, 2019
3) Carbone J, Sadasivan AP : Intracranial arachnoid cysts : review of natural history and proposed treatment algorithm. Surg Neurol Int 12 : 621, 2021
P.215 掲載の参考文献
4) Lim JW, Choi SW, Song SH, et al : Is arachnoid cyst a static disease? A case report and literature review. Childs Nerv Syst 35 : 385-388, 2019
5) Tinois J, Bretonnier M, Proisy M et al : Ruptured intracranial arachnoid cysts in the subdural space : evaluation of subduro-peritoneal shunts in a pediatric population. Childs Nerv Syst 36 : 2073-2078, 2020
P.216 掲載の参考文献
6) Furtado LMF, Costa Val Filho JA, Ferreira RI et al : Intracranial arachnoid cyst rupture after mild TBI in children : have we underestimated this risk? BMJ Case Rep 12 : e228790, 2019
7) Hamidi MF, Hamidi H : Ruptured middle cranial fossa arachnoid cysts after minor trauma in adolescent boys presenting with subdural hygroma : two case reports. J Med Case Rep 15 : 511, 2021
8) Li B, Ng C, Feldstein E et al : Non-operative management of a pediatric patient with bilateral subdural hematomas in the setting of ruptured arachnoid cyst. Cureus 13 : e20099, 2021
9) Singh G, Zuback A, Gattu R et al : Subdural hygroma after spontaneous rupture of an arachnoid cyst in a pediatric patient : a case report. Radiol Case Rep 16 : 309-311, 2020
P.217 掲載の参考文献
10) Maxwell CR, Joshi N, Feller CN et al : Reversal of cognitive, behavioral, and language impairments after the left frontal arachnoid cyst fenestration in a pediatric patient. Surg Neurol Int 12 : 371, 2021
P.218 掲載の参考文献
11) Kim KH, Lee JY, Phi JH et al : Neurocognitive profile in children with arachnoid cysts before and after surgical intervention. Childs Nerv Syst 35 : 517-522, 2019
12) Kwiatkowska K, Milczarek O, Debicka M et al : Are arachnoid cysts actually clinically mute in relation to neuropsychological symptoms? Cognitive functioning in children with AC of middle and cranial fossa. Clin Neurol Neurosurg 208 : 106825, 2021
P.220 掲載の参考文献
13) Sufianov RA, Abdumazhitova MM, Rustamov RR et al : Endoscopic treatment of middle cranial fossa arachnoid cysts in children : surgical results of 65 cases. World Neurosurg doi : 10.1016/j.wneu.2021.11.046, 2021 [online ahead of print]
P.221 掲載の参考文献
14) Soleman J, Kozyrev DA, Constantini S et al : Surgical treatment and outcome of posterior fossa arachnoid cysts in infants. J Neurosurg Pediatr 28 : 544-552, 2021
P.225 掲載の参考文献
15) Pitsika M, Sgouros S : Volume change of cranial arachnoid cysts after successful endoscopic fenestration in symptomatic children. Childs Nerv Syst 35 : 2313-2318, 2019
16) Prajsnar-Borak A, Oertel J, Antes S et al : Cerebral vasospasm after endoscopic fenestration of a temporal arachnoid cyst in a child-a case report and review of the literature. Childs Nerv Syst 35 : 695-699, 2019
17) Shao B, Banu MA, Carroll JJ et al : Cerebral vasospasm after open fenestration of an arachnoid cyst in a 4-year-old boy : case report and review of the literature. Pediatr Neurosurg 54 : 132-138, 2019
VI章 脊髄・脊椎・末梢神経
P.231 掲載の参考文献
1) Chiba K, Matsuyama Y, Seo T et al : Condoliase for the treatment of lumbar disc herniation : a randomized controlled trial. Spine (Phila Pa 1976) 43 : E869-E876, 2018
2) Matsuyama Y, Seo T, Chiba K : Condoliase chemonucleolysis for lumbar disc herniation : a post-hoc follow-up study of patients in previous clinical trials. J Orthop Sci doi : 10.1016/j.jos.2022.04.003, 2020 [online ahead of print]
3) Banno T, Hasegawa T, Yamato Y et al : Clinical outcome of condoliase injection treatment for lumbar disc herniation : Indications for condoliase therapy. J Orthop Sci 26 : 79-85, 2021
4) 吉岩豊三, 中村英次郎, 高谷純司他 : 椎間板内酵素注入療法の効果に影響する画像因子の検討. J Spine Res 11 : 931-935, 2020
P.232 掲載の参考文献
5) Nakajima H, Kubota A, Maezawa Y et al : Short-term outcome and predictors of therapeutic effects of intradiscal condoliase injection for patients with lumbar disc herniation. Spine Surg Relat Res 5 : 264-271, 2020
6) Okada E, Suzuki S, Nori S et al : The effectiveness of chemonucleolysis with condoliase for treatment of painful lumbar disc herniation. J Orthop Sci 26 : 548-554, 2021
7) Ishibashi K, Fujita M, Takano Y et al : Chemonucleolysis with chondroitin sulfate ABC endolyase for treating lumbar disc herniation : exploration of prognostic factors for good or poor clinical outcomes. Medicina (Kaunas) 56 : 627, 2020
8) Funayama T, Mataki K, Murakami K et al : Two cases of lateral lumbar disc herniation successfully treated with intradiscal condoliase injection. Spine Surg Relat Res : 437-441, 2020
9) Funayama T, Setojima Y, Shibao Y et al : A case of postoperative recurrent lumbar disc herniation conservatively treated with novel intradiscal condoliase injection. Case Rep Orthop 2022 : 3656753, 2022
P.233 掲載の参考文献
10) Banno T, Hasegawa T, Yamato Y et al : Disc degeneration could be recovered after chemonucleolysis with condoliase. -1 year clinical outcome of condoliase therapy. J Orthop Sci 27 : 767-773, 2022
11) Inoue M, Sainoh T, Kojima A et al : Efficacy and safety of condoliase disc administration as a new treatment for lumbar disc herniation. Spine Surg Relat Res 6 : 31-37, 2021
P.234 掲載の参考文献
12) Ju DG, Kanim LE, Bae HW : Intervertebral disc repair : current concepts. Global Spine J 10 (2 Suppl) : 130S-136S, 2020
13) 堀北夏美, 酒井大輔 : 再生医療技術を用いた椎間板疾患治療. Jpn J Rehabil Med 56 : 694-697, 2019
14) Schol J, Sakai D : Cell therapy for intervertebral disc herniation and degenerative disc disease : clinical trials. Int Orthop 43 : 1011-1025, 2019
15) Sun Y, Leung VY, Cheung KM : Clinical trials of intervertebral disc regeneration : current status and future developments. Int Orthop 43 : 1003-1010, 2019
16) 木下英幸, 鴨田博人, 折田純久他 : 最新基礎科学/知っておきたい脊椎領域におけるPRPを用いた組織再生. 臨整外 54 : 92-99, 2019
P.235 掲載の参考文献
17) Cheng J, Santiago KA, Nguyen JT et al : Treatment of symptomatic degenerative intervertebral discs with autologous platelet-rich plasma : follow-up at 5-9 years. Regen Med 14 : 831-840, 2019
18) Akeda K, Takegami N, Yamada J et al : Platelet-rich plasma-releasate (PRPr) for the treatment of discogenic low back pain patients : long-term follow-up survey. Medicina 58 : 428, 2022
19) Jiang Y, Zuo R, Yuan S et al : Transforaminal endoscopic lumbar discectomy with versus without platelet-rich plasma injection for lumbar disc herniation : a prospective cohort study. Pain Res Manag 2022 : 6181478, 2022
20) Muthu S, Jeyaraman M, Chellamuthu G et al : Does the intradiscal injection of platelet rich plasma have any beneficial role in the management of lumbar disc disease? Global Spine J 12 : 503-514, 2022
P.236 掲載の参考文献
1) Perfetti DC, Kisinde S, Rogers-LaVanne MP et al : Robotic spine surgery : past, present and future. Spine (Phila Pa 1976) doi : 10.1097/BRS.0000000000004357, 2022 [online ahead of print]
P.237 掲載の参考文献
2) Pojskic M, Bopp M, Nimsky C et al : Initial intraoperative experience with robotic-assisted pedicle screw placement with Cirq(R) robotic alignment : an evaluation of the first 70 screws. J Clin Med 10 : 5725, 2021
3) Farah K, Meyer M, Prost S et al : Robotic assistance for minimally invasive cervical pedicle instrumentation : report on feasibility and safety. World Neurosurg 150 : e777-e782, 2021
4) Li Y, Chen L, Liu Y et al : Accuracy and safety of robot-assisted cortical bone trajectory screw placement : a comparison of robot-assisted technique with fluoroscopy-assisted approach. BMC Musculoskelet Disord 23 : 328, 2022
P.238 掲載の参考文献
5) Fan M, Liu Y, He D et al : Improved accuracy of cervical spinal surgery with robot-assisted screw insertion : a prospective, randomized, controlled study. Spine (Phila Pa 1976) 45 : 285-291, 2020
6) Cui GY, Han XG, Wei Y et al : Robotassisted minimally invasive transforaminal lumbar interbody fusion in the treatment of lumbar spondylolisthesis. Orthop Surg 13 : 1960-1968, 2021
7) Yongqi L, Dehua Z, Hongzi W et al : Minimally invasive versus conventional fixation of tracer in robot-assisted pedicle screw insertion surgery : a randomized control trial. BMC Musculoskelet Disord 21 : 208, 2020
P.239 掲載の参考文献
8) Keric N, Eum DJ, Afghanyar F et al : Evaluation of surgical strategy of conventional vs. percutaneous robot-assisted spinal trans-pedicular instrumentation in spondy-lodiscitis. J Robot Surg 11 : 17-25, 2017
9) Kantelhaldt SR, Martinez R, Baerwinkel S et al : Perioperative course and accuracy of screw positioning in conventional, open robotic-guided and percutaneous robotic-guided, pedicle screw placement. Eur Spine J 20 : 860-868, 2011
10) Good CR, Orosz L, Schroerlucke SR et al : Complications and revision rates in minimally invasive robotic-guided versus fluoroscopic-guided spinal fusions : the MIS ReFRESH prospective comparative study. Spine (Phila Pa) 46 : 1661-1668, 2021
11) Lieber AM, Kirchner GJ, Kerbel YE et al : Robotic-assisted pedicle screw placement fails to reduce overall postoperative complications in fusion surgery. Spine J 19 : 212-217, 2019
12) Yang DS, Li NY, Kleinhenz DT et al : Risk of postoperative complications and revision surgery following robot-assisted posterior lumbar spinal fixation. Spine(Phila Pa 1976)45 : E1692-E1698, 2020
13) Kanaly CW, Backes DM : Letter to the editor : spinal navigation is not the same as robotic assistance in surgery. Spine (Phila Pa 1976)46 : E463-E464, 2021
14) Malik AT, Drain JP, Karnes JM : Letter to the editor regarding "Risk of postoperative complications and revision surgery following robot-assisted posterior lumbar spinal fusion". Spine (Phila Pa 1976) 46 : E411-E412, 2021
15) Yu CC, Carreon LY, Glassman SD et al : Propensity-matched comparison of 90-day complications in robotic-assisted versus non-robotic assisted lumbar fusion. Spine (Phila Pa 1976) 47 : 195-200, 2022
P.240 掲載の参考文献
16) Menger RP, Savardekar AR, Farokhi F et al : A cost-effectiveness analysis of the integration of robotic spine technology in spine surgery. Neurospine 15 : 216-224, 2018
17) Li Y, Huang L, Zhou W et al : Evaluation of a new spinal surgical robotic system of Kirschner wire placement for lumbar fusion : a multi-center, randomized controlled clinical study. Int J Med Robot 17 : e2207, 2021
18) Wewel JT, Kasliwal MK, Chmielewski GW et al : Complete anterior-posterior minimally invasive thoracoscopic robotic-assisted and posterior tubular approach for sesection of thoracic dumbbell tumor. J Craniovertebr Junction Spine 11 : 148-151, 2020
19) Rapoport BI, Sze C, Chen X et al : Robotic resection of a nerve sheath tumor via a retroperitoneal approach. Oper Neurosurg (Hagerstown) 20 : E85-E90, 2021
P.241 掲載の参考文献
20) Jun C, Sukumaran M, Wolinsky JP : Robot-assisted resection of pre-sacral schwannoma. Neurosurg Focus 45 (Video-Suppl 1) : V1, 2018
21) Petrov D, Spadola M, Berger C et al : Novel approach using ultrasonic bone curettage and transoral robotic surgery for en bloc resection of cervical spine chordoma : case report. J Neurosurg Spine 30 : 788-793, 2019
P.242 掲載の参考文献
1) Horii C, Iidaka T, Muraki S et al : The cumulative incidence of and risk factors for morphometric severe vertebral fractures in Japanese men and women : the ROAD study third and fourth surveys. Osteoporos Int 33 : 889-899, 2022
P.243 掲載の参考文献
2) Jin H, Ma X, Liu Y et al : Back Pain-Inducing Test, a novel and sensitive screening test for painful osteoporotic vertebral fractures : a prospective clinical study. J Bone Miner Res 35 : 488-497, 2020
3) Jin H, Ma X, Liu Y et al : Back pain from painful osteoporotic vertebral fractures : discrepancy between the actual fracture location and the location suggested by patient-reported pain or physical examination findings. Osteoporos Int 31 : 1721-1732, 2020
P.244 掲載の参考文献
4) Ahmadi SA, Takahashi S, Hoshino M et al : Association between MRI findings and back pain after osteoporotic vertebral fractures : a multicenter prospective cohort study. Spine J 19 : 1186-1193. 2019
5) Scheyerer MJ, Spiegl UJA, Grueninger S et al : Risk factors for failure in conservatively treated osteoporotic vertebral fractures : a systematic review. Global Spine J 12 : 289-297, 2022
6) Kato T, Inose H, Ichimura S et al : Comparison of rigid and soft-brace treatments for acute osteoporotic vertebral compression fracture : a prospective, randomized, multicenter study. J Clin Med 8 : 198, 2019
P.245 掲載の参考文献
7) Ebeling PR, Akesson K, Bauer DC et al : The efficacy and safety of vertebral augmentation : a second ASBMR Task Force report. J Bone Miner Res 34 : 3-21, 2019
8) Beall DP, Chambers MR, Thomas S et al : Prospective and multicenter evaluation of outcomes for quality of life and activities of daily living for balloon kyphoplasty in the treatment of vertebral compression fractures : the EVOLVE trial. Neurosurgery 84 : 169-178, 2019
9) Hoshino M, Takahashi S, Yasuda H et al : Balloon kyphoplasty versus conservative treatment for acute osteoporotic vertebral fractures with poor prognostic factors. Spine (Phila Pa 1976) 44 : 110-117, 2019
10) Takahashi S, Hoshino M, Yasuda H et al : Development of a scoring system for predicting adjacent vertebral fracture after balloon kyphoplasty. Spine J 19 : 1194-1201, 2019
11) Hijikata Y, Kamitani T, Nakahara M et al : Development and internal validation of a clinical prediction model for acute adjacent vertebral fracture after vertebral augmentation : the AVA score. Bone Joint J 104-B : 97-102, 2022
P.246 掲載の参考文献
12) Hosogane N, Nojiri K, Suzuki S et al : Surgical treatment of osteoporotic vertebral fracture with neurological deficit -a nationwide multicenter study in Japan. Spine Surg Relat Res 3 : 361-367, 2019
13) Fukuda K, Katoh H, Takahashi Y et al : Minimally invasive anteroposterior combined surgery using lateral lumbar interbody fusion without corpectomy for treatment of lumbar spinal canal stenosis associated with osteoporotic vertebral collapse. J Neurosurg Spine doi : 10.3171/2020.10.SPINE201293, 2021 [online ahead of print]
P.247 掲載の参考文献
14) Toth E, Banefelt J, Akesson K et al : History of previous fracture and imminent fracture risk in Swedish women aged 55 to 90 years presenting with a fragility fracture. J Bone Miner Res 35 : 861-868, 2020
15) Lee SB, Park Y, Kim DW et al : Association between mortality risk and the number, location, and sequence of subsequent fractures in the elderly. Osteoporos Int 32 : 233-241, 2021
P.248 掲載の参考文献
1) Hofstetter CP, Ahn Y, Choi G et al : AOSpine consensus paper on nomenclature for working-channel endoscopic spinal procedures. Global Spine J 10 (2 Suppl) : 111S-121S, 2020
P.249 掲載の参考文献
2) Li WS, Yan Q, Cong L et al : Comparison of endoscopic discectomy versus nonendoscopic discectomy for symptomatic lumbar disc herniation : a systematic review and meta-analysis. Global Spine J 12 : 1012-1026, 2022
3) Xu J, Li Y, Wang B et al : Minimum 2-year efficacy of percutaneous endoscopic lumbar discectomy versus microendoscopic discectomy : a meta-analysis. World Neurosurg 138 : 19-26, 2020
4) Kim HS, You JD, Ju CI et al : Predictive scoring and risk factors of early recurrence after percutaneous endoscopic lumbar discectomy. Biomed Res Int 2019 : 6492675, 2019
P.250 掲載の参考文献
5) Pfirrmann CW, Metzdorf A, Zanetti M et al : Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine (Phila Pa 1976) 26 : 1873-1878, 2001
6) Soliman HM : Irrigation endoscopic discectomy a novel percutaneous approach for lumbar disc prolapse. Eur Spine J 22 : 1037-1044, 2013
7) Zhu W, Yao Y, Hao J et al : Short-term postoperative pain and function of unilateral biportal endoscopic discectomy versus percutaneous endoscopic lumbar discectomy for single-segment lumbar disc herniation : a systematic review and meta-analysis. Appl Bionics Biomech 2022 : 5360277, 2022
8) Jiang HW, Chen CD, Zhan BS et al : Unilateral biportal endoscopic discectomy versus percutaneous endoscopic lumbar discectomy in the treatment of lumbar disc herniation : a retrospective study. J Orthop Surg Res 17 : 30, 2022
P.251 掲載の参考文献
9) Kim HS, Wu PH, Kim JY et al : Retrospective case control study : clinical and computer tomographic fusion and subsidence evaluation for single level uniportal endoscopic posterolateral approach transforaminal lumbar interbody fusion versus microscopic minimally invasive transforaminal interbody fusion. Global Spine J doi : 10.1177/2192568221994796, 2022 [online ahead of print]
10) Kim HS, Wu PH, Jang I-T et al : Technical note on uniportal full endoscopic posterolateral approach transforaminal lumbar interbody fusion with reduction for grade 2 spondylolisthesis. Interdiscip Neurosurg 21 : 100712, 2020
11) Wu PH, Kim HS, Lee YJ et al : Uniportal full endoscopic posterolateral transforaminal lumbar interbody fusion with endoscopic disc drilling preparation technique for symptomatic foraminal stenosis secondary to severe collapsed disc space : a clinical and computer tomographic study with technical note. Brain Sci 10 : 373, 2020
12) Kim HS, Wu PH, Lee YJ et al : Technical considerations of uniportal endoscopic posterolateral lumbar interbody fusion : a review of its early clinical results in application in adult degenerative scoliosis. World Neurosurg 145 : 682-692, 2021
13) Wang MY, Grossman J : Endoscopic minimally invasive transforaminal interbody fusion without general anesthesia : initial clinical experience with 1-year follow-up. Neurosurg Focus 40 : E13, 2016
14) Kolcun JPG, Brusko GD, Basil GW et al : Endoscopic transforaminal lumbar interbody fusion without general anesthesia : operative and clinical outcomes in 100 consecutive patients with a minimum 1-year follow-up. Neurosurg Focus 46 : E14, 2019
15) Kim HS, Wu PH, An JW et al : Evaluation of two methods (inside-out/outside-in) inferior articular process resection for uniportal full endoscopic posterolateral transforaminal lumbar interbody fusion : technical note. Brain Sci 11 : 1169, 2021
16) Morgenstern R, Morgenstern C, Jane R et al : Usefulness of an expandable interbody spacer for the treatment of foraminal stenosis in extremely collapsed disks : preliminary clinical experience with endoscopic posterolateral transforaminal approach. J Spinal Disord Tech 24 : 485-491, 2011
P.252 掲載の参考文献
17) Ishihama Y, Morimoto M, Tezuka F et al : Full-Endoscopic Trans-Kambin Triangle Lumbar Interbody Fusion : Surgical Technique and Nomenclature. J Neurol Surg A Cent Eur Neurosurg 83 : 308-313, 2022
18) Kim HS, Wu PH, Sairyo K et al : A narrative review of uniportal endoscopic lumbar interbody fusion : comparison of uniportal facet-preserving trans-kambin endoscopic fusion and uniportal facetsacrificing posterolateral transforaminal lumbar interbody fusion. Int J Spine Surg 15 (suppl 3) : S72-S83, 2021
21) Nakajima D, Yamashita K, Takeuchi M et al : Full-endoscopic spine surgery for discogenic low back pain with high-intensity zones and modic type 1 change in a professional baseball player. NMC Case Rep J 8 : 587-593, 2021
22) Manabe H, Yamashita K, Tezuka F et al : Thermal annuloplasty using percutaneous endoscopic discectomy for elite athletes with discogenic low back pain. Neurol Med Chir (Tokyo) 59 : 48-53, 2019
23) Sairyo K, Maeda T, Yamashita K et al : A new surgical strategy for the intractable chronic low back pain due to type 1 Modic change using transforaminal full-endoscopic disc cleaning (FEDC) surgery under the local anesthesia : a case report and literature review. J Med Invest 68 : 1-5, 2021
24) Modic MT, Masaryk TJ, Ross JS et al : Imaging of degenerative disk disease. Radiology 168 : 177-186, 1988
25) Modic MT, Steinberg PM, Ross JS et al : Degenerative disk disease : assessment of changes in vertebral body marrow with MR imaging. Radiology 166 : 193-199, 1988
26) Manniche C, O'Neill S : New insights link low-virulent disc infections to the etiology of severe disc degeneration and Modic changes. Future Sci OA 5 : FSO389, 2019
27) Jha SC, Sairyo K : The role of Propionibacterium acnes in and Modic type 1 changes : a literature review. J Med Invest 67 : 21-26, 2020
P.253 掲載の参考文献
28) Ohara Y, Nakajima Y, Kimura T et al : Full-endoscopic transcervical ventral decompression for pathologies of craniovertebral junction : case series. Neurospine 17 (Suppl 1) : S138-S144, 2020
29) Wolinsky JP, Sciubba DM, Suk I et al : Endoscopic image-guided odontoidectomy for decompression of basilar invagination via a standard anterior cervical approach. Technical note. J Neurosurg Spine 6 : 184-191, 2007
30) Ruetten S, Hahn P, Oezdemir S et al : The full-endoscopic uniportal technique for decompression of the anterior craniocervical junction using the retropharyngeal approach : an anatomical feasibility study in human cadavers and review of the literature. J Neurosurg Spine 29 : 615-621, 2018
P.257 掲載の参考文献
1) Bai LL, Wang WT, Wang JF et al : Anterior cervical discectomy and fusion combined with foraminotomy assisted by high-definition 3-dimensional exoscope in the treatment of cervical spondylotic radiculopathy secondary to bony foraminal stenosis. Orthop Surg 13 : 2318-2326, 2021
2) Rosler J, Georgiev S, Roethe AL et al : Clinical implementation of a 3D4K-exoscope (Orbeye) in microneurosurgery. Neurosurg Rev 45 : 627-635, 2022
P.258 掲載の参考文献
3) Roethe AL, Landgraf P, Schroder T et al : Monitor-based exoscopic 3D4k neurosurgical interventions : a two-phase prospective-randomized clinical evaluation of a novel hybrid device. Acta Neurochir (Wien) 162 : 2949-2961, 2020
4) Burkhardt BW, Csokonay A, Oertel JM : 3D-exoscopic visualization using the VITOM-3D in cranial and spinal neurosurgery. What are the limitations? Clin Neurol Neurosurg 198 : 106101, 2020
5) Visocchi M, Mattogno PP, Ciappetta P et al : Combined transoral exoscope and OArm-assisted approach for craniovertebral junction surgery : light and shadows in single-center experience with improving technologies. J Craniovertebr Junction Spine 11 : 293-299, 2020
6) Visocchi M, Mattogno PP, Signorelli F : Exoscope and OArm : what we can learn in craniovertebral junction surgery. J Neurosurg Sci 65 : 616-617, 2021
P.259 掲載の参考文献
7) Siller S, Zoellner C, Fuetsch M et al : A high-definition 3D exoscope as an alternative to the operating microscope in spinal microsurgery. J Neurosurg Spine doi : 10.3171/2020.4.SPINE20374, 2020 [online ahead of print]
8) Yao Y, Xiong C, Wei T et al : Three-dimensional high-definition exoscope (Kestrel View II) in anterior cervical discectomy and fusion : a valid alternative to operative microscope-assisted surgery. Acta Neurochir (Wien) 163 : 3287-3296, 2021
9) Lin H, Chen F, Mo J et al : Cervical spine microsurgery with the high-definition 3D exoscope : advantages and disadvantages. World Neurosurg 161 : e1-e7, 2022
10) Barbagallo GMV, Certo F : Three-dimensional, high-definition exoscopic anterior cervical discectomy and fusion : a valid alternative to microscope-assisted surgery. World Neurosurg 130 : e244-e250, 2019
11) Kim M, Wainwright J, Stein A et al : Posterior transdural approach for a calcified thoracic intradural disc herniation using a 3-dimensional exoscope : 2-dimensional operative video. Oper Neurosurg (Hagerstown) 21 : E44-E45, 2021
12) Murai Y, Sato S, Yui K et al : Preliminary clinical microneurosurgical experience with the 4K3-dimensional microvideoscope (ORBEYE) system for microneurological surgery : observation study. Oper Neurosurg (Hagerstown) 16 : 707-716, 2019
13) Oren J, Kwan K, Schneider J et al : Minimally invasive navigated foraminal discectomy via contralateral approach using a 3-dimensional 4K high-definition exoscope : 2-dimensional operative video. Oper Neurosurg (Hagerstown) 19 : E188, 2020
14) D'Ercole M, Serchi E, Zanello M et al : Clinical application of a high definition three-dimensional exoscope in anterior lumbar interbody fusion : technical note. Int J Spine Surg 14 : 1003-1008, 2020
15) Teo THL, Tan BJ, Loo WL et al : Utility of a high-definition 3D digital exoscope for spinal surgery during the COVID-19 pandemic. Bone Jt Open 1 : 359-363, 2020
P.260 掲載の参考文献
16) De Divitiis O, D'avella E, Denaro L et al : Vitom 3D : preliminary experience with intradural extramedullary spinal tumors. J Neurosurg Sci doi : 10.23736/S0390-5616.19.04666-6, 2019 [online ahead of print
P.262 掲載の参考文献
1) Holly LT, Batzdorf U : Chiari malformation and syringomyelia. J Neurosurg Spine 31 : 619-628, 2019
2) Luzzi S, Giotta Lucifero A, Elsawaf Y et al : Pulsatile cerebrospinal fluid dynamics in Chiari I malformation syringomyelia : predictive value in posterior fossa decompression and insights into the syringogenesis. J Craniovertebr Junction Spine 12 : 15-25, 2021
3) Yamada S, Ishikawa M, Ito H et al : Cerebrospinal fluid dynamics in idiopathic normal pressure hydrocephalus on four-dimensional flow imaging. Eur Radiol 30 : 4454-4465, 2020
4) Jaeger E, Sonnabend K, Schaarschmidt F et al : Compressed-sensing accelerated 4D flow MRI of cerebrospinal fluid dynamics. Fluids Barriers CNS 17 : 43, 2020
P.263 掲載の参考文献
5) Iwasaki M, Yokohama T, Oura D et al : Decreased value of highly accurate fractional anisotropy using 3-Tesla ZOOM diffusion tensor imaging after decompressive surgery in patients with cervical spondylotic myelopathy : aligned fibers effect. World Neurosurg X 4 : 100056, 2019
P.264 掲載の参考文献
6) Ogunlade J, Wiginton JG 4th, Elia C et al : Primary spinal astrocytomas : a literature review. Cureus 11 : e5247, 2019
7) Zhao M, Shi B, Chen T et al : Axial MR diffusion tensor imaging and tractography in clinical diagnosed and pathology confirmed cervical spinal cord astrocytoma. J Neurol Sci 375 : 43-51, 2017
8) Takai K, Komori T, Kurita H et al : Intradural radicular arteriovenous fistula that mimics dural arteriovenous fistula : report of three cases. Neuroradiology 61 : 1203-1208, 2019
P.265 掲載の参考文献
9) Takai K, Komori T, Taniguchi M : Angioarchitecture of filum terminale arteriovenous fistulas : relationship with a tethered spinal cord. World Neurosurg 122 : e795-e804, 2019
10) Takai K, Endo T, Yasuhara T et al : Microsurgical versus endovascular treatment of spinal epidural arteriovenous fistulas with intradural venous drainage : a multicenter study of 81 patients. J Neurosurg Spine doi : 10.3171/2020.2.SPINE191432, 2020 [online ahead of print]
P.266 掲載の参考文献
11) Takamiya S, Osanai T, Seki T et al : Estimation of the number of feeding arteries of spinal arteriovenous malformations by using three-dimensional digital subtraction angiography. Eur Spine J 28 : 842-848, 2019
12) Patel PY, Dalal I, Griffith B : [18F] FDGPET evaluation of spinal pathology in patients in oncology : pearls and pitfalls for the neuroradiologist. AJNR Am J Neuroradiol 43 : 332-340, 2022
13) Marner L, Nysom K, Sehested A et al : Early Postoperative 18F-FET PET/MRI for Pediatric Brain and Spinal Cord Tumors. J Nucl Med 60 : 1053-1058, 2019
P.267 掲載の参考文献
14) Han B, Wu D, Jia W et al : Intraoperative ultrasound and contrast-enhanced ultrasound in surgical treatment of intramedullary spinal tumors. World Neurosurg 137 : e570-e576, 2020
15) Timonin SY, Konovalov NA : Surgical treatment of intramedullary hemangioblastomas : current state of problem (review). Sovrem Tekhnologii Med 13 : 83-94, 2021
16) Kato N, Prinz V, Dengler J et al : Blood flow assessment of arteriovenous malformations using intraoperative indocyanine green videoangiography. Stroke Res Treat 2019 : 7292304, 2019
P.268 掲載の参考文献
17) Banat M, Wach J, Salemdawod A et al : The role of intraoperative image guidance systems (three-dimensional C-arm versus O-arm) in spinal surgery : results of a single-center study. World Neurosurg 146 : e817-e821, 2021
18) Kelly PD, Zuckerman SL, Yamada Y et al : Image guidance in spine tumor surgery. Neurosurg Rev 43 : 1007-1017, 2020
19) Kochanski RB, Lombardi JM, Laratta JL et al : Image-guided navigation and robotics in spine surgery. Neurosurgery 84 : 1179-1189, 2019
20) Lemay A, Gros C, Zhuo Z et al : Automatic multiclass intramedullary spinal cord tumor segmentation on MRI with deep learning. Neuroimage Clin 31 : 102766, 2021
VII章 水頭症
P.270 掲載の参考文献
1) Nakajima M, Yamada S, Miyajima M et al : Guidelines for management of idiopathic normal pressure hydrocephalus (third edition) : endorsed by the Japanese Society of Normal Pressure Hydrocephalus. Neurol Med Chir (Tokyo) 61 : 63-97, 2021
2) Andersson J, Rosell M, Kockum K et al : Prevalence of idiopathic normal pressure hydrocephalus : A prospective, population-based study. PLoS One 14 : e0217705, 2019
P.271 掲載の参考文献
3) Vibha D, Tripathi M : Normal-pressure hydrocephalus-patient evaluation and decision-making. Neurol India 69 (Supplement) : S406-S412, 2021
4) Griffa A, Bommarito G, Assal F et al : CSF tap test in idiopathic normal pressure hydrocephalus : still a necessary prognostic test? J Neurol doi : 10.1007/s00415-022-11168-x, 2022 [online ahead of print]
5) Nakajima M, Yamada S, Miyajima M et al : Tap test can predict cognitive improvement in patients with iNPH-results from the multicenter prospective studies SINPHONI-1 and -2. Front Neurol 12 : 769216, 2021
6) Kamohara C, Nakajima M, Kawamura K et al : Neuropsychological tests are useful for predicting comorbidities of idiopathic normal pressure hydrocephalus. Acta Neurol Scand 142 : 623-631, 2020
P.272 掲載の参考文献
7) Kockum K, Virhammar J, Riklund K et al : Diagnostic accuracy of the iNPH Radscale in idiopathic normal pressure hydrocephalus. PLoS One 15 : e0232275, 2020
8) Fallmar D, Andersson O, Kilander L et al : Imaging features associated with idiopathic normal pressure hydrocephalus have high specificity even when comparing with vascular dementia and atypical parkinsonism. Fluids Barriers CNS 18 : 35, 2021
9) Laticevschi T, Lingenberg A, Armand S et al : Can the radiological scale "iNPH Radscale" predict tap test response in idiopathic normal pressure hydrocephalus? J Neurol Sci 420 : 117239, 2021
10) Kimihira L, Iseki C, Takahashi Y et al : A multi-center, prospective study on the progression rate of asymptomatic ventriculomegaly with features of idiopathic normal pressure hydrocephalus on magnetic resonance imaging to idiopathic normal pressure hydrocephalus. J Neurol Sci 419 : 117166, 2020
11) Miyazaki K, Ishii K, Hanaoka K et al : The tight medial and high convexity subarachnoid spaces is the first finding of idiopathic normal pressure hydrocephalus at the preclinical stage. Neurol Med Chir (Tokyo) 59 : 436-443, 2019
P.273 掲載の参考文献
12) Yamada S, Ito H, Ishikawa M et al : Quantification of oscillatory shear stress from reciprocating CSF motion on 4D flow imaging. AJNR Am J Neuroradiol 42 : 479-486, 2021
13) Martinoni M, Miccoli G, Riccioli LA et al : Idiopathic aqueductal stenosis : late neurocognitive outcome in ETV operated adult patients. Front Neurol 13 : 806885, 2022
14) Keong NC, Lock C, Soon S et al : Diffusion tensor imaging profiles can distinguish diffusivity and neural properties of white matter injury in hydrocephalus vs. non-hydrocephalus using a strategy of a periodic table of DTI elements. Front Neurol 13 : 868026, 2022
15) Demiral SB, Tomasi D, Sarlls J et al : Apparent diffusion coefficient changes in human brain during sleep-Does it inform on the existence of a glymphatic system? Neuroimage 185 : 263-273, 2019
16) Kikuta J, Kamagata K, Taoka T et al : Water diffusivity changes along the perivascular space after lumboperitoneal shunt surgery in idiopathic normal pressure hydrocephalus. Front Neurol 13 : 843883, 2022
17) Akiyama Y, Yokoyama R, Takashima H et al : Accumulation of macromolecules in idiopathic normal pressure hydrocephalus. Neurol Med Chir (Tokyo) 61 : 211-218, 2021
P.274 掲載の参考文献
18) Aso T, Sugihara G, Murai T et al : A venous mechanism of ventriculomegaly shared between traumatic brain injury and normal ageing. Brain 143 : 1843-1856, 2020
19) Kanemoto H, Mori E, Tanaka T et al : Cerebrospinal fluid amyloid beta and response of cognition to a tap test in idiopathic normal pressure hydrocephalus : a case-control study. Int Psychogeriatr doi : 10.1017/S1041610221000661, 2021 [online ahead of print]
20) Hua R, Liu C, Liu X et al : Predictive value of cerebrospinal fluid biomarkers for tap test responsiveness in patients with suspected idiopathic normal pressure hydrocephalus. Front Aging Neurosci 13 : 665878, 2021
21) Jeppsson A, Bjerke M, Hellstrom P et al : Shared CSF biomarker profile in idiopathic normal pressure hydrocephalus and subcortical small vessel disease. Front Neurol 13 : 839307, 2022
22) Kawamura K, Miyajima M, Nakajima M et al : Cerebrospinal fluid amyloid-beta oligomer levels in patients with idiopathic normal pressure hydrocephalus. J Alzheimers Dis 83 : 179-190, 2021
P.275 掲載の参考文献
23) Vanninen A, Nakajima M, Miyajima M et al : Elevated CSF LRG and decreased Alzheimer's disease biomarkers in idiopathic normal pressure hydrocephalus. J Clin Med. 10 : 1105, 2021
24) Nakajima M, Rauramaa T, Makinen PM et al : Protein tyrosine phosphatase receptor type Q in cerebrospinal fluid reflects ependymal cell dysfunction and is a potential biomarker for adult chronic hydrocephalus. Eur J Neurol 28 : 389-400, 2021
25) Ishii K : Diagnostic imaging of dementia with Lewy bodies, frontotemporal lobar degeneration, and normal pressure hydrocephalus. Jpn J Radiol 38 : 64-76, 2020
26) Pozzi NG, Brumberg J, Todisco M et al : Striatal dopamine deficit and motor impairment in idiopathic normal pressure hydrocephalus. Mov Disord 36 : 124-132, 2021
27) Sakurai A, Tsunemi T, Ishiguro Y et al : Comorbid alpha synucleinopathies in idiopathic normal pressure hydrocephalus. J Neurol 269 : 2022-2029, 2022
P.276 掲載の参考文献
28) Macki M, Mahajan A, Shatz R et al : Prevalence of alternative diagnoses and implications for management in idiopathic normal pressure hydrocephalus patients. Neurosurgery 87 : 999-1007, 2020
29) Niermeyer M, Gaudet C, Malloy P et al : Frontal behavior syndromes in idiopathic normal pressure hydrocephalus as a function of Alzheimer's disease biomarker status. J Int Neuropsychol Soc 26 : 883-893, 2020
30) Goh ET, Lock C, Tan AJL et al : Clinical outcomes after ventriculo-peritoneal shunting in patients with Classic vs. Complex NPH. Front Neurol 13 : 868000, 2022
31) Reeves BC, Karimy JK, Kundishora AJ et al : Glymphatic system impairment in Alzheimer's disease and idiopathic normal pressure hydrocephalus. Trends Mol Med 26 : 285-295, 2020
32) Torretta E, Arosio B, Barbacini P et al : Novel insight in idiopathic normal pressure hydrocephalus (iNPH) biomarker discovery in CSF. Int J Mol Sci 22 : 8034, 2021
P.277 掲載の参考文献
33) Wetzel C, Goertz L, Noe P et al : Flow-regulated versus differential pressure valves for idiopathic normal pressure hydrocephalus : comparison of overdrainage rates and neurological outcome. Acta Neurochir (Wien) 162 : 15-21, 2020
34) Sakurai A, Tsunemi T, Shimada T et al : Effect of comorbid Parkinson's disease and Parkinson's disease dementia on the course of idiopathic normal pressure hydrocephalus. J Neurosurg doi : 10.3171/2022.1.JNS212282, 2022 [online ahead of print]
35) Tinelli M, Guldemond N, Kehler U : Idiopathic normal-pressure hydrocephalus : the cost-effectiveness of delivering timely and adequate treatment in Germany. Eur J Neurol 28 : 681-690, 2021
36) Kamo M, Kajimoto Y, Ohmura T et al : Weight and abdominal pressure-induced shunt trouble in patients with shunted normal pressure hydrocephalus : a comprehensive study on pressure environment of shunt system. Front Neurol 13 : 882757, 2022
P.278 掲載の参考文献
37) Yamada S, Ishikawa M, Nakajima M et al : Reconsidering ventriculoperitoneal shunt surgery and postoperative shunt valve pressure adjustment : our approaches learned from past challenges and failures. Front Neurol 12 : 798488, 2022
P.279 掲載の参考文献
1) Jin SC, Dong W, Kundishora AJ et al : Exome sequencing implicates genetic disruption of prenatal neuro-gliogenesis in sporadic congenital hydrocephalus. Nat Med 26 : 1754-1765, 2020
2) Duy PQ, Weise SC, Marini C et al : Impaired neurogenesis alters brain biomechanics in a neuroprogenitor-based genetic subtype of congenital hydrocephalus. Nat Neurosci 25 : 458-473, 2022
P.280 掲載の参考文献
3) Park YS, Kotani Y, Kim TK et al : Efficacy and safety of intraventricular fibrinolytic therapy for post-intraventricular hemorrhagic hydrocephalus in extreme low birth weight infants : a preliminary clinical study. Childs Nerv Syst 37 : 69-79, 2021
4) Frassanito P, Serrao F, Gallini F et al : Ventriculosubgaleal shunt and neuroendoscopic lavage : refining the treatment algorithm of neonatal post-hemorrhagic hydrocephalus. Childs Nerv Syst 37 : 3531-3540, 2021
5) Tirado-Caballero J, Rivero-Garvia M, Arteaga-Romero F et al : Neuroendoscopic lavage for the management of posthemorrhagic hydrocephalus in preterm infants : safety, effectivity, and lessons learned. J Neurosurg Pediatr 26 : 237-246, 2020
6) Schaumann A, Buhrer C, Schulz M et al : Neuroendoscopic surgery in neonates-indication and results over a 10-year practice. Childs Nerv Syst 37 : 3541-3548, 2021
7) Honeyman SI, Boukas A, Jayamohan J et al : Neuroendoscopic lavage for the management of neonatal post-haemorrhagic hydrocephalus : a retrospective series. Childs Nerv Syst 38 : 115-121, 2022
8) Kandula V, Mohammad LM, Thirunavu V et al : The role of blood product removal in intraventricular hemorrhage of prematurity : a meta-analysis of the clinical evidence. Childs Nerv Syst 38 : 239-252, 2022
P.281 掲載の参考文献
9) Thomale UW, Auer C, Spennato P et al : TROPHY registry-status report. Childs Nerv Syst 37 : 3549-3554, 2021
10) Hauptman JS, Kestle J, Riva-Cambrin J et al : Predictors of fast and ultrafast shunt failure in pediatric hydrocephalus : a Hydrocephalus Clinical Research Network study. J Neurosurg Pediatr 27 : 277-286, 2020
11) Rymarczuk GN, Keating RF, Coughlin DJ et al : A comparison of ventriculoperitoneal and ventriculoatrial shunts in a population of 544 consecutive pediatric patients. Neurosurgery 87 : 80-85, 2020
12) Gmeiner M, Wagner H, van Ouwerkerk WJR et al : Long-term outcomes in ventriculoatrial shunt surgery in patients with pediatric hydrocephalus : retrospective single-center study. World Neurosurg 138 : e112-e118, 2020
13) Yamashita S, Kimiwada T, Hayashi T et al : Reconversion to ventriculoperitoneal shunt following ventriculoatrial shunt malfunction in children. Childs Nerv Syst 37 : 2207-2213, 2021
P.282 掲載の参考文献
14) Christian EA, Quezada JJ, Melamed EF et al : Ventriculopleural shunts in a pediatric population : a review of 170 consecutive patients. J Neurosurg Pediatr 28 : 450-457, 2021
15) Tsuda K, Ihara S : Transependymal edema as a predictor of endoscopic third ventriculostomy success in pediatric hydrocephalus. World Neurosurg 156 : e215-e221, 2021
16) Sherrod BA, Iyer RR, Kestle JRW : Endoscopic third ventriculostomy for pediatric tumor-associated hydrocephalus. Neurosurg Focus 48 : E5, 2020
P.283 掲載の参考文献
17) Tamber MS, Kestle JRW, Reeder RW et al : Temporal trends in surgical procedures for pediatric hydrocephalus : an analysis of the Hydrocephalus Clinical Research Network Core Data Project. J Neurosurg Pediatr 27 : 269-276, 2020
18) Reynolds RA, Bhebhe A, Garcia RM et al : Pediatric hydrocephalus outcomes in Lusaka, Zambia. J Neurosurg Pediatr 26 : 624-635, 2020
19) Polis B, Polis L, Nowoslawska E : Surgical treatment of post-inflammatory hydrocephalus. Analysis of 101 cases. Childs Nerv Syst 35 : 237-243, 2019
20) Pindrik J, Riva-Cambrin J, Kulkarni AV et al : Surgical resource utilization after initial treatment of infant hydrocephalus : comparing ETV, early experience of ETV with choroid plexus cauterization, and shunt insertion in the Hydrocephalus Clinical Research Network. J Neurosurg Pediatr 26 : 337-345, 2020
21) Texakalidis P, Tora MS, Wetzel JS et al : Endoscopic third ventriculostomy versus shunt for pediatric hydrocephalus : a systematic literature review and meta-analysis. Childs Nerv Syst 35 : 1283-1293, 2019
22) Pande A, Lamba N, Mammi M et al : Endoscopic third ventriculostomy versus ventriculoperitoneal shunt in pediatric and adult population : a systematic review and meta-analysis. Neurosurg Rev 44 : 1227-1241, 2021
P.284 掲載の参考文献
23) Hersh DS, Kumar R, Klimo P et al : Hydrocephalus surveillance following shunt placement or endoscopic third ventriculostomy : a survey of surgeons in the Hydrocephalus Clinical Research Networks. J Neurosurg Pediatr doi : 10.3171/2020.12.PEDS20830, 2021 [online ahead of print]
VIII章 感染症
P.286 掲載の参考文献
1) Karvouniaris M, Brotis A, Tsiakos K et al : Current perspectives on the diagnosis and management of healthcare-associated ventriculitis and meningitis. Infect Drug Resist 15 : 697-721, 2022
P.287 掲載の参考文献
2) Hersh EH, Yaeger KA, Neifert SN et al : Patterns of health care costs due to external ventricular drain infections. World Neurosurg 128 : e31-e37, 2019
3) Finger G, Worm PV, Dos Santos SC et al : Cerebrospinal fluid collected by lumbar puncture has a higher diagnostic accuracy than collected by ventriculostomy. World Neurosurg 138 : e683-e689, 2020
4) Tunkel AR, Hasbun R, Bhimraj A et al : 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis 64 : e34-e65, 2017
P.288 掲載の参考文献
5) Wong GK, Poon WS, Wai S et al : Failure of regular external ventricular drain exchange to reduce cerebrospinal fluid infection : result of a randomised controlled trial. J Neurol Neurosurg Psychiatry 73 : 759-761, 2002
6) Nau R, Blei C, Eiffert H : Intrathecal antibacterial and antifungal therapies. Clin Microbiol Rev 33 : e00190-19, 2020
7) Lewin JJ 3rd, Cook AM, Gonzales C et al : Current practices of intraventricular antibiotic therapy in the treatment of meningitis and ventriculitis : results from a multicenter retrospective cohort study. Neurocrit Care 30 : 609-616, 2019
8) Adapa AR, Linzey JR, Moriguchi F et al : Risk factors and morbidity associated with surgical site infection subtypes following adult neurosurgical procedures. Br J Neurosurg 29 : 1-7, 2021
P.289 掲載の参考文献
9) Antonello RM, Riccardi N : How we deal with Staphylococcus aureus (MSSA, MRSA) central nervous system infections. Front Biosci (Schol Ed) 14 : 1, 2022
10) Pintado V, Pazos R, Jimenez-Mejias ME et al : Staphylococcus aureus meningitis in adults : a comparative cohort study of infections caused by meticillin-resistant and meticillin-susceptible strains. J Hosp Infect 102 : 108-115, 2019
P.290 掲載の参考文献
11) Ceraudo M, Prior A, Balestrino A et al : Ultra-short antibiotic prophylaxis guided by preoperative microbiological nasal swabs in endoscopic endonasal skull base surgery. Acta Neurochir (Wien) 163 : 369-382, 2021
12) Chen HA, Yang CJ, Tsai MS et al : Linezolid as salvage therapy for central nervous system infections due to methicillin-resistant Staphylococcus aureus at two medical centers in Taiwan. J Microbiol Immunol Infect 53 : 909-915, 2020
13) Sharma R, Goda R, Borkar SA et al : Outcome following postneurosurgical Acinetobacter meningitis : an institutional experience of 72 cases. Neurosurg Focus 47 : E8, 2019
P.291 掲載の参考文献
14) Wan D, Du T, Hong W et al : Neurological complications and infection mechanism of SARS-COV-2. Signal Transduct Target Ther 6 : 406, 2021
15) Cervantes-Arslanian AM, Venkata C, Anand P et al : Neurologic manifestations of severe acute respiratory syndrome coronavirus 2 infection in hospitalized patients during the first year of the COVID-19 pandemic. Crit Care Explor 4 : e0686, 2022
16) Sharma R, Nalleballe K, Shah V et al : Spectrum of hemorrhagic encephalitis in COVID-19 patients : a case series and review. Diagnostics (Basel) 12 : 924, 2022
P.293 掲載の参考文献
1) Huang J, Wu H, Huang H et al : Clinical characteristics and outcome of primary brain abscess : a retrospective analysis. BMC Infect Dis 21 : 1245, 2021
2) Sonneville R, Ruimy R, Benzonana N et al : An update on bacterial brain abscess in immunocompetent patients. Clin Microbiol Infect 23 : 614-620, 2017
3) Xiang Q, Jiang C, Wen J et al : Unusual presentation of brain abscess in a 23-month-old infant. Childs Nerv Syst 37 : 305-309, 2021
4) Corsini Campioli C, Castillo Almeida NE, O'Horo JC et al : Bacterial brain abscess : an outline for diagnosis and management. Am J Med 134 : 1210-1217.e2, 2021
5) Toh CH, Siow TY, Wong AM et al : Brain abscess apparent diffusion coefficient is associated with microbial culture yields. J Magn Reson Imaging 54 : 598-606, 2021
6) Zhang F, Hsu G, Das S et al : Independent risk factors associated with higher mortality rates and recurrence of brain abscesses from head and neck sources. Oral Surg Oral Med Oral Pathol Oral Radiol 131 : 173-179, 2021
7) van Gijn J, Hijdra A, Wijdicks EF et al : Acute hydrocephalus after aneurysmal subarachnoid hemorrhage. J Neurosurg 63 : 355-362, 1985
8) Rizas KD, McNitt S, Hamm W et al : Prediction of sudden and non-sudden cardiac death in post-infarction patients with reduced left ventricular ejection fraction by periodic repolarization dynamics : MADIT-II substudy. Eur Heart J 38 : 2110-2118, 2017
9) Angraal S, Mortazavi BJ, Gupta A et al : Machine learning prediction of mortality and hospitalization in heart failure with preserved ejection fraction. JACC Heart Fail 8 : 12-21, 2020
10) Rueda AM, Ormond M, Gore M et al : Hyperglycemia in diabetics and non-diabetics : effect on the risk for and severity of pneumococcal pneumonia. J Infect 60 : 99-105, 2010
P.294 掲載の参考文献
11) Zeng T, Xu Z, Yan J : The value of asphericity derived from T1-weighted MR in differentiating intraparenchymal ringenhancing lesions-comparison of glioblastomas and brain abscesses. Neurol Sci 42 : 5171-5175, 2021
12) Xiao D, Wang J, Wang X et al : Distinguishing brain abscess from necrotic glioblastoma using MRI-based intranodular radiomic features and peritumoral edema/tumor volume ratio. J Integr Neurosci 20 : 623-634, 2021
P.295 掲載の参考文献
13) Darlow CA, McGlashan N, Kerr R et al : Microbial aetiology of brain abscess in a UK cohort : prominent role of Streptococcus intermedius. J Infect 80 : 623-629, 2020
15) Laulajainen-Hongisto A, Lempinen L, Farkkila E et al : Intracranial abscesses over the last four decades ; changes in aetiology, diagnostics, treatment and outcome. Infect Dis (Lond) 48 : 310-316, 2016
16) Kruthika P, Raj P, Jabeen S et al : Clinicomycological overview of brain abscess in a tertiary care center : a 38 year retrospection : fungal brain abscess. J Mycol Med 31 : 101156, 2021
P.296 掲載の参考文献
17) Myrianthefs P, Markantonis SL, Vlachos K et al : Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients. Antimicrob Agents Chemother 50 : 3971-3976, 2006
18) Mameli C, Genoni T, Madia C et al : Brain abscess in pediatric age : a review. Childs Nerv Syst 35 : 1117-1128, 2019
19) Udayakumaran S, Onyia CU, Kumar RK : Forgotten? Not yet. Cardiogenic brain abscess in children : a case series-based review. World Neurosurg 107 : 124-129, 2017
20) Shovlin CL, Condliffe R, Donaldson JW et al ; British Thoracic Society : British thoracic society clinical statement on pulmonary arteriovenous malformations. Thorax 72 : 1154-1163, 2017
21) Bank DE, Carolan PL : Cerebral abscess formation following ocular trauma : a hazard associated with common wooden toys. Pediatr Emerg Care 9 : 285-288, 1993
P.297 掲載の参考文献
22) Kanu OO, Ojo O, Esezobor C et al : Pediatric brain abscess-etiology, management challenges and outcome in Lagos Nigeria. Surg Neurol Int 12 : 592, 2021
23) Bodilsen J, Dalager-Pedersen M, Nielsen H : Long-term mortality and risk of epilepsy in children and young adults with brain abscess. Pediatr Infect Dis J 39 : 877-882, 2020
IX章 神経科学
P.301 掲載の参考文献
1) Umekage M, Sato Y, Takasu N : Overview : an iPS cell stock at CiRA. Inflamm Regen 39 : 17, 2019
2) Xu H, Wang B, Ono M et al : Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility. Cell Stem Cell 24 : 566-578.e7, 2019
3) Mandai M, Watanabe A, Kurimoto Y et al : Autologous induced stem-cell-derived retinal cells for macular degeneration. N Engl J Med 376 : 1038-1046, 2017
4) Takagi S, Mandai M, Gocho K et al : Evaluation of transplanted autologous induced pluripotent stem cell-derived retinal pigment epithelium in exudative age-related macular degeneration. Ophthalmology Retina 3 : 850-859, 2019
5) Yamasaki S, Tu HY, Matsuyama T et al : A Genetic modification that reduces ON-bipolar cells in hESC-derived retinas enhances functional integration after transplantation. iScience 25 : 103657, 2021
P.302 掲載の参考文献
6) Kikuchi T, Morizane A, Doi D et al : Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model. Nature 548 : 592-596, 2017
7) Kim TW, Piao J, Koo SY et al : Biphasic activation of WNT signaling facilitates the derivation of midbrain dopamine neurons from hESCs for translational use. Cell Stem Cell 28 : 343-355.e5, 2021
8) Garitaonandia I, Gonzalez R, Sherman G et al : Novel approach to stem cell therapy in Parkinson's disease. Stem Cells Dev 27 : 951-957, 2018
9) Schweitzer JS, Song B, Herrington TM et al : Personalized iPSC-derived dopamine progenitor cells for Parkinson's disease. N Engl J Med 382 : 1926-1932, 2020
P.303 掲載の参考文献
10) Takahashi J : iPS cell-based therapy for Parkinson's disease : a Kyoto trial. Regen Ther 13 : 18-22, 2020
11) Doi D, Magotani H, Kikuchi T et al : Preclinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson's disease. Nat Commun 11 : 3369, 2020
12) Piao J, Zabierowski S, Dubose BN et al : Preclinical efficacy and safety of a human embryonic stem cell-derived midbrain dopamine progenitor product, MSK-DA01. Cell Stem Cell 28 : 217-229.e7, 2021
13) Barker RA, TRANSEURO consortium : Designing stem-cell-based dopamine cell replacement trials for Parkinson's disease. Nat Med 25 : 1045-1053, 2019
14) Gantner CW, de Luzy IR, Kauhausen JA et al : Viral delivery of GDNF promotes functional integration of human stem cell grafts in Parkinson's disease. Cell Stem Cell 26 : 511-526.e5, 2020
15) Torikoshi S, Morizane A, Shimogawa T et al : Exercise promotes neurite extensions from grafted dopaminergic neurons in the direction of the dorsolateral striatum in Parkinson's disease model rats. J Parkinsons Dis 10 : 511-521, 2020
P.304 掲載の参考文献
16) McKenna SL, Ehsanian R, Liu CY et al : Ten-year safety of pluripotent stem cell transplantation in acute thoracic spinal cord injury. J Neurosurg Spine doi : 10.3171/2021.12.SPINE21622, 2022 [online ahead of print]
17) Sugai K, Sumida M, Shofuda T et al : First-in-human clinical trial of transplantation of iPSC-derived NS/PCs in subacute complete spinal cord injury : study protocol. Regen Ther 18 : 321-333, 2021
18) Kitagawa T, Nagoshi N, Kamata Y et al : Modulation by DREADD reveals the therapeutic effect of human iPSC-derived neuronal activity on functional recovery after spinal cord injury. Stem Cell Reports 17 : 127-142, 2022
19) Kawabori M, Shichinohe H, Kuroda S et al : Clinical trials of stem cell therapy for cerebral ischemic stroke. Int J Mol Sci 21 : 7380, 2020
P.305 掲載の参考文献
20) Peron S, Droguerre M, Debarbieux F et al : A delay between motor cortex lesions and neuronal transplantation enhances graft integration and improves repair and recovery. J Neurosci 37 : 1820-1834, 2017
21) Palma-Tortosa S, Tornero D, Gronning Hansen M et al : Activity in grafted human iPS cell-derived cortical neurons integrated in stroke-injured rat brain regulates motor behavior. Proc Natl Acad Sci U S A 117 : 9094-9100, 2020
22) Kitahara T, Sakaguchi H, Morizane A et al : Axonal extensions along corticospinal tracts from transplanted human cerebral organoids. Stem Cell Reports 15 : 467-481, 2020
P.306 掲載の参考文献
1) Jaillard A, Hommel M, Moisan A et al : Autologous mesenchymal stem cells improve motor recovery in subacute ischemic stroke : a randomized clinical trial. Transl Stroke Res 11 : 910-923, 2020
2) Steinberg GK, Kondziolka D, Wechsler LR et al : Two-year safety and clinical outcomes in chronic ischemic stroke patients after implantation of modified bone marrow-derived mesenchymal stem cells (SB623) : a phase 1/2a study. J Neurosurg doi : 10.3171/2018.5.JNS173147, 2018 [online ahead of print]
P.307 掲載の参考文献
3) Levy ML, Crawford JR, Dib N et al : Phase I/II study of safety and preliminary efficacy of intravenous allogeneic mesenchymal stem cells in chronic stroke. Stroke 50 : 2835-2841, 2019
4) Honmou O, Yamashita T, Morita T et al : Intravenous infusion of auto serum-expanded autologous mesenchymal stem cells in spinal cord injury patients : 13 case series. Clin Neurol Neurosurg 203 : 106565, 2021
P.308 掲載の参考文献
5) Kiyose R, Sasaki M, Kataoka-Sasaki Y et al : Intravenous infusion of mesenchymal stem cells enhances therapeutic efficacy of reperfusion therapy in cerebral ischemia. World Neurosurg 149 : e160-e169, 2021
6) Nakazaki M, Oka S, Sasaki M et al : Prevention of neointimal hyperplasia induced by an endovascular stent via intravenous infusion of mesenchymal stem cells. J Neurosurg doi : 10.3171/2019.7.JNS19575, 2019 [online ahead of print]
7) Takemura M, Sasaki M, Kataoka-Sasaki Y et al : Repeated intravenous infusion of mesenchymal stem cells for enhanced functional recovery in a rat model of chronic cerebral ischemia. J Neurosurg doi : 10.3171/2021.8.JNS21687, 2021
P.309 掲載の参考文献
8) Oshigiri T, Sasaki T, Sasaki M et al : Intravenous infusion of mesenchymal stem cells alters motor cortex gene expression in a rat model of acute spinal cord injury. J Neurotrauma 36 : 411-420, 2019
9) Yasuda N, Sasaki M, Kataoka-Sasaki Y et al : Intravenous delivery of mesenchymal stem cells protects both white and gray matter in spinal cord ischemia. Brain Res 1747 : 147040, 2020
P.310 掲載の参考文献
10) Magota H, Sasaki M, Kataoka-Sasaki Y et al : Intravenous infusion of mesenchymal stem cells delays disease progression in the SOD1G93A transgenic amyotrophic lateral sclerosis rat model. Brain Res 1757 : 147296, 2021
11) Magota H, Sasaki M, Kataoka-Sasaki Y et al : Repeated infusion of mesenchymal stem cells maintain the condition to inhibit deteriorated motor function, leading to an extended lifespan in the SOD1G93A rat model of amyotrophic lateral sclerosis. Mol Brain 14 : 76, 2021
12) Nakazaki M, Sasaki M, Kataoka-Sasaki Y et al : Intravenous infusion of mesenchymal stem cells improves impaired cognitive function in a cerebral small vessel disease model. Neuroscience 408 : 361-377, 2019
13) Nakazaki M, Oka S, Sasaki M et al : Prolonged lifespan in a spontaneously hypertensive rat (stroke prone) model following intravenous infusion of mesenchymal stem cells. Heliyon 6 : e05833, 2020
P.313 掲載の参考文献
1) Louis DN, Perry A, Wesseling P et al : The 2021 WHO Classification of Tumors of the Central Nervous System : a summary. Neuro Oncol 23 : 1231-1251, 2021
P.314 掲載の参考文献
2) Reardon DA, Brandes AA, Omuro A et al : Effect of nivolumab vs bevacizumab in patients with recurrent glioblastoma : the checkMate 143 phase 3 randomized clinical trial. JAMA Oncol 6 : 1003-1010, 2020
3) Marabelle A, Fakih M, Lopez J et al : Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab : prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study. Lancet Oncol 21 : 1353-1365, 2020
4) Natsume A, Aoki K, Ohka F et al : Genetic analysis in patients with newly diagnosed glioblastomas treated with interferon-beta plus temozolomide in comparison with temozolomide alone. J Neurooncol 148 : 17-27, 2020
P.315 掲載の参考文献
5) Touat M, Li YY, Boynton AN et al : Mechanisms and therapeutic implications of hypermutation in gliomas. Nature 580 : 517-523, 2020
6) Doebele RC, Drilon A, Paz-Ares L et al : Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours : integrated analysis of three phase 1-2 trials. Lancet Oncol 21 : 271-282, 2020
7) Drilon A, Laetsch TW, Kummar S et al : Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children. N Engl J Med 378 : 731-739, 2018
8) Boyer J, Birzu C, Bielle F et al : Dramatic response of STRN-NTRK-fused malignant glioneuronal tumor to larotrectinib in adult. Neuro Oncol 23 : 1200-1202, 2021
P.316 掲載の参考文献
9) Mellinghoff IK, Ellingson BM, Touat M et al : Ivosidenib in isocitrate dehydrogenase 1-mutated advanced glioma. J Clin Oncol 38 : 3398-3406, 2020
10) Mellinghoff IK, Penas-Prado M, Peters KB et al : Vorasidenib, a dual inhibitor of mutant IDH1/2, in recurrent or progressive glioma ; results of a first-in-human phase I trial. Clin Cancer Res 27 : 4491-4499, 2021
11) Natsume A, Arakawa Y, Narita Y et al : The first-in-human phase I study of a brain penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomas. Neuro Oncol doi : 10.1093/neuonc/noac155, 2022 [online ahead of print]
12) Amankulor NM, Kim Y, Arora S et al : Mutant IDH1 regulates the tumor-associated immune system in gliomas. Genes Dev 31 : 774-786, 2017
13) Bunse L, Pusch S, Bunse T et al : Suppression of antitumor T cell immunity by the oncometabolite (R) -2-hydroxyglutarate. Nat Med 24 : 1192-1203, 2018
14) Kaley T, Touat M, Subbiah V et al : BRAF inhibition in BRAFV600-mutant gliomas : results from the VE-BASKET study. J Clin Oncol 36 : 3477-3484, 2018
P.317 掲載の参考文献
15) Wen PY, Stein A, van den Bent M et al : Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR) : a multicentre, open-label, single-arm, phase 2, basket trial. Lancet Oncol 23 : 53-64, 2022
16) Di Stefano AL, Picca A, Saragoussi E et al : Clinical, molecular, and radiomic profile of gliomas with FGFR3-TACC3 fusions. Neuro Oncol 22 : 1614-1624, 2020
17) Picca A, Berzero G, Bielle F et al : FGFR1 actionable mutations, molecular specificities, and outcome of adult midline gliomas. Neurology 90 : e2086-e2094, 2018
18) Lassman AB, Sepulveda-Sanchez JM, Cloughesy TF et al : Infigratinib in patients with recurrent gliomas and FGFR alterations : a multicenter phase II study. Clin Cancer Res 28 : 2270-2277, 2022
P.319 掲載の参考文献
1) Nagata Y, Takeuchi K, Yamamoto T et al : Peel-off resection of the pituitary gland for functional pituitary adenomas : pathological significance and impact on pituitary function. Pituitary 22 : 507-513, 2019
2) Truong HQ, Lieber S, Najera E et al : The medial wall of the cavernous sinus. Part 1 : Surgical anatomy, ligaments, and surgical technique for its mobilization and/or resection. J Neurosurg 131 : 122-130, 2018
3) Cohen-Cohen S, Gardner PA, Alves-Belo JT et al : The medial wall of the cavernous sinus. Part 2 : Selective medial wall resection in 50 pituitary adenoma patients. J Neurosurg 131 : 131-140, 2018
4) Schwartz TH, Morgenstern PF, Anand VK : Lessons learned in the evolution of endoscopic skull base surgery. J Neurosurg 130 : 337-346, 2019
P.320 掲載の参考文献
5) Nagata Y, Takeuchi K, Sasaki H et al : Mordified shoelace dural closure with collagen matrix in extended transsphenoidal surgery. Neurol Med Chir (Tokyo) 62 : 203-208, 2022
6) Teramoto S, Tahara S, Hattori Y et al : Skull base dural closure using a modified nonpenetrating clip device via an ndoscopic endonasal approach : technical note. Neurol Med Chir (Tokyo) 60 : 514-519, 2020
7) Ali M, Zhang X, Ascanio LC et al : Long-term functional independence after minimally invasive endoscopic intracerebral hemorrhage evacuation. J Neurosurg doi : 10.3171/2022.3.JNS22286, 2022 [online ahead of print]
P.321 掲載の参考文献
8) Lu L, Chen H, Weng S et al : Endoscopic third ventriculostomy versus ventriculoperitoneal shunt in patients with obstructive hydrocephalus : meta-analysis of randomized controlled trials. World Neurosurg 129 : 334-340, 2019
9) Pande A, Lamba N, Mammi M et al : Endoscopic third ventriculostomy versus ventriculoperitoneal shunt in pediatric and adult population : a systematic review and meta-analysis. Neurosurg Rev 44 : 1227-1241, 2021
10) Legaspi GD, Espiritu AI, Omar AT 2nd : Success and complication rates of endoscopic third ventriculostomy for tuberculous meningitis : a systematic review and meta-analysis. Neurosurg Rev 44 : 2201-2209, 2021
11) Guida L, Beccaria K, Benichi S et al : Endoscopic aqueductal stenting in the management of pediatric hydrocephalus. J Neurosurg Pediatr 26 : 346-352, 2020
12) Yamamoto T, Takeuchi K, Nagata Y et al : A novel endoscopic ventriculocisternostomy and stenting technique with a transparent acryl puncture needle for a trapped temporal horn : a technical report and literature review. Neurosurg Rev 45 : 1783-1789, 2022
P.322 掲載の参考文献
13) Kang KB, Shin YS, Seo EM : Endoscopic spinal surgery (BESS and UESS) versus microscopic surgery in lumbar spinal stenosis : systematic review and meta-analysis. Global Spine J doi : 10.1177/21925682221083271, 2022 [online ahead of print]
14) Siller S, Zoellner C, Fuetsch M et al : A high-definition 3D exoscope as an alternative to the operating microscope in spinal microsurgery. J Neurosurg Spine doi : 10.3171/2020.4.SPINE20374, 2020 [online ahead of print]
P.323 掲載の参考文献
15) Eichberg DG, Di L, Shah AH et al : Minimally invasive resection of intracranial lesions using tubular retractors : a large, multi-surgeon, multi-institutional series. J Neurooncol 149 : 35-44, 2020
16) Marenco-Hillembrand L, Prevatt C, Suarez-Meade P et al : Minimally invasive surgical outcomes for deep-seated brain lesions treated with different tubular retraction systems : a systematic review and meta-analysis. World Neurosurg 143 : 537-545.e3, 2020
17) Ishikawa T, Takeuchi K, Yamamoto T et al : Importance of hydrostatic pressure and irrigation for hemostasis in neuroendoscopic surgery. Neurol Med Chir (Tokyo) 61 : 117-123, 2021
P.324 掲載の参考文献
1) Zhang H, Ille S, Sogerer L et al : Elucidating the structural-functional connectome of language in glioma-induced aphasia using nTMS and DTI. Hum Brain Mapp 43 : 1836-1849, 2022
P.325 掲載の参考文献
2) McGlashan EM, Poudel GR, Jamadar SD et al : Afraid of the dark : light acutely suppresses activity in the human amygdala. Plos One 16 : e0252350, 2021
3) Alkawadri R, Zaveri HP, Sheth KN et al : Passive localization of the central sulcus during sleep based on intracranial EEG. Cereb Cortex doi : 10.1093/cercor/bhab443, 2021 [online ahead of print]
4) Lu J, Zhao Z, Zhang J et al : Functional maps of direct electrical stimulation-induced speech arrest and anomia : a multicentre retrospective study. Brain 144 : 2541-2553, 2021
P.326 掲載の参考文献
5) Nakajima R, Kinoshita M, Okita H et al : Preserving right pre-motor and posterior prefrontal cortices contribute to maintaining overall basic emotion. Front Hum Neurosci 15 : 612890, 2021
6) Sarubbo S, Tate M, Benedictis AD et al : Mapping critical cortical hubs and white matter pathways by direct electrical stimulation : an original functional atlas of the human brain. Neuroimage 205 : 116237, 2020
7) Lemaitre AL, Herbet G, Ng S et al : Cognitive preservation following awake mapping-based neurosurgery for low-grade gliomas : a longitudinal, within-patient design study. Neuro Oncol 24 : 781-793, 2022
8) Cuisenier P, Testud B, Minotti L et al : Relationship between direct cortical stimulation and induced high-frequency activity for language mapping during SEEG recording. J Neurosurg 134 : 1251-1261, 2020
9) Grande KM, Ihnen SKZ, Arya R : Electrical stimulation mapping of brain function : a comparison of subdural electrodes and stereo-EEG. Front Hum Neurosci 14 : 611291, 2020
P.327 掲載の参考文献
10) Arya R, Ervin B, Dudley J et al : Electrical stimulation mapping of language with stereo-EEG. Epilepsy Behav 99 : 106395, 2019
11) Mazzola L, Mauguiere F, Isnard J : Functional mapping of the human insula : data from electrical stimulations. Rev Neurol (Paris) 175 : 150-156, 2019
12) Singh R, Principe A, Tadel F et al : Mapping the insula with stereo-electroencephalography : the emergence of semiology in insula lobe seizures. Ann Neurol 88 : 477-488, 2020
13) Sonoda M, Rothermel R, Carlson A et al : Naming-related spectral responses predict neuropsychological outcome after epilepsy surgery. Brain 145 : 517-530, 2022
P.328 掲載の参考文献
14) Alasfour A, Gabriel P, Jiang X et al : Coarse behavioral context decoding. J Neural Eng 16 : 016021, 2019
15) Bijanzadeh M, Khambhati AN, Desai M et al : Decoding naturalistic affective behaviour from spectro-spatial features in multiday human iEEG. Nat Hum Behav 6 : 823-836, 2022
16) Willett FR, Avansino DT, Hochberg LR et al : High-performance brain-to-text communication via handwriting. Nature 593 : 249-254, 2021
17) Angrick M, Herff C, Mugler E et al : Speech synthesis from ECoG using densely connected 3D convolutional neural networks. J Neural Eng 16 : 036019, 2019
18) Anumanchipalli GK, Chartier J, Chang EF : Speech synthesis from neural decoding of spoken sentences. Nature 568 : 493-498, 2019
19) Moses DA, Metzger SL, Liu JR et al : Neuroprosthesis for decoding speech in a paralyzed person with anarthria. N Engl J Med 385 : 217-227, 2021
20) Fukuma R, Yanagisawa T, Nishimoto S et al : Voluntary control of semantic neural representations by imagery with conflicting visual stimulation. Commun Biol 5 : 214, 2022
P.330 掲載の参考文献
1) Cloughesy TF, Petrecca K, Walbert T et al : Effect of vocimagene amiretrorepvec in combination with flucytosine vs standard of care on survival following tumor resection in patients with recurrent high-grade glioma : a randomized clinical trial. JAMA Oncol 6 : 1939-1946, 2020
2) Desjardins A, Gromeier M, Herndon JE 2nd et al : Recurrent glioblastoma treated with recombinant poliovirus. N Engl J Med 379 : 150-161, 2018
3) Friedman GK, Johnston JM, Bag AK et al : Oncolytic HSV-1 G207 immunovirotherapy for pediatric high-grade gliomas. N Engl J Med 384 : 1613-1622, 2021
4) Tamura R, Miyoshi H, Morimoto Y et al : Gene therapy using neural stem/progenitor cells derived from human induced pluripotent stem cells : visualization of migration and bystander killing effect. Hum Gene Ther 31 : 352-366, 2020
P.331 掲載の参考文献
5) Ge LJ, Yang FH, Li W et al : In vivo Neuroregeneration to treat ischemic stroke through NeuroD1 AAV-based gene therapy in adult non-human primates. Front Cell Dev Biol 8 : 590008, 2020
6) Zeng J, Wang Y, Luo Z et al : TRIM9-mediated resolution of neuroinflammation confers neuroprotection upon ischemic stroke in mice. Cell Rep 27 : 549-560, 2019
7) Rosenblad C, Li Q, Pioli EY et al : Vectormediated l-3,4-dihydroxyphenylalanine delivery reverses motor impairments in a primate model of Parkinson's disease. Brain 142 : 2402-2416, 2019
8) Nutt JG, Curtze C, Hiller A et al : Aromatic L-amino acid decarboxylase gene therapy enhances levodopa response in Parkinson's disease. Mov Disord 35 : 851-858, 2020
9) Ogden PJ, Kelsic ED, Sinai S et al : Comprehensive AAV capsid fitness landscape reveals a viral gene and enables machine-guided design. Science 366 : 1139-1143, 2019
10) Verdera HC, Kuranda K, Mingozzi F : AAV vector immunogenicity in humans : a long journey to successful gene transfer. Mol Ther 28 : 723-746, 2020
11) Chan YK, Wang SK, Chu CJ et al : Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses. Sci Transl Med 13 : eabd3438, 2021
12) Barnes C, Scheideler O, Schaffer D : Engineering the AAV capsid to evade immune responses. Curr Opin Biotechnol 60 : 99-103, 2019
13) Takahashi J : iPS cell-based therapy for Parkinson's disease : a Kyoto trial. Regen Ther 13 : 18-22, 2020
P.332 掲載の参考文献
14) Heinzen EL, Depondt C, Cavalleri GL et al : Exome sequencing followed by large-scale genotyping fails to identify single rare variants of large effect in idiopathic generalized epilepsy. Am J Hum Genet 91 : 293-302, 2012
15) Walker MC, Kullmann DM : Optogenetic and chemogenetic therapies for epilepsy. Neuropharmacology 168 : 107751, 2020
16) Kagiava A, Karaiskos C, Richter J et al : AAV9-mediated Schwann cell-targeted gene therapy rescues a model of demyelinating neuropathy. Gene Ther 28 : 659-675, 2021
17) Sahenk Z, Ozes B : Gene therapy to promote regeneration in Charcot-Marie-Tooth disease. Brain Res 1727 : 146533, 2020
18) Eggers R, de Winter F, Tannemaat MR et al : GDNF gene therapy to repair the injured peripheral nerve. Front Bioeng Biotechnol 8 : 583184, 2020
P.333 掲載の参考文献
19) Islamov R, Bashirov F, Fadeev F et al : Epidural stimulation combined with triple gene therapy for spinal cord injury treatment. Int J Mol Sci 21 : 8896, 2020
20) Leibinger M, Zeitler C, Gobrecht P et al : Transneuronal delivery of hyperinterleukin-6 enables functional recovery after severe spinal cord injury in mice. Nat Commun 12 : 391, 2021
21) Patel M, Li Y, Anderson J et al : Gsx1 promotes locomotor functional recovery after spinal cord injury. Mol Ther 29 : 2469-2482, 2021
22) Kessler JA, Shaibani A, Sang CN et al : Gene therapy for diabetic peripheral neuropathy : A randomized, placebo-controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor. Clin Transl Sci 14 : 1176-1184, 2021
X章 手術・手技
P.336 掲載の参考文献
1) Guo S, Wang Z, Kang X et al : A meta-analysis of endoscopic vs. microscopic transsphenoidal surgery for non-functioning and functioning pituitary adenomas : comparisons of efficacy and safety. Front Neurol 12 : 614382, 2021
P.337 掲載の参考文献
2) Dhandapani S, Narayanan R, Jayant SS et al : Endonasal endoscopic versus microscopic transsphenoidal surgery in pituitary tumors among the young : a comparative study & meta-analysis. Clin Neurol Neurosurg 200 : 106411, 2021
3) Dai W, Zhuang Z, Ling H et al : Systematic review and network meta-analysis assess the comparative efficacy and safety of transsphenoidal surgery for pituitary tumor. Neurosurg Rev 44 : 515-527, 2021
4) Chen J, Liu H, Man S et al : Endoscopic vs. microscopic transsphenoidal surgery for the treatment of pituitary adenoma : a meta-analysis. Front Surg 8 : 806855, 2021
5) Li K, Zhang J, Wang XS et al : A systematic review of effects and complications after transsphenoidal pituitary surgery : endoscopic versus microscopic approach. Minim Invasive Ther Allied Technol 29 : 317-325, 2020
6) Cannizzaro D, Tropeano MP, Milani D et al : Microsurgical versus endoscopic trans-sphenoidal approaches for clivus chordoma : a pooled and meta-analysis. Neurosurg Rev 44 : 1217-1225, 2021
P.338 掲載の参考文献
7) Yu S, Taghvaei M, Reyes M et al : Delayed symptomatic hyponatremia in trans-sphenoidal surgery : Systematic review and meta-analysis of its incidence and prevention with water restriction. Clin Neurol Neurosurg 214 : 107166, 2022
8) Lee CC, Wang YC, Liu YT et al : Incidence and factors associated with postoperative delayed hyponatremia after transsphenoidal pituitary surgery : a meta-analysis and systematic review. Int J Endocrinol 2021 : 6659152, 2021
9) Tomita Y, Kurozumi K, Inagaki K et al : Delayed postoperative hyponatremia after endoscopic transsphenoidal surgery for pituitary adenoma. Acta Neurochir (Wien) 161 : 707-715, 2019
10) Shah VS, Martinez-Perez R, Kreatsoulas D et al : Anatomic feasibility of endoscopic endonasal intracranial aneurysm clipping : a systematic review of anatomical studies. Neurosurg Rev 44 : 2381-2389, 2021
P.339 掲載の参考文献
11) Martinez-Perez R, Hardesty DA, Silveira-Bertazzo G et al : Safety and effectiveness of endoscopic endonasal intracranial aneurysm clipping : a systematic review. Neurosurg Rev 44 : 889-896, 2021
12) Sun S, Li Y, Zhang H et al : Neuroendoscopic surgery versus craniotomy for supratentorial hypertensive intracerebral hemorrhage : a systematic review and meta-analysis. World Neurosurg 134 : 477-488, 2020
13) Guo G, Pan C, Guo W et al : Efficacy and safety of four interventions for spontaneous supratentorial intracerebral hemorrhage : a network meta-analysis. J Neurointerv Surg 12 : 598-604, 2020
P.340 掲載の参考文献
14) Li D, Ravindra VM, Lam SK : Rigid versus flexible neuroendoscopy : a systematic review and meta-analysis of endoscopic third ventriculostomy for the management of pediatric hydrocephalus. J Neurosurg Pediatr 28 : 439-449, 2021
15) Soleman J, Guzman R : Neurocognitive complications after ventricular neuroendoscopy : a systematic review. Behav Neurol 2020 : 2536319, 2020
16) D'alessandris QG, Rigante M, Mattogno PP et al : Impact of 4K ultra-high definition endoscope in pituitary surgery : analysis of a comparative institutional case series. J Neurosurg Sci doi : 10.23736/S0390-5616.20.04875-4, 2020 [online ahead of print]
P.341 掲載の参考文献
17) Tsukamoto S, Kuchiba A, Moritani K et al : Laparoscopic surgery using 8 K ultrahigh-definition technology : outcomes of a phase II study. Asian J Endosc Surg 15 : 7-14, 2022
18) Yamashita H, Kobayashi E : Mechanism and design of a novel 8K ultra-high-definition video microscope for microsurgery. Heliyon 7 : e06244, 2021
19) Soldozy S, Young S, Yagmurlu K et al : Transsphenoidal surgery using robotics to approach the sella turcica : integrative use of artificial intelligence, realistic motion tracking and telesurgery. Clin Neurol Neurosurg 197 : 106152, 2020
20) Zappa F, Madoglio A, Ferrari M et al : Hybrid robotics for endoscopic transnasal skull base surgery : single-centre case series. Oper Neurosurg (Hagerstown) 21 : 426-435, 2021
P.342 掲載の参考文献
21) Koizumi S, Shiraishi Y, Makita I et al : A novel technique for fence-post tube placement in glioma using the robot-guided frameless neuronavigation technique under exoscope surgery : patient series. J Neurosurg Case Lessons 2 : CASE21466, 2021
P.343 掲載の参考文献
1) Ding D, Chen CJ, Starke RM et al : Risk of brain arteriovenous malformation hemorrhage before and after stereotactic radiosurgery. Stroke 50 : 1384-1391, 2019
P.344 掲載の参考文献
2) Hasegawa T, Kato T, Naito T et al : Long-term risks of hemorrhage and adverse radiation effects of stereotactic radiosurgery for brain arteriovenous malformations. Neurosurgery 90 : 784-792, 2022
3) Borcek AO, Celtikci E, Aksogan Y et al : Clinical outcomes of stereotactic radiosurgery for cerebral arteriovenous malformations in pediatric patients : systematic review and meta-analysis. Neurosurgery 85 : E629-E640, 2019
4) Chen CJ, Lee CC, Ding D et al : Stereotactic radiosurgery for unruptured versus ruptured pediatric brain arteriovenous malformations. Stroke 50 : 2745-2751, 2019
5) Chen CJ, Ding D, Lee CC et al : Stereotactic radiosurgery with versus without prior Onyx embolization for brain arteriovenous malformations. J Neurosurg 135 : 742-750, 2021
6) Chen CJ, Ding D, Lee CC et al : Embolization of brain arteriovenous malformations with versus without Onyx before Stereotactic radiosurgery. Neurosurgery 88 : 366-374, 2021
7) Mooney J, Erickson N, Salehani A et al : Seizure rates after stereotactic radiosurgery for cerebral AVMs : a single center study. World Neurosurg doi : 10.1016/j.wneu.2021.11.021, 2021 [online ahead of print]
P.345 掲載の参考文献
8) Hasegawa T, Kato T, Naito T et al : Long-term outcomes of sporadic vestibular schwannomas treated with recent stereotactic radiosurgery techniques. Int J Radiat Oncol Biol Phys 108 : 725-733, 2020
9) Kawashima M, Hasegawa H, Shin M et al : Outcomes of stereotactic radiosurgery in young adults with vestibular schwannomas. J Neurooncol 154 : 93-100, 2021
10) Wolf A, Naylor K, Tam M et al : Risk of radiation-associated intracranial malignancy after stereotactic radiosurgery : a retrospective, multicentre, cohort study. Lancet Oncol 20 : 159-164, 2019
P.346 掲載の参考文献
11) Martinez-Perez R, Florez-Perdomo W, Freeman L et al : Long-term disease control and treatment outcomes of stereotactic radiosurgery in cavernous sinus meningiomas. J Neurooncol 152 : 439-449, 2021
12) Umekawa M, Shinya Y, Hasegawa H et al : Long-term outcomes of stereotactic radiosurgery for skull base tumors involving the cavernous sinus. J Neurooncol 156 : 377-386, 2022
13) Graffeo CS, Link MJ, Stafford SL et al : Risk of internal carotid artery stenosis or occlusion after single-fraction radiosurgery for benign parasellar tumors. J Neurosurg 133 : 1388-1395, 2020
14) Bin Alamer O, Palmisciano P, Mallela AN et al : Stereotactic radiosurgery in the management of petroclival meningiomas : a systematic review and meta-analysis of treatment outcomes of primary and adjuvant radiosurgery. J Neurooncol 157 : 207-219, 2022
P.347 掲載の参考文献
15) Gendreau JL, Sheaffer K, Macdonald N et al : Stereotactic radiosurgery for cerebellopontine meningiomas : a systematic review and meta-analysis. Br J Neurosurg doi : 10.1080/02688697.2022.2064425, 2022 [online ahead of print]
16) El-Shehaby AMN, Reda WA, Abdel Karim KM et al : Hearing preservation after Gamma Knife radiosurgery for cerebellopontine angle meningiomas. J Neurosurg 129 (Suppl 1) : 38-46, 2018
17) Redmond KJ, De Salles AAF, Fariselli L et al : Stereotactic radiosurgery for postoperative metastatic surgical cavities : a critical review and International Stereotactic Radiosurgery Society (ISRS) practice guidelines. Int J Radiat Oncol Biol Phys 111 : 68-80, 2021
P.348 掲載の参考文献
18) Lehrer EJ, Peterson JL, Zaorsky NG et al : Single versus multifraction stereotactic radiosurgery for large brain metastases : an international meta-analysis of 24 trials. Int J Radiat Oncol Biol Phys 103 : 618-630, 2019
19) Myrehaug S, Hudson J, Soliman H et al : Hypofractionated stereotactic radiation therapy for intact brain metastases in 5 daily fractions : effect of dose on treatment response. Int J Radiat Oncol Biol Phys 112 : 342-350, 2022
P.349 掲載の参考文献
1) Khakhar R, You F, Chakkalakal D et al : Hands-free adjustment of the microscope in microneurosurgery. World Neurosurg 148 : e155-e163, 2021
2) Colasanti R, Giannoni L, Dallari S et al : Application of a scanner-assisted carbon dioxide laser system for neurosurgery. World Neurosurg 153 : e250-e258, 2021
3) Reichert D, Erkkilae MT, Gesperger J et al : Fluorescence lifetime imaging and spectroscopic co-validation for protoporphyrin IX-guided tumor visualization in neurosurgery. Front Oncol 11 : 741303, 2021
P.350 掲載の参考文献
4) Fiani B, Jarrah R, Griepp DW et al : The role of 3D exoscope systems in neurosurgery : an optical innovation. Cureus 13 : e15878, 2021
5) Montemurro N, Scerrati A, Ricciardi L et al : The exoscope in neurosurgery : an overview of the current literature of intraoperative use in brain and spine surgery. J Clin Med 11 : 223, 2021
6) Ricciardi L, Chaichana KL, Cardia A et al : The exoscope in neurosurgery : an innovative "point of view". A systematic review of the technical, surgical, and educational aspects. World Neurosurg doi : 10.1016/j.wneu.2018.12.202, 2019 [online ahead of print]
7) Burkhardt BW, Csokonay A, Oertel JM : 3D-exoscopic visualization using the VITOM-3D in cranial and spinal neurosurgery. What are the limitations? Clin Neurol Neurosurg 198 : 106101, 2020
8) Hafez A, Elsharkawy A, Schwartz C et al : Comparison of conventional microscopic and exoscopic experimental bypass anastomosis : a technical analysis. World Neurosurg 135 : e293-e299, 2020
9) Rubini A, Di Gioia S, Marchioni D : 3D exoscopic surgery of lateral skull base. Eur Arch Otorhinolaryngol 277 : 687-694, 2020
P.351 掲載の参考文献
10) Rotermund R, Regelsberger J, Osterhage K et al : 4K 3-dimensional video microscope system (orbeye) for transsphenoidal pituitary surgery. Acta Neurochir (Wien) 163 : 2097-2106, 2021
11) Maurer S, Prinz V, Qasem LE et al : Evaluation of a novel three-dimensional robotic digital microscope (Aeos) in neurosurgery. Cancers (Basel) 13 : 4273, 2021
12) Haeren R, Hafez A, Lehecka M : Visualization and maneuverability features of a robotic arm three-dimensional exoscope and operating microscope for clipping an unruptured intracranial aneurysm : video comparison and technical evaluation. Oper Neurosurg (Hagerstown) 22 : 28-34, 2022
P.352 掲載の参考文献
13) Hafez A, Haeren RHL, Dillmann J et al : Comparison of operating microscope and exoscope in a highly challenging experimental setting. World Neurosurg 147 : e468-e475, 2021
14) Piloni M, Bailo M, Gagliardi F et al : Resection of intracranial tumors with a robotic-assisted digital microscope : a preliminary experience with robotic scope. World Neurosurg 152 : e205-e211, 2021
15) Scaglioni MF, Meroni M, Fritsche E et al : Use of the BHS robotic scope to perform lymphovenous anastomosis. Microsurgery 41 : 298-299, 2021
16) Herlan S, Marquardt JS, Hirt B et al : 3D exoscope system in neurosurgery-comparison of a standard operating microscope with a new 3D exoscope in the cadaver lab. Oper Neurosurg (Hagerstown) 17 : 518-524, 2019
P.353 掲載の参考文献
17) Cenzato M, Fratianni A, Stefini R : Using a smartphone as an exoscope where an operating microscope is not available. World Neurosurg 132 : 114-117, 2019
P.354 掲載の参考文献
1) Widhalm G, Olson J, Weller J et al : The value of visible 5-ALA fluorescence and quantitative protoporphyrin IX analysis for improved surgery of suspected low-grade gliomas. J Neurosurg 133 : 79-88, 2020
P.355 掲載の参考文献
2) Kaneko S, Molina ES, Ewelt C et al : Fluorescence-based measurement of real-time kinetics of protoporphyrin IX after 5-aminolevulinic acid administration in human in situ malignant gliomas. Neurosurgery 85 : E739-E746, 2019
3) Suero Molina E, Kaneko S, Black D et al : 5-aminolevulinic acid-induced porphyrin contents in various brain tumors : implications regarding imaging device design and their validation. Neurosurgery 89 : 1132-1140, 2021
4) Jaber M, Ewelt C, Wolfer J et al : Is visible aminolevulinic acid-induced fluorescence an independent biomarker for prognosis in histologically confirmed (World health organization 2016) low-grade gliomas? Neurosurgery 84 : 1214-1224, 2019
5) Kaneko S, Suero Molina E, Sporns P et al : Fluorescence real-time kinetics of protoporphyrin IX after 5-ALA administration in low-grade glioma. J Neurosurg 136 : 9-15, 2021
P.356 掲載の参考文献
6) Muther M, Stummer W : Ependymal fluorescence in fluorescence-guided resection of malignant glioma : a systematic review. Acta Neurochir (Wien) 162 : 365-372, 2020
7) Marhold F, Mercea PA, Scheichel F et al : Detailed analysis of 5-aminolevulinic acid induced fluorescence in different brain metastases at two specialized neurosurgical centers : experience in 157 cases. J Neurosurg 133 : 1032-1043, 2019
8) Hussein A, Rohde V, Wolfert C et al : Survival after resection of brain metastases with white light microscopy versus fluorescence-guidence : a matched cohort analysis of the metastasys study data. Oncotarget 11 : 3026-3034, 2020
9) Mercea PA, Mischkulnig M, Kiesel B et al : Prognostic value of 5-ALA fluorescence, tumor cell infiltration and angiogenesis in the peritumoral brain tissue of brain metastases. Cancers 13 : 603, 2021
10) Katsevman GA, Turner RC, Urhie O et al : Utility of fluorescein for achieving resection targets in glioblastoma : increased gross- or near-total resections and prolonged survival. J Neurosurg 132 : 914-920, 2019
P.357 掲載の参考文献
11) Smith EJ, Gohil K, Thompson CM et al : Fluorescein-guided resection of high grade gliomas : a meta-analysis. World Neurosurg 155 : 181-188.e7, 2021
12) Hansen RW, Pederson CB, Halle B et al : Comparison of 5-aminolevulinic acid and sodium fluorescein for intraoperative tumor visualization in patients with high-grade gliomas : a single-center retrospective study. J Neurosurg 133 : 1324-1331, 2019
13) Neurosurgical Forum : LETTER TO THE EDITOR. J Neurosurg 133 : 1616-1633, 2020
14) Naik A, Smith EJ, Barreau A et al : Comparison of fluorescein sodium, 5-ALA and intraoperative MRI for resection of high-grade gliomas : a systematic review and network meta-analysis. J Clin Neurosci 98 : 240-247, 2022
P.358 掲載の参考文献
15) Cho SS, Salinas R, De Ravin E et al : Nearinfrared imaging with second-window indocyanine green in newly diagnosed high-grade gliomas predicts gadolinium resonance imaging. Mol Imaging Biol 22 : 1427-1437, 2020
16) Teng CW, Cho SS, Singh Y et al : Second window ICG predicts gross-total resection and progression-free survival during brain metastasis surgery. J Neurosurg 135 : 1026-1035, 2021
17) Erkkila MT, Reichert D, Gesperger J et al : Macroscopic fluorescence-lifetimeimaging of NADH and protoporphyrin IX improves the detection and grading of 5-aminolevulinic acid-stained brain tumors. Sci Rep 10 : 20492, 2020
18) Alfonso-Garcia A, Zhou X, Bec J et al : First in patient assessment of brain tumor infiltrative margins using simultaneous timeresolved measurements of 5-LA-induced PpIX fluorescence and tissue autofluorescence. J Biomed Opt 27 : 020501, 2022
19) Erkkila MT, Reichert D, Hecker-Denschlag N et al : Surgical microscope with integrated fluorescence lifetime imaging for 5-aminolevulinic acid fluorescence-guided neurosurgery. J Biomed Opt 25 : 1-7, 2020
20) Belykh E, Zhao X, Ngo B et al : Intraoperative confocal laser endomicroscopy ex vivo examination of tissue microstructure during fluorescence-guided brain tumor surgery. Front Oncol 10 : 599250, 2020
21) Hohne J, Schebesch KM, Zoubaa S et al : Intraoperative imaging of brain tumors with fluorescein : confocal laser endoscopy in neurosurgery. Clinical and user experience. Neurosurg Focus 50 : E19, 2021
22) Livermore LJ, Isabelle M, Bell IM et al : Raman spectroscopy to differenciate between fresh tissue samples of glioma and normal brain : a comparison with 5-ALA-induced fluorescence-guided surgery. J Neurosurg 135 : 469-479, 2021
P.359 掲載の参考文献
23) Patil CG, Walker DG, Miller DM et al : Phase 1 safety, pharmacokinetics, and fluorescence imaging study of tozuleristide (BLZ-100) in adults with newly diagnosed or recurrent gliomas. Neurosurgery 85 : E641-E649, 2019
24) Cho SS, Jeon J, Buch L et al : Intraoperative near-infrared imaging with receptorspecific versus passive delivery of fluorescent agents in pituitary adenomas. J Neurosurg 131 : 1974-1984, 2018
25) Kitagawa Y, Tanaka S, Kamiya M et al : A novel topical fluorescent probe for detection of glioblastoma. Clin Cancer Res 27 : 3936-3947, 2021
P.360 掲載の参考文献
1) Marbacher S, Halter M, Vogt DR et al : Value of 3-dimensional digital subtraction angiography for detection and classification of intracranial aneurysm remnants after clipping. Oper Neurosurg (Hagerstown) 21 : 63-72, 2021
P.361 掲載の参考文献
2) Marbacher S, Kienzler JC, Mendelowitsch I et al : Comparison of intra- and postoperative 3-dimensional digital subtraction angiography in evaluation of the surgical result after intracranial aneurysm treatment. Neurosurgery 87 : 689-696, 2020
3) Zhang Y, Tian Z, Li C et al : A modified endovascular treatment protocol for iatrogenic internal carotid artery injuries following endoscopic endonasal surgery. J Neurosurg 132 : 343-350, 2019
4) Jiang WJ, Liu AF, Yu W et al : Outcomes of Multimodality In situ Recanalization in Hybrid Operating Room (MIRHOR) for symptomatic chronic internal carotid artery occlusions. J Neurointerv Surg 11 : 825-832, 2019
5) Durner G, Wahler H, Braun M et al : The value of intraoperative angiography in the time of indocyanine green videoangiography in the treatment of cerebrovascular lesions : efficacy, workflow, risk-benefit and cost analysis A prospective study. Clin Neurol Neurosurg 205 : 106628, 2021
6) Shimada K, Yamaguchi T, Miyamoto T et al : Efficacy of intraarterial superselective indocyanine green videoangiography in cerebral arteriovenous malformation surgery in a hybrid operating room. J Neurosurg 134 : 1544-1552, 2020
P.362 掲載の参考文献
7) Bohoun CA, Naito K, Yamagata T et al : Safety and accuracy of spinal instrumentation surgery in a hybrid operating room with an intraoperative cone-beam computed tomography. Neurosurg Rev 42 : 417-426, 2019
8) Skyrman S, Lai M, Edstrom E et al : Augmented reality navigation for cranial biopsy and external ventricular drain insertion. Neurosurg Focus 51 : E7, 2021
9) Yavas G, Caliskan KE, Cagli MS : Three-dimensional-printed marker-based augmented reality neuronavigation : a new neuronavigation technique. Neurosurg Focus 51 : E20, 2021
10) Edstrom E, Burstrom G, Persson O et al : Does augmented reality navigation increase pedicle screw density compared to free-hand technique in deformity surgery? Single surgeon case series of 44 patients. Spine (Phila Pa 1976) 45 : E1085-e1090, 2020
P.363 掲載の参考文献
11) Scherer M, Ahmeti H, Roder C et al : Surgery for diffuse WHO grade II gliomas : volumetric analysis of a multicenter retrospective cohort from the German study group for intraoperative magnetic resonance imaging. Neurosurgery 86 : E64-E74, 2020
12) Yahanda AT, Patel B, Shah AS et al : Impact of intraoperative magnetic resonance imaging and other factors on surgical outcomes for newly diagnosed grade II astrocytomas and oligodendrogliomas : a multicenter study. Neurosurgery 88 : 63-73, 2020
P.364 掲載の参考文献
13) Golub D, Hyde J, Dogra S et al : Intraoperative MRI versus 5-ALA in high-grade glioma resection : a network meta-analysis. J Neurosurg doi : 103171/2019.12.JNS191203, 2020 [online ahead of print]
14) Fountain DM, Bryant A, Barone DG et al : Intraoperative imaging technology to maximise extent of resection for glioma : a network meta-analysis. Cochrane Database Syst Rev 1 : CD013630, 2021
P.365 掲載の参考文献
15) Shah AS, Yahanda AT, Sylvester PT et al : Using histopathology to assess the reliability of intraoperative magnetic resonance imaging in guiding additional brain tumor resection : a multicenter study. Neurosurgery 88 : E49-E59, 2020
16) Miskin N, Unadkat P, Carlton ME et al : Frequency and evolution of new postoperative enhancement on 3 Tesla intraoperative and early postoperative magnetic resonance imaging. Neurosurgery 87 : 238-246, 2020
17) Roder C, Haas P, Tatagiba M et al : Technical limitations and pitfalls of diffusionweighted imaging in intraoperative high-field MRI. Neurosurg Rev 44 : 327-334, 2021
18) Voglis S, Hiller A, Hofer AS et al : Failure of diffusion-weighted imaging in intraoperative 3 Tesla MRI to identify hyperacute strokes during glioma surgery. Sci Rep 11 : 16137, 2021
P.366 掲載の参考文献
19) Juthani RG, Reiner AS, Patel AR et al : Radiographic and clinical outcomes using intraoperative magnetic resonance imaging for transsphenoidal resection of pituitary adenomas. J Neurosurg 134 : 1824-1835, 2020
20) Soneru CP, Riley CA, Hoffman K et al : Intra-operative MRI vs endoscopy in achieving gross total resection of pituitary adenomas : a systematic review. Acta Neurochir (Wien) 161 : 1683-1698, 2019
21) Bezchlibnyk YB, Sharma VD, Naik KB et al : Clinical outcomes of globus pallidus deep brain stimulation for Parkinson disease : a comparison of intraoperative MRI- and MER-guided lead placement. J Neurosurg 134 : 1072-1082, 2020
P.367 掲載の参考文献
22) Ille S, Schroeder A, Wagner A et al : Intraoperative MRI-based elastic fusion for anatomically accurate tractography of the corticospinal tract : correlation with intraoperative neuromonitoring and clinical status. Neurosurg Focus 50 : E9, 2021
23) Tamura M, Kurihara H, Saito T et al : Combining pre-operative diffusion tensor images and intraoperative magnetic resonance images in the navigation is useful for detecting white matter tracts during glioma surgery. Front Neurol 12 : 805952, 2022
24) Oelschlagel M, Meyer T, Morgenstern U et al : Mapping of language and motor function during awake neurosurgery with intraoperative optical imaging. Neurosurg Focus 48 : E3, 2020
25) Eichberg DG, Shah AH, Di L et al : Stimulated Raman histology for rapid and accurate intraoperative diagnosis of CNS tumors : prospective blinded study. J Neurosurg doi : 10.3171/2019.9.JNS192075, 2019 [online ahead of print]
P.369 掲載の参考文献
1) Sollmann N, Krieg SM, Saisanen L et al : Mapping of motor function with neuronavigated transcranial magnetic stimulation : a review on clinical application in brain tumors and methods for ensuring feasible accuracy. Brain Sci 11 : 897, 2021
2) Aguilar-Salinas P, Gutierrez-Aguirre SF, Avila MJ et al : Current status of augmented reality in cerebrovascular surgery : a systematic review. Neurosurg Rev 45 : 1951-1964, 2022
3) Gosal JS, Tiwari S, Sharma T et al : Simulation of surgery for supratentorial gliomas in virtual reality using a 3D volume rendering technique : a poor man's neuronavigation. Neurosurg Focus 51 : E23, 2021
4) Xue Z, Kong L, Hao S et al : Combined application of sodium fluorescein and neuronavigation techniques in the resection of brain gliomas. Front Neurol 12 : 747072, 2021
P.370 掲載の参考文献
5) Tamura M, Kurihara H, Saito T et al : Combining pre-operative diffusion tensor images and intraoperative magnetic resonance images in the navigation is useful for detecting white matter tracts during glioma surgery. Front Neurol 12 : 805952, 2022
6) Barbagallo GMV, Altieri R, Garozzo M et al : High grade glioma treatment in elderly people : is it different than in younger patients? Analysis of surgical management guided by an intraoperative multimodal approach and its impact on clinical outcome. Front Oncol 10 : 631255, 2021
7) Alluhaybi AA, Altuhaini KS, Soualmi L et al : Thalamic tumors in a pediatric population : surgical outcomes and utilization of high-definition fiber tractography and the fiber tracking technique. Cureus 14 : e23611, 2022
8) Lim J, Park Y, Ahn JW et al : Maximal surgical resection and adjuvant surgical technique to prolong the survival of adult patients with thalamic glioblastoma. PLoS One 16 : e0244325, 2021
9) Patil NR, Dhandapani S, Sahoo SK et al : Differential independent impact of the intraoperative use of navigation and angled endoscopes on the surgical outcome of endonasal endoscopy for pituitary tumors : a prospective study. Neurosurg Rev 44 : 2291-2298, 2021
P.371 掲載の参考文献
10) Pennacchietti V, Stoelzel K, Tietze A et al : First experience with augmented reality neuronavigation in endoscopic assisted midline skull base pathologies in children. Childs Nerv Syst 37 : 1525-1534, 2021
11) Lakomkin N, Van Gompel JJ, Post KD et al : Fluorescence guided surgery for pituitary adenomas. J Neurooncol 151 : 403-413, 2021
12) Sas B, Pojskic M, Zivkovic D et al : Utilizing intraoperative navigated 3D color doppler ultrasound in glioma surgery. Front Oncol 11 : 656020, 2021
13) De Almeida Bastos DC, Juvekar P, Tie Y et al : Challenges and opportunities of intraoperative 3D ultrasound with neuronavigation in relation to intraoperative MRI. Front Oncol 11 : 656519, 2021
P.372 掲載の参考文献
14) Drakopoulos F, Tsolakis C, Angelopoulos A et al : Adaptive physics-based non-rigid registration for immersive image-guided neuronavigation systems. Front Digit Health 2 : 613608, 2021
15) Kendlbacher P, Tkatschenko D, Czabanka M et al : Workflow and performance of intraoperative CT, cone-beam CT, and robotic cone-beam CT for spinal navigation in 503 consecutive patients. Neurosurg Focus 52 : E7, 2022
16) Coric D, Rossi V : Percutaneous posterior cervical pedicle instrumentation (C1 to C7) with navigation guidance : early eeries of 27 eases. Global Spine J 12 (2_suppl) : 27S-33S, 2022
17) Kelly PD, Zuckerman SL, Yamada Y et al : Image-guidance in spine tumor surgery. Neurosurg Rev 43 : 1007-1017, 2020
18) Jannelli G, Moiraghi A, Paun L et al : Atlantoaxial posterior screw fixation using intra-operative spinal navigation with three-dimensional isocentric C-arm fluoroscopy. Int Orthop 46 : 321-329, 2022
19) Pojskic M, Bopp M, Sas B et al : Intraoperative computed tomography-based navigation with augmented reality for lateral approaches to the spine. Brain Sci 11 : 646, 2021
20) Kiessling JW, Ramnot A, Odell T et al : Use of O-arm with intraoperative arteriography for localization and stealth navigation of the vertebral arteries during posterior cervical spine surgery. Int J Spine Surg 14 : S10-S15, 2021
P.374 掲載の参考文献
1) Miro Llado J, Lopes-Ojeda P, Pedro J et al : Evaluation of multimodal intraoperative neurophysiologic monitoring during supratentorial aneurysm surgery : a comparative study. Neurosurg Rev 45 : 2161-2173, 2022
P.375 掲載の参考文献
2) Byoun HS, Oh CW, Kwon OK et al : Intraoperative neuromonitoring during microsurgical clipping for unruptured anterior choroidal artery aneurysm. Clin Neurol Neurosurg 186 : 105503, 2019
3) Lee JK, Choi JH, Shin YS : Multiple anterior choroidal arteries and perioperative ishemic complictions in unruptured anterior choroidal artery aneurysms treated with microsugical clipping. Acta Neurochir (Wien) 163 : 2947-2953, 2021
4) Li Z, Fan X, Wang M et al : Prediction of postoperative motor deficits using motor evoked potential deterioration duration in intracranial aneurysm surgery. Clin Neurophysiol 130 : 707-713, 2019
P.376 掲載の参考文献
5) Gurung P, Motoyama Y, Takatani T et al : Transient augumentation of intraoperative motor evoked potentials during middle cerebral artery aneurysm surgery. World Neurosurg 130 : e127-e132, 2019
6) Gogos AJ, Young JS, Morshed RA et al : Triple motor mapping : transcranial, bipolar, and monopolar mapping for supratentorial glioma resection adjacent to motor pathways. J Neurosurg 134 : 1728-1737, 2020
P.377 掲載の参考文献
7) Wang J, Guo L, Holdefer RN et al : Intraoperative neurophysiology and transcranial doppler for detection of cerebral ischemia and hyperperfusion during carotid endarterectomy. World Neurosurg 154 : e245-e253, 2021
8) Uno M, Yagi K, Takai H et al : Comparison of single and dual monitoring during carotid endarterectomy. Neurol Med Chir (Tokyo) 61 : 124-133, 2021
9) Nakagawa I, Park H, Kotsugi M et al : Diagnostic impact of monitoring transcranial motor-evoked potentials to prevent ischemic complications during endovascular treatment for intracranial aneurysms. Neurosurg Rev 44 : 1493-1501, 2021
P.378 掲載の参考文献
10) Tanaka S, Watanabe T, Takanashi J et al : Effect of compound muscle action potential after peripheral nerve stimulation normalization on anesthetic fade of intraoperative transcranial motor-evoked potential. J Clin Neurophysiol 38 : 306-311, 2021
11) Gonzalez AA, Akopian V, Lagoa I et al : Crossover phenomena in motor evoked potentials during intraoperative neurophysiological monitoring of cranial surgeries. J Clin Neurophsiol 36 : 236-241, 2019
P.379 掲載の参考文献
12) Takatani T, Motoyama Y, Park YS et al : Tetanic stimulation of the pudendal nerve prior to taranscranial electrical stimulation auguments the amplitude of motor evoked potentials during pediatric neurosurgery. J Neurosurg Pediatr 27 : 707-715, 2021
13) Yi YG, Kim K, Shin HI et al : Feasibility of intraoperative monitoring of motor evoked potentials abtained through transcranial electrical stimulation in infants younger than 3 months. J Neurosurg Pediatr 23 : 758-766, 2019
14) Roth J, Korn A, Sala F et al : Intraoperative neurophysiology in pediatric supratentorial surgery : experience with 57 cases. Childs Nerv Syst 36 : 315-324, 2020
P.380 掲載の参考文献
15) Qiao N, Yang X, Li C et al : The predictive value of intraoperative visual evoked potential for visual outcome after extended endoscopic endonasal surgery for adult craniopharyngioma. J Neurosurg 135 : 1714-1724, 2021
16) Tao N, Yang X, Fan X et al : Prediction of post-operative visual deterioration using visual-evoked potential latency in extended endoscopic endonasal resection of craniopharyngiomas. Front Neurol 12 : 753902, 2021
P.381 掲載の参考文献
17) Nakagawa I, Park HS, Kotsugi M et al : Diagnostic impact of monitoring visual evoked potentials to prevent visual complications during endovascular treatment for intracranial aneurysms. Front Neurol 13 : 761263, 2022
18) Suzuki Y, Enatsu R, Kanno A et al : The influence of anesthesia on corticocortical evoked potential monitoring network between frontal and temporoparietal cortices. World Neurosurg 123 : e685-e692, 2019
19) Yamao Y, Matsumoto R, Kunieda T et al : Effects of propofol in cortico-cortical evoked potentials in the dorsal language white matter pathway. Clin Neurophysiol 132 : 1919-1926, 2021
P.382 掲載の参考文献
20) Giampiccolo D, Parmigiani S, Basaldella F et al : Recording cortico-cortical evoked potentials of the human arcuate fasciculus under general anesthesia. Clin Neurophysiol 132 : 1966-1973, 2021
21) Yoshimoto T, Maruichi K, Itoh Y et al : Monitoring corticocortical evoked potentials during intracranial vascular surgery. World Neurosurg 122 : e947-e954, 2019
22) Momjian S, Tyrand R, Landis BN et al : Intraoperative monitoring of olfactory function : a feasibility study. J Neurosurg 132 : 1659-1664, 2019
P.383 掲載の参考文献
23) Ying T, Bao B, Yuan Y et al : Blink reflex monitoring in microvascular decompression for trigeminal neuralgia. Neurol Res 43 : 591-594, 2021
24) Hardian RF, Goto T, Fujii Y et al : Intraoperative facial motor evoked potential monitoring for pontine cavernous malformation resection. J Neurosurg 132 : 265-271, 2019
P.384 掲載の参考文献
25) Hiruta R, Sato T, Itakura T et al : Intraoperative transcranial facial motor evoked potential monitoring in surgery of cerebellopontine angle tumors predicts early and late postoperative facial nerve function. Clin Neurophysiol 132 : 864-871, 2021
26) Greve T, Wang L, Katzendobler S et al : Bilateral and optimistic warning paradigms improve the predictive power of intraoperative facial motor evoked potential during vestibular schwannoma surgery. Cancers (Basel) 13 : 6196, 2021
27) Kim M, Park SK, Lee S et al : Lateral spread response of different facial muscles during microvascular decompression in hemifacial spasm. Clin Neurophysiol 132 : 2503-2509, 2021
P.385 掲載の参考文献
28) Cho M, Ji SY, Go KO et al : The novel prognostic value of postoperative follow-up lateral spread response after microvascular decompression for hemifacial spasm. J Neurosurg doi : 10.3171/2021.3.JNS21137, 2021 [online ahead of print]
29) Nakayama Y, Kawaguchi T, Fukuda M et al : Intraoperative findings of abnormal muscle response for hemifacial spasm following botulinum neurotoxin treatment. Acta Neurochir (Wein) 163 : 3303-3309, 2021
30) Matsushima K, Kohno M, Ichimasu N et al : Intraoperative continuous vagus nerve monitoring with repetitive direct stimulation in surgery for jugular foramen tumors. J Neurosurg 135 : 1036-1043, 2021
P.386 掲載の参考文献
31) Tellez MJ, Mirallave-Pescador A, Seidel K et al : Neurophysiological monitoring of the laryngeal adductor reflex during cerebellar-pontine angle and braistem surgery. Clin Neurophysiol 132 : 622-631, 2021
32) Sarnthein J, Albisser C, Regli L : Transcranial electrical stimulation elicits short and long latency responses in the tongue muscles. Clin Neurophysiol 138 : 148-152, 2022
XI章 画像診断
P.388 掲載の参考文献
1) Grovik E, Yi D, Iv M et al : Deep learning enables automatic detection and segmentation of brain metastases on multisequence MRI. J Magn Reson Imaging 51 : 175-182, 2020
2) Hsu DG, Ballangrud A, Shamseddine A et al : Automatic segmentation of brain metastases using T1 magnetic resonance and computed tomography images. Phys Med Biol 66 : 10.1088/1361-6560/ac1835, 2021
3) Takao H, Amemiya S, Kato S et al : Deeplearning single-shot detector for automatic detection of brain metastases with the combined use of contrast-enhanced and non-enhanced computed tomography images. Eur J Radiol 144 : 110015, 2021
P.389 掲載の参考文献
4) Laukamp KR, Thiele F, Shakirin G et al : Fully automated detection and segmentation of meningiomas using deep learning on routine multiparametric MRI. Eur Radiol 29 : 124-132, 2019
5) Ranjbarzadeh R, Bagherian Kasgari A, Jafarzadeh Ghoushchi S et al : Brain tumor segmentation based on deep learning and an attention mechanism using MRI multimodalities brain images. Sci Rep 11 : 10930, 2021
6) Quon JL, Bala W, Chen L et al : Deep learning for pediatric posterior fossa tumor detection and classification : a multiinstitutional study. AJNR Am J Neuroradiol 41 : 1718-1725, 2020
7) McAvoy M, Prieto PC, Kaczmarzyk JR et al : Classification of glioblastoma versus primary central nervous system lymphoma using convolutional neural networks. Sci Rep 11 : 15219, 2021
8) Bangalore Yogananda CG, Shah BR, Vejdani-Jahromi M et al : A novel fully automated MRI-based deep-learning method for classification of IDH mutation status in brain gliomas. Neuro Oncol 22 : 402-411, 2020
9) Yogananda CGB, Shah BR, Nalawade SS et al : MRI-based deep-learning method for determining glioma MGMT promoter methylation status. AJNR Am J Neuroradiol 42 : 845-852, 2021
P.390 掲載の参考文献
10) Haim O, Abramov S, Shofty B et al : Predicting EGFR mutation status by a deep learning approach in patients with non-small cell lung cancer brain metastases. J Neurooncol 157 : 63-69, 2022
11) Tang Z, Xu Y, Jin L et al : Deep learning of imaging phenotype and genotype for predicting overall survival time of glioblastoma patients. IEEE Trans Med Imaging 39 : 2100-2109, 2020
12) Li Z C, Yan J, Zhang S et al : Glioma survival prediction from whole-brain MRI without tumor segmentation using deep attention network : a multicenter study. Eur Radiol 32 : 5719-5729, 2022
13) Maki S, Furuya T, Horikoshi T et al : A deep convolutional neural network with performance comparable to radiologists for differentiating between spinal schwannoma and meningioma. Spine (Phila Pa 1976) 45 : 694-700, 2020
14) Lemay A, Gros C, Zhuo Z et al : Automatic multiclass intramedullary spinal cord tumor segmentation on MRI with deep learning. Neuroimage Clin 31 : 102766, 2021
P.391 掲載の参考文献
15) Ye H, Gao F, Yin Y et al : Precise diagnosis of intracranial hemorrhage and subtypes using a three-dimensional joint convolutional and recurrent neural network. Eur Radiol 29 : 6191-6201, 2019
16) Shahzad R, Pennig L, Goertz L et al : Fully automated detection and segmentation of intracranial aneurysms in subarachnoid hemorrhage on CTA using deep learning. Sci Rep 10 : 21799, 2020
17) Nishi T, Yamashiro S, Okumura S et al : Artificial intelligence trained by deep learning can improve computed tomography diagnosis of nontraumatic subarachnoid hemorrhage by nonspecialists. Neurol Med Chir (Tokyo) 61 : 652-660, 2021
18) Kellogg RT, Vargas J, Barros G et al : Segmentation of chronic subdural hematomas using 3D convolutional neural networks. World Neurosurg 148 : e58-e65, 2021
19) Nazari-Farsani S, Nyman M, Karjalainen T et al : Automated segmentation of acute stroke lesions using a data-driven anomaly detection on diffusion weighted MRI. J Neurosci Methods 333 : 108575, 2020
20) Naganuma M, Tachibana A, Fuchigami T et al : Alberta Stroke Program Early CT Score calculation using the deep learning-based brain hemisphere comparison algorithm. J Stroke Cerebrovasc Dis 30 : 105791, 2021
21) Nael K, Gibson E, Yang C et al : Automated detection of critical findings in multiparametric brain MRI using a system of 3D neural networks. Sci Rep 11 : 6876, 2021
22) Wang T, Lei Y, Tian S et al : Learning-based automatic segmentation of arteriovenous fmalformations on contrast CT images in brain stereotactic radiosurgery. Med Phys 46 : 3133-3141, 2019
P.392 掲載の参考文献
23) Hao X, Xu L, Liu Y et al : Construction of diagnosis model of moyamoya disease based on convolution neural network algorithm. Comput Math Methods Med 2022 : 4007925, 2022
P.394 掲載の参考文献
1) Cosottini M, Roccatagliata L : Neuroimaging at 7 T : are we ready for clinical transition? Eur Radiol Exp 5 : 37, 2021
2) Regnery S, Behl NGR, Platt T et al : Ultrahigh-field sodium MRI as biomarker for tumor extent, grade and IDH mutation status in glioma patients. Neuroimage Clin 28 : 102427, 2020
3) Su J, Ni W, Yang B et al : Preliminary study on the application of ultrahigh field magnetic resonance in moyamoya disease. Oxid Med Cell Longev 2021 : 5653948, 2021
4) Opheim G, van der Kolk A, Bloch KM et al : 7T Epilepsy Task Force consensus recommendations on the use of 7T MRI in clinical practice. Neurology 96 : 327-341, 2021
5) Wang I, Oh S, Blumcke I et al : Value of 7T MRI and post-processing in patients with nonlesional 3T MRI undergoing epilepsy presurgical evaluation. Epilepsia 61 : 2509-2520, 2020
P.395 掲載の参考文献
6) Zong X, Lian C, Jimenez J et al : Morphology of perivascular spaces and enclosed blood vessels in young to middle-aged healthy adults at 7T : dependences on age, brain region, and breathing gas. Neuroimage 218 : 116978, 2020
7) Zhang H, Schneider T, Wheeler-Kingshott CA et al : NODDI : practical in vivo neurite orientation dispersion and density imaging of the human brain. Neuroimage 61 : 1000-1116, 2012
8) Broad RJ, Gabel MC, Dowell NG et al : Neurite orientation and dispersion density imaging (NODDI) detects cortical and corticospinal tract degeneration in ALS. J Neurol Neurosurg Psychiatry 90 : 404-411, 2019
P.396 掲載の参考文献
9) Taoka T, Aida N, Fujii Y et al : White matter microstructural changes in tuberous sclerosis : Evaluation by neurite orientation dispersion and density imaging (NODDI) and diffusion tensor images. Sci Rep 10 : 436, 2020
10) Hara S, Hori M, Ueda R et al : Unraveling specific brain microstructural damage in Moyamoya disease using diffusion magnetic resonance imaging and positron emission tomography. J Stroke Cerebrovasc. Dis 28 : 1113-1125, 2019
11) Churchill NW, Caverzasi E, Graham SJ et al : White matter during concussion recovery : comparing diffusion tensor imaging (DTI) and neurite orientation dispersion and density imaging (NODDI). Hum Brain Mapp 40 : 1908-1918, 2019
12) Kadota Y, Hirai T, Azuma M et al : Differentiation between glioblastoma and solitary brain metastasis using neurite orientation dispersion and density imaging. J Neuroradiol 47 : 197-202, 2020
13) Vogt NM, Hunt JF, Adluru N et al : Cortical microstructural alterations in mild cognitive impairment and Alzheimer's disease dementia. Cereb Cortex 30 : 2948-2960, 2020
P.397 掲載の参考文献
14) Bandt SK, de Rochefort L, Chen W et al : Clinical integration of quantitative susceptibility mapping magnetic resonance imaging into neurosurgical practice. World Neurosurg 122 : e10-e19, 2019
15) Uchida Y, Kan H, Inoue H et al : Penumbra detection with oxygen extraction fraction using magnetic susceptibility in patients with acute ischemic stroke. Front Neurol 13 : 752450, 2022
16) Ishii D, Nakagawa D, Zanaty M et al : Quantitative susceptibility mapping and vessel wall imaging as screening tools to detect microbleed in sentinel headache. J Clin Med 9 : 979, 2020
17) Nakagawa D, Kudo K, Awe O et al : Detection of microbleeds associated with sentinel headache using MRI quantitative susceptibility mapping : pilot study. J Neurosurg 130 : 1391-1397, 2019
18) Fan AP, Khalil AA, Fiebach JB et al : Elevated brain oxygen extraction fraction measured by MRI susceptibility relates to perfusion status in acute ischemic stroke. J Cereb Blood Flow Metab 40 : 539-551, 2020
P.398 掲載の参考文献
19) Koch KM, Nencka AS, Swearingen B et al : Acute post-concussive assessments of brain tissue magnetism using magnetic resonance imaging. J Neurotrauma 38 : 848-857, 2021
20) Ma D, Gulani V, Seiberlich N et al : Magnetic resonance fingerprinting. Nature 495 : 187-192, 2013
21) Ma D, Jones SE, Deshmane A et al : Development of high-resolution 3D MR fingerprinting for detection and characterization of epileptic lesions. J Magn Reson Imaging 49 : 1333-1346, 2019
22) Keil VC, Bakoeva SP, Jurcoane A et al : MR fingerprinting as a diagnostic tool in patients with frontotemporal lobe degeneration : a pilot study. NMR Biomed 32 : e4157, 2019
23) Chen Y, Lu L, Zhu T et al : Technical overview of magnetic resonance finger-printing and its applications in radiation therapy. Med Phys 49 : 2846-2860, 2022
24) Hamilton JI, Jiang Y, Ma D et al : Simultaneous multislice cardiac magnetic resonance fingerprinting using low rank reconstruction. NMR Biomed 32 : e4041, 2019
P.400 掲載の参考文献
1) 礒田治夫 : 4D-Flowの精度検証と解析アプリケーション. JJMRM 39 : 126-136, 2019
2) Dunas T, Holmgren M, Wahlin A et al : Accuracy of blood flow assessment in cerebral arteries with 4D flow MRI : evaluation with three segmentation methods. J Magn Reson Imaging 50 : 511-518, 2019
3) Wen B, Tian S, Cheng J et al : Test-retest multisite reproducibility of neurovascular 4D flow MRI. J Magn Reson Imaging 49 : 1543-1552, 2019
4) Birnefeld J, Wahlin A, Eklund A et al : Cerebral arterial pulsatility is associated with features of small vessel disease in patients with acute stroke and TIA : a 4D flow MRI study. J Neurol 267 : 721-730, 2020
P.401 掲載の参考文献
5) Orita E, Murai Y, Sekine T et al : Four-dimensional flow MRI analysis of cerebral blood flow before and after high-flow extracranial-intracranial bypass surgery with internal carotid artery ligation. Neurosurgery 85 : 58-64, 2019
6) Bolar DS, Gagoski B, Orbach D et al : Comparison of CBF measured with combined velocity-selective arterial spin-labeling and pulsed arterial spin-labeling to blood flow patterns assessed by conventional angiography in pediatric moyamoya. AJNR Am J Neuroradiol 40 : 1842-1849, 2019
P.402 掲載の参考文献
7) Abdel Razek AAK, Talaat M, El-Serougy L et al : Clinical applications of arterial spin labeling in brain tumors. J Comput Assist Tomogr 43 : 525-532, 2019
8) Pellerin A, Khalife M, Sanson M et al : Simultaneously acquired PET and ASL imaging biomarkers may be helpful in differentiating progression from pseudoprogression in treated gliomas. Eur Radiol 31 : 7395-7405, 2021
9) Abdel Razek AAK, El-Serougy L, Abdelsalam M et al : Differentiation of primary central nervous system lymphoma from glioblastoma : quantitative analysis using arterial-spin labeling and diffusion tensor imaging. World Neurosurg 123 : e303-e309, 2019
10) Kano Y, Inui S, Uchida Y et al : Quantitative arterial spin labeling magnetic resonance imaging analysis of reversible cerebral vasoconstriction syndrome : a case series. Headache 61 : 687-693, 2021
P.403 掲載の参考文献
11) Michels L, Villanueva J, O'Gorman R et al : Interictal hyperperfusion in the higher visual cortex in patients with episodic migraine. Headache 59 : 1808-1820, 2019
12) Lam J, Tomaszewski P, Gilbert G et al : The utility of arterial spin labeling in the presurgical evaluation of poorly defined focal epilepsy in children. J Neurosurg Pediatr 27 : 243-252, 2020
13) Puig O, Vestergaard MB, Lindberg U et al : Phase contrast mapping MRI measurements of global cerebral blood flow across different perfusion states-a direct comparison with 15O-H2O positron emission tomography using a hybrid PET/MR system. J Cereb Blood Flow Metab 39 : 2368-2378, 2019
P.404 掲載の参考文献
14) Ishii Y, Thamm T, Guo J et al : Simultaneous phase-contrast MRI and PET for noninvasive quantification of cerebral blood flow and reactivity in healthy subjects and patients with cerebrovascular disease. J Magn Reson Imaging 51 : 183-194, 2020
15) Yamada S, Ito H, Ishikawa M et al : Quantification of oscillatory shear stress from reciprocating CSF motion on 4D flow imaging. AJNR Am J Neuroradiol 42 : 479-486, 2021
16) Sakakibara Y, Yatsushiro S, Konta N et al : Respiratory-driven cyclic cerebrospinal fluid motion in the intracranial cavity on magnetic resonance imaging : insights into the pathophysiology of neurofluid dysfunction. Neurol Med Chir (Tokyo) 61 : 711-720, 2021
P.405 掲載の参考文献
17) Tarumi T, Yamabe T, Fukuie M et al : Brain blood and cerebrospinal fluid flow dynamics during rhythmic handgrip exercise in young healthy men and women. J Physiol 599 : 1799-1813, 2021
18) Yamada S : [Hydrocephalus]. No Shinkei Geka 49 : 317-327, 2021
19) Yamada S : Cerebrospinal fluid dynamics. Croat Med J 62 : 399-410, 2021
20) Klarica M, Rados M, Oreskovic D : The movement of cerebrospinal fluid and its relationship with substances behavior in cerebrospinal and interstitial fluid. Neuroscience 414 : 28-48, 2019
21) Taoka T, Naganawa S : Neurofluid dynamics and the glymphatic system : a neuroimaging perspective. Korean J Radiol 21 : 1199-1209, 2020
22) Zhou Y, Cai J, Zhang W et al : Impairment of the glymphatic pathway and putative meningeal lymphatic vessels in the aging human. Ann Neurol 87 : 357-369, 2020
23) Wong SM, Backes WH, Drenthen GS et al : Spectral diffusion analysis of intravoxel incoherent motion MRI in cerebral small vessel disease. J Magn Reson Imaging 51 : 1170-1180, 2020
24) Ohene Y, Harrison IF, Nahavandi P et al : Non-invasive MRI of brain clearance pathways using multiple echo time arterial spin labelling : an aquaporin-4 study. Neuroimage 188 : 515-523, 2019
25) Oshio K, Yui M, Shimizu S et al : The spatial distribution of water components with similar T2 may provide insight into pathways for large molecule transportation in the brain. Magn Reson Med Sci 20 : 34-39, 2021
P.406 掲載の参考文献
1) Kitakami K, Kubo Y, Yabuki M et al : Five-year outcomes of medical management alone for adult patients with ischemic moyamoya disease without cerebral misery perfusion. Cerebrovasc Dis 51 : 158-164, 2022
2) Oomori D, Kubo Y, Yabuki M et al : Angiographic disease progression in medically treated adult patients with ischemic moyamoya disease without cerebral misery perfusion : supplementary analysis of a 5-year prospective cohort. Neurosurg Rev 45 : 1553-1561, 2022
3) Ogasawara K, Uchida S, Akamatsu Y et al : Outcomes of medical management alone for adult patients with cerebral misery perfusion due to ischemic moyamoya diseas. J Stroke Cerebrovasc Dis 31 : 106588, 2022
P.407 掲載の参考文献
4) Arai N, Horiguchi T, Takahashi S et al : Hemodynamic stress distribution identified by SPECT reflects ischemic symptoms of Moyamoya disease patients. Neurosurg Rev 43 : 1323-1329, 2020
5) Takahashi S, Horiguchi T : Relationship between ischaemic symptoms during the early postoperative period in patients with moyamoya disease and changes in the cerebellar asymmetry index. Clin Neurol Neurosurg 197 : 106090, 2020
6) Uchino H, Kazumata K, Ito M et al : Crossed cerebellar diaschisis as an indicator of severe cerebral hyperperfusion after direct bypass for moyamoya disease. Neurosurg Rev 44 : 599-605, 2021
7) Kameyama M, Fujimura M, Tashiro R et al : Significance of quantitative cerebral blood flow measurement in the acute stage after revascularization surgery for adult moyamoya disease : implication for the pathological threshold of local cerebral hyperperfusion. Cerebrovasc Dis 48 : 217-225, 2019
P.408 掲載の参考文献
8) Kanoke A, Fujimura M, Tashiro R et al : Transient global cerebral hypoperfusion as a characteristic cerebral hemodynamic pattern in the acute stage after combined revascularization surgery for pediatric moyamoya disease : N-isopropyl-p- [123I] iodoamphetamine single-photon emission computed tomography study. Cerebrovasc Dis 51 : 453-460, 2022
9) Uchida S, Kubo Y, Oomori D et al : Long-term cognitive changes after revascularization surgery in adult patients with ischemic moyamoya disease. Cerebrovasc Dis Extra 11 : 145-154, 2021
10) Ando T, Shimada Y, Fujiwara S et al : Revascularisation surgery improves cognition in adult patients with moyamoya disease. J Neurol Neurosurg Psychiatry 91 : 332-334, 2020
P.409 掲載の参考文献
11) Hara S, Kudo T, Hayashi S et al : Improvement in cognitive decline after indirect bypass surgery in adult moyamoya disease_implication of 15O-gas positron emission tomography. Ann Nucl Med 34 : 467-475, 2020
12) Kimura K, Kubo Y, Dobashi K et al : Angiographic, cerebral hemodynamic, and cognitive outcomes of indirect revascularization surgery alone for adult patients with misery perfusion due to ischemic moyamoya disease. Neurosurgery 90 : 676-683, 2022
13) Yasuda S, Katakura Y, Kubo Y et al : Recovery of cortical neurotransmitter receptor function and its impact on cognitive improvement after indirect revascularization surgery alone for adult patients with ischemic moyamoya disease : 123I-iomazenil single-photon emission computed tomography study. World Neurosurg doi : 10.1016/j.wneu.2022.05.118, 2022 [online ahead of print]
P.410 掲載の参考文献
14) Hara S, Seida M, Kumagai K et al : Beneficial effect of carotid artery stenting on cerebral hemodynamic impairment and cognitive function. Neurol Med Chir (Tokyo) 60 : 66-74, 2020
15) Shimada Y, Kobayashi M, Yoshida K et al : Reduced hypoxic tissue and cognitive improvement after revascularization surgery for chronic cerebral ischemia. Cerebrovasc Dis 47 : 57-64, 2019
16) Sato S, Fujiwara S, Miyoshi K et al : Improvement in gait function after carotid endarterectomy is associated with postoperative recovery in perfusion and neurotransmitter receptor function in the motor-related cerebral cortex : a 123I-iomazenil SPECT study. Nucl Med Commun. 41 : 1161-1168, 2020
17) Kubo Y, Koji T, Murakami T et al : Long-term outcomes of cerebral blood flow and neurotransmitter receptor function on iodine-123-iomazenil single-photon emission computed tomography and cognitive assessments after parent artery occlusion combined with cerebral revascularization for internal carotid artery aneurysms. World Neurosurg 143 : e199-e205, 2020
P.411 掲載の参考文献
1) Hasegawa H, Shin M, Kin T et al : Fully endoscopic minimally invasive tumor resection for cystic cerebellar hemangioblastoma. World Neurosurg 126 : 484-490, 2019
2) Tel A, Bagatto D, Tuniz F et al : The evolution of craniofacial resection : a new workflow for virtual planning in complex craniofacial procedures. J Craniomaxillofac Surg 47 : 1475-1483, 2019
3) Filimonov A, Zeiger J, Goldrich D et al : Virtual reality surgical planning for endoscopic endonasal approaches to the craniovertebral junction. Am J Otolaryngol 43 : 103219, 2022
P.412 掲載の参考文献
4) Yoshino M, Kin T, Hara T : Usefulness of high-resolution three-dimensional multifusion medical imaging for preoperative planning in patients with cerebral arteriovenous malformation. World Neurosurg 124 : e755-e763, 2019
5) Wang B, Chen Y, Mo J et al : Preoperative evaluation of neurovascular relationships for microvascular decompression : Visualization using Brainvis in patients with idiopathic trigeminal neuralgia. Clin Neurol Neurosurg 210 : 106957, 2021
6) Kuribara T, Mikami T, Komatsu K et al : Preoperatively estimated graft flow rate contributes to the improvement of hemodynamics in revascularization for Moyamoya disease. J Stroke Cerebrovasc Dis 30 : 105450, 2021
7) Uzunoglu I, Kizmazoglu C, Husemoglu RB et al : Three-dimensional printing assisted preoperative surgical planning for cerebral arteriovenous malformation. J Korean Neurosurg Soc 64 : 882-890, 2021
8) Uchikawa H, Kin T, Takeda Y et al : Correlation of inflow velocity ratio detected by phase contrast magnetic resonance angiography with the bleb color of unruptured intracranial aneurysms. World Neurosurg X 10 : 100098, 2021
9) Steineke TC, Barbery D : Microsurgical clipping of middle cerebral artery aneurysms : preoperative planning using virtual reality to reduce procedure time. Neurosurg Focus 51 : E12, 2021
10) Uchida T, Kin T, Koike T et al : Identification of the facial colliculus in two-dimensional and three-dimensional images. Neurol Med Chir (Tokyo) 61 : 376-384, 2021
11) Gosal JS, Tiwari S, Sharma T et al : Simulation of surgery for supratentorial gliomas in virtual reality using a 3D volume rendering technique : a poor man's neuronavigation. Neurosurg Focus 51 : E23, 2021
12) Koike T, Tanaka S, Kin T et al : Accurate preoperative identification of motor speech area as termination of arcuate fasciculus depicted by Q-ball imaging tractography. World Neurosurg doi : 10.1016/j.wnew.2022.05.041, 2022 [online ahead of print]
13) Yamada K, Tanaka Y, Sumita K et al : Computational fluid dynamics analysis of the offending artery at sites of neurovascular compression in trigeminal neuralgia using preoperative MRI data. Neurol Med Chir (Tokyo) 59 : 415-422, 2019
P.413 掲載の参考文献
14) Zawy Alsofy S, Nakamura M, Suleiman A et al : Cerebral anatomy detection and surgical planning in patients with anterior skull base meningiomas using a virtual reality technique. J Clin Med 10 : 681, 2021
15) Zawy Alsofy S, Sakellaropoulou I, Stroop R : Evaluation of surgical approaches for tumor resection in the deep infratentorial region and impact of virtual reality technique for the surgical planning and strategy. J Craniofac Surg 31 : 1865-1869, 2020
16) Sugiyama T, Clapp T, Nelson J et al : Immersive 3-dimensional virtual reality modeling for case-specific presurgical discussions in cerebrovascular neurosurgery. Oper Neurosurg (Hagerstown) 20 : 289-299, 2021
17) Perin A, Galbiati TF, Ayadi R et al : Informed consent through 3D virtual reality : a randomized clinical trial. Acta Neurochir (Wien) 163 : 301-308, 2021
18) Zawy Alsofy S, Sakellaropoulou I, Nakamura M et al : Impact of virtual reality in arterial anatomy detection and surgical planning in patients with unruptured anterior communicating artery aneurysms. Brain Sci 10 : 963, 2020
P.415 掲載の参考文献
19) Zawy Alsofy S, Saravia HW, Nakamura M et al : Virtual reality-based evaluation of neurovascular conflict for the surgical planning of microvascular decompression in trigeminal neuralgia patients. Neurosurg Rev 44 : 3309-3321, 2021
P.416 掲載の参考文献
20) Dundar TT, Yurtsever I, Pehivanoglu MK et al : Machine learning-based surgical planning for neurosurgery : artificial intelligent approaches to the cranium. Front Surg 9 : 863633, 2022
21) Wu CT, Yang YH, Chang YZ : Three-dimensional deep learning to automatically generate cranial implant geometry. Sci Rep 12 : 2683, 2022
最近チェックした商品履歴
Loading...